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Experimental Section 
General. All solvents used in the reactions were purified before use. Dry diethyl ether, 
tetrahydrofuran, and toluene were distilled from sodium and benzophenone, whereas dry CH2Cl2, 
dimethylformamide, methanol, ethyl acetate, benzene, and triethylamine were distilled from CaH2. 
Distilled petroleum ether (petroleum ether) with a boiling range of 40–60 °C was used. Reactions 
were generally run under argon or nitrogen atmosphere. All commercially available compounds 
(Acros, Aldrich, Fluka, Merck) were used without purification. 
1
H and 
13
C NMR: Bruker Avance 
400, spectra were recorded at 295 K; chemical shifts are calibrated to the residual proton and carbon 
resonance of the solvent: CDCl3 (δH 7.25, δC 77.0 ppm), MeOD (δH 3.30, δC 49.0 ppm), DMSO-
d6 (δH 2.49, δC 39.5 ppm). HRMS (FT-ICR): Bruker Daltonic APEX 2 with electron spray 
ionization(ESI). Column chromatography: J. T. Baker silica gel 43–60 µm. Thin-layer 
chromatography: Machery-Nagel Polygram Sil G/UV254. Optical rotations: JASCO Polarimeter P-
1020, sodium D line (589 nm), c = g × 100 mL
–1
. From the depsipeptides 22 onwards, chondramide 
A numbering was used. 
 
 
Procedures for Scheme 2 
 
Me
CO2Me
9bMe
CHO
Ph3P=CHCO2Me
CH2Cl2, rt, 3 d10b
(98%)  
 
(E)-Methyl 3-p-tolylacrylate (9b). To a solution of 4-methylbenzaldehyde (10b) (2.00 g, 16.6 
mmol) in CH2Cl2 (65 mL) was added methyl (triphenylphosphoranylidene)acetate (6.66 g, 19.9 
mmol) in one portion. The mixture was stirred at room temperature for 3 d and then concentrated in 
vacuo. The residue containing Ph3P=O and the acrylate was purified by flash chromatography 
(petroleum ether/EtOAc, 20:1) to give the cinnamate
1,2
 9b (2.73 g, 96%) as a colorless solid, m.p. = 
85 °C. Rf = 0.34 (petroleum ether/EtOAc, 20:1); 
1
H NMR (400 MHz, CDCl3): δ = 2.36 (s, 3H, 
CH3), 3.79 (s, 3H, OCH3), 6.39 (d, J = 16.0 Hz, 1H, 2-H), 7.18 (d, J = 8.1 Hz, 2H, Ar), 7.41 (d, J = 
8.1 Hz, 2H, Ar), 7.66 (d, J = 16.0 Hz, 1H, 3-H); 
13
C NMR (100 MHz, CDCl3): δ = 21.4 (CH3), 51.6 
(OCH3), 116.7 (C-2), 128.0 (Ar), 129.6 (Ar), 131.6 (Ar), 140.7 (Ar), 144.8 (C-3), 167.6 (CO); 
HRMS (ESI): m/z: calcd for C11H12O2 [M+Na]
+
: 199.07295; found: 199.072842. 
 
 
MeO
CO2Me
9cMeO
CHO
Ph3P=CHCO2Me
CH2Cl2, rt, 3 d10c
(96%)  
 
(E)-Methyl 3-(4-methoxyphenyl)acrylate (9c). To a solution of anisaldehyde 10c (2.00 g, 14.7 
mmol) in CH2Cl2 (60 mL) was added methyl (triphenylphosphoranylidene)acetate (5.90 g, 17.6 
mmol) in one portion. The mixture was stirred at room temperature for 3 d and then concentrated in 
vacuo. The residue containing Ph3P=O and the acrylate was purified by flash chromatography 
(petroleum ether/EtOAc, 5:1) to give the cinnamate
1
 9c (2.73 g, 96%) as a colorless solid, m.p. = 86 
°C. Rf = 0.38 (petroleum ether/EtOAc, 5:1); 
1
H NMR (400 MHz, CDCl3): δ = 3.78 (s, 3H, OCH3), 
3.82 (s, 3H, OCH3), 6.30 (d, J = 16.0 Hz, 1H, 2-H), 6.89 (d, J = 8.9 Hz, 2H, Ar), 7.46 (d, J = 8.7 
Hz, 2H, Ar), 7.64 (d, J = 15.8 Hz, 1H, 3-H); 
13
C NMR (100 MHz, CDCl3): δ = 51.5 (OCH3), 55.3 
                                                 
1
 M. Hatsuda, T. Kuroda, M. Seki, Synth. Commun. 2003, 33, 427-434. 
2
 G. Moyna, H. J. Williams, A. I. Scott, Synth. Commun. 1996, 26, 2235-2239. 
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(OCH3), 114.3 (Ar), 115.2 (C-2), 127.1 (Ar), 129.7 (Ar), 144.5 (C-3), 161.4 (CO), 167.7 (CO); 
HRMS (ESI): m/z: calcd for C11H12O3 [M+Na]
+
: 215.06787; found: 215.06788. 
 
 
F
CO2Me
9dF
CHO
Ph3P=CHCO2Me
CH2Cl2, rt, 3 d10d
(94%)  
 
(E)-Methyl 3-(4-fluorophenyl)acrylate (9d). To a solution of 4-fluorobenzaldehyde (10d) (2.00 g, 
16.1 mmol) in CH2Cl2 (65 mL) was added methyl (triphenylphosphoranylidene)acetate (6.45 g, 
19.3 mmol) in one portion. The mixture was stirred at room temperature for 3 d and then 
concentrated in vacuo. The residue containing Ph3P=O and the acrylate was purified by flash 
chromatography (petroleum ether/EtOAc, 20:1) to give the cinnamate
2,3
 9d (2.73 g, 94%) as a 
colorless solid, m.p. = 74 °C. Rf = 0.29 (petroleum ether/EtOAc, 20:1); 
1
H NMR (400 MHz, 
CDCl3): δ = 3.79 (s, 3H, OCH3), 6.34 (d, J = 16.0 Hz, 1H, 2-H), 7.06 (dd, J = 8.7, 8.7 Hz, 2H, Ar), 
7.49 (dd, J = 8.6 Hz, 2H, Ar), 7.64 (d, J = 16.0 Hz, 1H, 3-H); 
13
C NMR (100 MHz, CDCl3): δ = 
51.7 (OCH3), 115.6 (d, J = 22.0 Hz, Ar), 117.5 (d, J = 2.2 Hz, C-2), 129.9 (d, J = 8.8 Hz, Ar), 130.6 
(d, J = 3.7 Hz, Ar), 143.5 (C-3), 163.9 (d, J = 251.0 Hz, Ar), 167.3 (CO); HRMS (ESI): m/z: calcd 
for C10H9FO2 [M+Na]
+
: 203.04788; found: 203.04768. 
 
 
O2N
CHO
O2N
CO2Me
1. CH2(CO2H)2, pyridine
EtOH, reflux
2. SOCl2, MeOH
reflux (93%)
10e 9e  
 
(E)-Methyl 4-nitrocinnamate (9e) (by Knoevenagel reaction). A solution of nitrobenzaldehyde 
(1.51 g, 0.01 mol), malonic acid (1.14 g, 1.1 equiv), and pyridine (0.25 mL, 0.31 equiv) in ethanol 
(2 mL) was heated at reflux. Already after 10–15 min a white solid began to precipitate. After 1.5 h, 
when TLC (EtOAc/petroleum ether, 1:2) indicated complete consumption of the aldehyde, the 
reaction mixture was cooled and acidified with diluted aqueous HCl. The precipitate was filtered, 
washed with water and dried in vacuo to afford crude but pure (2E)-3-(4-nitrophenyl)acrylic acid in 
quantitative yield (note: the free acid is soluble in acetone, DMSO, but hardly soluble in CH2Cl2, 
EtOAc). It was taken up in methanol (20 mL), thionyl chloride (1.3 equiv) was carefully added and 
the resulting suspension was heated at reflux for 1 h. At this time TLC (EtOAc/petroleum ether, 
1:2) indicated complete consumption of the acid and the volume of precipitates visually increased. 
The product was obtained by crystallization directly from the reaction mixture as follows. The 
reaction mixture was concentrated in vacuo till a thick suspension resulted, that was filtered on a 
glass frit and the precipitate was washed with a small amount of cold methanol to afford 1.52 g 
(93%) of pure methyl (2E)-3-(4-nitrophenyl)acrylate (9e) as a slightly yellow solid. Analytical data 
are in agreement with literature data.
4
 
 
 
(81%)
O2N
CHO
O2N
CO2Me
10e 9e
Ph3P=CHCO2Me
CH2Cl2, rt
 
 
                                                 
3
 (a) M. Beck, S. Jaunich, A. W. Frahm, Arch. Pharm. 1986, 319, 29-37; (b) G. Xie, P. Chellan, J. Mao, K. Chibale, G. 
S. Smith, Adv. Synth. Catal. 2010, 352, 1641-1647. 
4
 Z. Zhang, Z. Wang, J. Org. Chem. 2006, 71, 7485-7487. 
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(E)-Methyl 4-nitrocinnamate (9e) (by Wittig reaction). Taking advantage of the low solubility of 
the product in cold methanol, the following one-step Wittig reaction procedure was efficiently 
applied. A solution of nitrobenzaldehyde (1.51 g, 0.01 mol), methyl 
(triphenylphosphoranylidene)acetate (4.0 g, 1.2 equiv) in CH2Cl2 (20 mL) was stirred overnight 
(slighty exothermic at the beginning) at room temperature. Then it was concentrated in vacuo to 
dryness, the residue was suspended in a small amount of methanol, enough to dissolve the bulk of 
triphenylphosphineoxide, the precipitate was filtered and washed with cold methanol to afford pure 
methyl (2E)-3-(4-nitrophenyl)acrylate (9e) (1.68 g, 81%). 
 
 
(99%)
Ph
CHO
Ph
CO2Me
10k 9k
Ph3P=CHCO2Me
CH2Cl2, rt
 
 
(E)-Methyl 4-phenylcinnamate (9k). This was obtained by the same procedure as (2E)-3-(4-
nitrophenyl)acrylate (9e). Thus, a solution of 4-biphenylcarbaldehyde (10k) (1.09 g, 6.0 mmol) and 
methyl (triphenylphosphoranylidene)acetate (2.40 g, 1.2 equiv) in CH2Cl2 (15 mL) was stirred at 
room temperature overnight. To monitor the progress of the reaction, a small sample was taken, 
evaporated and directly analyzed by NMR. (If the reaction was not finished completely, then 
additional methyl (triphenylphosphoranylidene)acetate should be added to achieve complete 
conversion.) The mixture was concentrated in vacuo to dryness, the residue was suspended in a 
small amount of methanol (but enough to dissolve the bulk of triphenylphosphineoxide), the 
precipitate was filtered and washed with cold methanol to afford pure methyl (2E)-methyl 4-
phenylcinnamate (9k) (1.42 g, 99%). The analytical data were in agreement with previously 
reported data.
5
 
 
 
OHC
Br
Pd(OAc)2 (0.04 mol%)
CH2=CHCO2Me
NMP, 120 °C, 1 h (99%)
OHC
CO2Me
13g12  
 
(E)-Methyl 4-formylcinnamate (13). A dry Schlenk vessel was charged with anhydrous NaOAc 
(2.7 g, 33.0 mmol), p-bromobenzaldehyde (5.55 g, 30.0 mmol), Pd(OAc)2 (2.6 mg, 0.04% mol) and 
anhydrous NMP (40 mL). Nitrogen atmosphere was applied and methyl acrylate (3.9 mL, 43.3 
mmol, 1.4 equiv) was introduced via syringe and the reaction mixture was heated at 115–120 °C for 
40–60 min to complete the reaction (TLC control EtOAc/petroleum ether, 1:4, Rf 0.45). The 
resulting orange to red solution containing a white precipitate was diluted with water (100 mL) and 
extracted with ethyl acetate (2 × 70 mL). The combined organic layers were washed twice with 
water, once with saturated NaCl solution, dried over Na2SO4, and filtered. The solvent was 
evaporated in vacuo to leave crude methyl (2E)-3-(4-formylphenyl)acrylate (5.63 g, 99%) as a 
yellow solid, which was almost pure and was used in synthesis of cinnamate 9g without further 
purification. The analytical data were in agreement with the previously reported ones.
6
 
 
 
OHC
CO2Me
13
CO2Me
9g
1. NaBH4, MeOH
rt, 1 h
2. TBSCl, imid.
CH2Cl2, rt, 1 h
OTBS(82%)  
 
                                                 
5
 R. Imashiro, M. Seki, J. Org. Chem. 2004, 69, 4216-4226. 
6
 A. R. Hajipour, K. Karami, A. Pirisedigh, A. E. Ruoho, J. Organomet. Chem. 2009, 694, 2548-2554. 
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(E)-Methyl 4-[tert-butyldimethylsilyloxymethyl]cinnamate (9g). To a stirred solution of methyl 
(2E)-3-(4-formylphenyl)acrylate (13) (1.48 g, 7.8 mmol) in methanol (10 mL) was added NaBH4 
(0.3 g, 7.9 mmol) portionwise. The reaction mixture was stirred for 1 h at room temperature, and 
then it was concentrated, diluted with water and extracted with EtOAc. The organic phase was 
washed with saturated NaCl solution, dried with Na2SO4, filtered, and evaporated to afford crude 
benzyl alcohol (1.42 g, quantitative yield, TLC: EtOAc/petroleum ether, 1:2, Rf 0.2). The alcohol 
was dissolved in dry CH2Cl2 (10 mL) and TBSCl (1.22 g, 8.1 mmol, 1.1 equiv) was added. Then, 
imidazole (0.554 g, 8.1 mmol, 1.1 equiv) was added portionwise while cooling the reaction flask in 
a cold water bath. The reaction mixture was stirred for 1 h at room temperature (TLC: 
EtOAc/petroleum ether, 1:2, Rf 0.8), the precipitate was filtered off and washed with portions of 
EtOAc. The filtrate was concentrated and the residue purified by flash chromatography 
(EtOAc/petroleum ether, 1:10) through a short column to afford the title compound (1.95 g, 82%) as 
an oil which crystallizes upon standing. 
1
H NMR (400 MHz, CDCl3): δ = 0.09 (s, 6H, SiCH3), 0.94 
(s, 9H, C(CH3)3), 3.79 (s, 3H, OCH3), 4.74 (s, 2H, CH2O), 6.41 (d, J = 16.0 Hz, 1H), 7.33 (d, J = 
8.1 Hz, 2H, Ar), 7.48 (d, J = 8.1 Hz, 2H, Ar), 7.68 (d, J = 16.0 Hz, 1H); 
13
C NMR (100 MHz, 
CDCl3): δ = –5.3 (SiCH3), 18.4 (C(CH3)3), 25.9 (C(CH3)3), 51.7 (OCH3), 64.6 (CH2Ar), 117.2, 
126.4 (2C, Ar), 128.0 (2C, Ar), 133.0 (quat.), 144.1 (quat.), 144.8, 167.6 (CO2CH3). 
 
 
NC
CO2Me
9i
NC
Br
Pd(OAc)2 (0.04 mol%)
CH2=CHCO2Me
NMP, 120 °C, 1 h (99%)11  
 
(E)-Methyl 3-(4-cyanophenyl)acrylate (9i). This compound was prepared from p-
bromobenzonitrile by the same procedure as described for (2E)-3-(4-formylphenyl)acrylate in 
quantitative yield. Thus, a dry Schlenk vessel was charged with anhydrous NaOAc (0.9 g, 11 
mmol), p-bromobenzonitrile (1.82 g, 10.0 mmol), Pd(OAc)2 (1.0 mg, 0.04% mol) and anhydrous 
NMP (10 mL). Nitrogen atmosphere was applied and methyl acrylate (1.4 mL, 15.5 mmol, 1.55 
equiv) was introduced via syringe and the reaction mixture was heated at 115–120 °C for 40–60 
min to complete the reaction (TLC control: EtOAc/petroleum ether, 1:2, Rf 0.53). The resulting 
slightly orange solution containing a white precipitate was diluted with water (30 mL) and extracted 
with ethyl acetate (2 × 25 mL). The combined organic layers were washed twice with water, once 
with saturated NaCl solution, dried over Na2SO4, and filtered. The solvent was evaporated in vacuo 
to leave crude acrylate 9i (1.91 g, 100%) as a slightly yellow solid (TLC: EtOAc/petroleum ether, 
1:2, Rf 0.53). Analytical data were in agreement with previously reported ones.
6
 
 
 
Br
CO2H 14
Br
OTBS
1. LiAlH4, THF
rt, 12 h
2. TBSCl, imid.
CH2Cl2, rt, 1 h
(53%)
15
 
 
1-Bromo-4-[(2-tert-butyldimethylsilyloxy)ethyl]benzene (15). To a solution of 2-(4-
bromophenyl)acetic acid (14) (4.30 g, 20.0 mmol) in absolute THF (40 mL) was slowly added 
LiAlH4 (0.608 g, 16.0 mmol, 0.8 equiv) while cooling the reaction flask in a cold water bath. The 
reaction mixture was stirred at room temperature overnight (actually, this may be too much), then 
water (2 mL) was carefully added, the resulting suspension was diluted with EtOAc, the precipitate 
was filtered off (using a paper filter) and washed three times with portions of EtOAc. The filtrate 
was concentrated and diluted with a small amount of CH2Cl2. This mixture was filtered and the 
filtrate concentrated in vacuo to leave the crude alcohol as slightly turbid oil (2.94 g, 73%). The 
crude alcohol was dissolved in CH2Cl2 (20 mL), TBSCl (2.31 g, 15.3 mmol, 1.05 equiv) was added 
 6
and imidazole (1.09 g, 16.0 mmol, 1.1 equiv) was added portionwise while cooling the reaction 
flask in a cold water bath. The reaction mixture was stirred for 1 h at room temperature (TLC 
control: EtOAc/petroleum ether, 1:2), the precipitate was filtered off, the filtrate was concentrated 
and the residue purified by flash chromatography (EtOAc/petroleum ether, 1:10) to afford silyl 
ether 15 (3.31 g, 72%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = –0.04 (s, 6H, SiCH3), 
0.85 (s, 9H, C(CH3)3), 2.75 (t, J = 6.8 Hz, 2H, ArCH2), 3.79 (s, 3H, OCH3), 3.76 (t, J = 6.8 Hz, 2H, 
CH2O), 7.07 (d, J = 8.4 Hz, 2H, Ar), 7.38 (d, J = 8.4 Hz, 2H, Ar). 
 
 
Br
OTBS
nBuLi, THF, –90 °C
DMF, 1 h
15
CHO
OTBS 16 OTBS 9h
CO2Me
(83%)
Ph3P=CHCO2Me
CH2Cl2, rt
 
 
(E)-Methyl 3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)acrylate (9h). To a solution of aryl 
bromide 15 (2.629 g, 8.34 mmol) in absolute THF (35 mL) was added butyllithium (3.2 mL of a 
2.5M solution in hexane, 1.05 equiv) dropwise at –90 °C followed by stirring of the mixture at –90–
80 °C for 1 h. Then the reaction mixture was cooled to –100 °C and DMF (1.29 mL, 16.7 mmol, 2 
equiv) was introduced quickly in one portion by syringe. The cooling bath was removed and the 
mixture was allowed to warm to –10 °C within 30 min and quenched with saturated aqueous NH4Cl 
solution. Some EtOAc was added to the mixture to allow for better phase separation. The organic 
layer was washed with saturated NaCl solution, dried with MgSO4, filtered, and concentrated in 
vacuo to afford crude aldehyde 16 in essentially quantitative yield as colorless oil which was used 
in the next step without purification (the reaction was practically clean). 
To the solution of crude aldehyde 16 in dry CH2Cl2 (20 mL) was added methyl 
(triphenylphosphoranylidene)acetate (3.0 g, 8.98 mmol) and the mixture was stirred overnight at 
room temperature. The reaction was conveniently controlled by NMR. The reaction mixture was 
concentrated in vacuo and the residue subjected to flash chromatography (petroleum ether/EtOAc, 
4:1) to yield the cinnamic ester 9h (2.01 g, 83% from bromide 15) as a colorless oil. It should be 
noted, that complete conversion should be checked, otherwise it is much more difficult to separate 
cinnamate 9g from the starting aldehyde 16 by chromatography. Rf (petroleum ether/EtOAc, 2:1) 
0.75; 
1
H NMR (400 MHz, CDCl3): δ = –0.04 (s, 6H, SiCH3), 0.85 (s, 9H, C(CH3)3), 2.82 (t, J = 6.9 
Hz, 2H, ArCH2), 3.79 (s, 3H, OCH3), 3.80 (t, J = 6.9 Hz, 2H, CH2O), 6.40 (d, J = 16.0 Hz, 1H, 2-
H), 7.22 (d, J = 8.1 Hz, 2H, Ar), 7.43 (d, J = 8.1 Hz, 2H, Ar), 7.67 (d, J = 16.0 Hz, 1H, 3-H); 
13
C 
NMR (100 MHz, CDCl3): δ = –5.5 (SiCH3), 18.3 (C(CH3)3), 25.9 (C(CH3)3), 39.4, 51.6 (OCH3), 
64.1 (CH2Ar), 117.0 (=CH), 128.0 (Car), 129.8 (Car), 132.3 (Car), 142.1 (Car), 144.9 (=CH), 167.6 
(CO2CH3). 
 
Procedures for Scheme 3 
 
Me
CO2Me
9b
Me
CO2Me
OH
OH
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2 17b
5 h (80%)  
 
(2S,3R)-Methyl 2,3-dihydroxy-3-p-tolylpropanoate (17b). To a mixture of K3Fe(CN)6 (1.68 g, 
5.11 mmol), (DHQD)2PHAL (13.0 mg, 0.017 mmol) and K2CO3 (0.71 g, 5.11 mmol) in 
tBuOH/H2O (16 mL, 1:1) were added K2OsO2(OH)4 (3.0 mg, 0.007 mmol) and MeSO2NH2 (0.162 
g, 1.70 mmol). The mixture was stirred for 15 min, then cooled to 0 °C before cinnamate 9b (0.30 
 7
g, 1.7 mmol) was added in one portion. The mixture was now stirred for 5 h while it warmed to 
room temperature. Thereafter, solid Na2SO3 (1.3 g), water (8 mL) and EtOAc (15 mL) were added. 
After separation of the layers, the aqueous phase was extracted with EtOAc (2 × 15 mL). The 
combined organic layers were washed with cold 1N NaOH solution (15 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude diol was purified by flash chromatography 
(petroleum ether/EtOAc, 1:1) providing diol
7
 17b (0.288 g, 80%) as a colorless solid, m.p. = 85 °C 
(ref.
7
 m.p. 97.5–99 °C). Rf (petroleum ether/EtOAc, 3:2) 0.32; [α]
20
D = –8.2 (c 1.00, CH2Cl2) {ref.
7
 
ent-17b [α]
25
D = +6.3 (c 1.00, EtOH)}; 
1
H NMR (400 MHz, CDCl3): δ = 2.34 (s, 3H, CH3), 2.76 (d, 
J = 7.1 Hz, 1H, OH), 3.13 (d, J = 6.1 Hz, 1H, OH), 3.80 (s, 3H, OCH3), 4.34 (dd, J = 6.1, 3.1 Hz, 
1H, 2-H), 4.98 (dd, J = 7.1, 2.8 Hz, 1H, 3-H), 7.17 (d, J = 7.9 Hz, 2H, Ar), 7.27 (d, J = 8.1 Hz, 2H, 
Ar); 
13
C NMR (100 MHz, CDCl3): δ = 21.1 (CH3), 52.8 (OCH3), 74.3 (C-3), 74.1 (C-2), 126.1 (Ar), 
129.1 (Ar), 136.1 (Ar), 137.8 (Ar), 173.2 (CO); HRMS (ESI): m/z: calcd for C11H14O4 [M+Na]
+
: 
233.07843; found: 233.07837. 
 
 
MeO
CO2Me
9c
MeO
CO2Me
OH
OH
tBuOH/H2O, 0 
οC to rt
K2OsO2(OH)4
(DHQD)2PHAL, NMO
17c
(89%)  
 
(2S,3R)-Methyl 2,3-dihydroxy-3-(4-methoxyphenyl)propanoate (17c). To a solution of 
cinnamate 9c (1.00 g, 5.20 mmol) in t-BuOH (4 mL) were added successively (DHQD)2PHAL 
(18.0 mg, 0.026 mmol) and NMO (0.774 g, 5.57 mmol, 60% solution in H2O, 1.24 mL). The 
mixture was cooled to 0 °C before K2OsO2(OH)4 (4.0 mg, 0.01 mmol) was added. The cooling bath 
was removed and the mixture stirred for 2 h at room temperature. Then solid Na2SO3 (0.8 g), water 
(4 mL) and EtOAc (10 mL) were added. After separation of the layers, the aqueous phase was 
extracted with EtOAc (2 × 20 mL). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated in vacuo. The crude diol was purified by flash chromatography (petroleum 
ether/EtOAc, 1:1) providing diol 17c (1.05 g, 89%) as a colorless solid, m.p. = 103 °C (ref.
7
 m.p. 
106–107 °C). [α]
20
D = –5.8 (c 1.00, CH2Cl2) {ref.
7
 ent-17c [α]
25
D = +5.5 (c 1.00, EtOH)}; 
1
H NMR 
(400 MHz, CDCl3): δ = 2.92 (bs, 2H, 2 × OH), 3.78 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 4.31 (d, J = 
3.1 Hz, 1H, 2-H), 4.93 (d, J = 3.1 Hz, 1H, 3-H), 6.88 (d, J = 8.7 Hz, 2H, Ar), 7.31 (d, J = 8.4 Hz, 
2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.8 (OCH3), 55.2 (OCH3), 74.1 (C-3), 74.8 (C-2), 
113.8 (Ar), 127.5 (Ar), 132.0 (Ar), 159.4 (Ar), 173.2 (CO); HRMS (ESI): m/z: calcd for C11H14O5 
[M+Na]
+
: 249.07334; found: 249.07327. 
 
 
F
CO2Me
9d
F
CO2Me
OH
OH
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2 17d
2 h (72%)  
 
(2S,3R)-Methyl 3-(4-fluorophenyl)-2,3-dihydroxypropanoate (17d). To a mixture of K3Fe(CN)6 
(2.19 g, 6.66 mmol), (DHQD)2PHAL (17.0 mg, 0.022 mmol) and K2CO3 (0.92 g, 6.66 mmol) in 
tBuOH/H2O (22 mL, 1:1) were added K2OsO2(OH)4 (3.3 mg, 0.009 mmol) and MeSO2NH2 (0.211 
g, 2.22 mmol). The mixture was stirred for 15 min, then cooled to 0 °C before cinnamate 9d (0.40 
g, 2.22 mmol) was added in one portion. The mixture was now stirred for 2 h while it warmed to 
                                                 
7
 P. Liu, W. He, Y. Zhao, P.-A. Wang, X.-L. Sun, X.-Y. Li, S.-Y. Zhang, Chirality 2008, 20, 75-83. 
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room temperature. Thereafter, solid Na2SO3 (1.7 g), water (10 mL) and EtOAc (20 mL) were added. 
After separation of the layers, the aqueous phase was extracted with EtOAc (2 × 15 mL). The 
combined organic layers were washed with cold 1N NaOH solution (15 mL), dried over Na2SO4, 
filtered, and concentrated in vacuo. The crude diol was purified by flash chromatography 
(petroleum ether/EtOAc, 1:1) providing diol 17d (0.345 g, 72%) as a colorless solid, m.p. = 74 °C 
(ref.
7
 m.p. 61.5–62.5 °C). Rf (petroleum ether/EtOAc, 3:2) 0.32; [α]
20
D = –8.6 (c 1.00, CH2Cl2) 
{ref.
7
 ent-17d [α]
25
D = +9.1 (c 1.00, EtOH)}; 
1
H NMR (400 MHz, CDCl3): δ = 2.95 (d, J = 6.9 Hz, 
1H, OH), 3.27 (d, J = 6.1 Hz, 1H, OH), 3.78 (s, 3H, OCH3), 4.30 (dd, J = 6.1, 3.1 Hz, 1H, 2-H), 
4.96 (dd, J = 6.9, 3.1 Hz, 1H, 3-H), 7.00–7.07 (m, 2H, Ar), 7.33–7.38 (m, 2H, Ar); 
13
C NMR (100 
MHz, CDCl3): δ = 52.9 (OCH3), 73.8 (C-3), 74.6 (C-2), 115.3 (d, J = 21.2 Hz, Ar), 128.0 (d, J = 8.1 
Hz, Ar), 135.7 (d, J = 2.9 Hz, Ar), 162.5 (d, J = 246.6 Hz, Ar), 173.0 (CO); HRMS (ESI): m/z calcd 
for C10H11FO4 [M+Na]
+
: 237.05336; found: 237.05334. 
 
 
O2N
CO2Me
OH
OH
17e
O2N
CO2Me
9e
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2
8–9 h (39%)  
 
(2S,3R)-Methyl 3-(4-cyanophenyl)-2,3-dihydroxypropanoate (17e). A mixture of K3Fe(CN)6 
(7.22 g, 22.0 mmol, 3 equiv), K2CO3 (3.04 g, 22.0 mmol, 3 equiv), MeSO2NH2 (0.70 g, 7.37 mmol, 
1 equiv), K2OsO2(OH)4 (10 mg, 0.027 mmol, 0.0037 equiv), and the ligand (DHQD)2PHAL (57 
mg, 0.073 mmol, 0.01 equiv) was stirred in a mixture of water (35 mL) and tBuOH (35 mL) until 
dissolved and then the solution was cooled to 0 °C in an ice bath. At this point cinnamate 9e (1.52 
g, 7.34 mmol) was added and the reaction mixture was allowed to reach room temperature slowly 
while being stirred overnight, at which time a yellow suspension was formed and complete or 
almost complete conversion was observed according to TLC (petroleum ether/EtOAc, 1:1). Then 
solid Na2SO3 (9.2 g, 73.4 mmol, 10 equiv) was added and the mixture was stirred for several min. 
The suspension was filtered, and the filter cake was washed with EtOAc. The filtrate was 
transferred to a separatory funnel, the organic phase was separated, and the water phase was 
extracted twice with EtOAc. The combined organic extracts were washed with saturated NaCl 
solution, dried with Na2SO4, filtered, and evaporated. The residue was purified by flash 
chromatography (CH2Cl2/MeOH, 95:5) to afford pure diol 17e (0.698 g, 39%) as a colorless solid.  
 
Sometimes it was difficult to purify the diol from CH3SO3NH2 (as a contaminant in different 
compounds comes at δ = 3.08–3.10 (s, 3H), 4.67–4.79 (bs, 2H)), but the sulfone amide impurity did 
not influence the next Mitsunobu azidation as was established later. 
1
H NMR (400 MHz, CDCl3): δ 
= 2.81 (bs, 1H, OH), 3.13 (bs, 1H, OH), 3.86 (s, 3H, OCH3), 4.39 (bs, 1H, 2-H), 5.14 (bs, 1H, 3-H), 
7.59 (d, J = 8.4 Hz, 2H, Ar), 8.23 (d, J = 8.4 Hz, 2H, Ar). 
 
In one experiment, after extraction of the reaction mixture with THF/EtOAc, the organic extract 
was concentrated (but not till dyness) and some precipitate (the salt), insoluble in EtOAc, was 
isolated by filtration. It was taken up in diluted HCl and extracted with EtOAc. Upon evaporation of 
the solvent, white crystals were obtained, soluble in EtOAc, but insoluble in CHCl3, that was 
proved to be an acid, the product of saponification of 17e. 
1
H NMR (400 MHz, DMSO-d6): δ = 4.16 
(d, J = 2.8 Hz, 1H, 2-H), 5.04 (d, J = 2.8 Hz, 1H, 3-H), 7.65 (d, J = 8.6 Hz, 2H, Ar), 8.17 (d, J = 8.6 
Hz, 2H, Ar). 
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CO2Me
OH
OH
17g
OTBS
CO2Me
9g
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2, KHCO3
8–9 h (93%)OTBS  
 
(2S,3R)-Methyl 3-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-2,3-dihydroxypropanoate 
(17g). Representative procedure. A mixture of K3Fe(CN)6 (3.68 g, 11.2 mmol, 3 equiv), K2CO3 
(1.54 g, 11.2 mmol, 3 equiv), KHCO3 (0.374 g, 3.74 mmol, 1 equiv), MeSO2NH2 (0.356 g, 3.74 
mmol, 1 equiv), K2OsO2(OH)4 (14 mg, 0.038 mmol, 0.01 equiv), and the ligand (DHQD)2PHAL 
(44 mg, 0.056 mmol, 0.015 equiv) was stirred in a mixture of water (18 mL) and tBuOH (18 mL) 
until dissolved and then the solution was cooled to 0 °C in an ice bath. At this point cinnamate 9g 
(1.15 g, 3.74 mmol) was added and the reaction mixture was allowed to reach room temperature 
slowly while being stirred for 8–9 h, at which time a yellow suspension was formed and complete 
or almost complete conversion was observed according to TLC (petroleum ether/EtOAc, 1:1). Then 
solid Na2SO3 (1.74 g, 13.8 mmol, 3.7 equiv) was added and the mixture was stirred for several min. 
The suspension was filtered, and the filter cake was washed with EtOAc. The filtrate was 
transferred to a separatory funnel, the organic phase was separated, and the water phase was 
extracted twice with EtOAc. The combined organic extracts were washed with saturated NaCl 
solution, dried with Na2SO4, filtered, and evaporated. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, gradient 2:1 → 1:1 → 0:1) to afford pure diol 17g (1.18 
g, 93%) as a colorless oil. [α]
20
D = –3.8 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = –0.09 
(s, 6H, SiCH3), 0.93 (s, 9H, C(CH3)3), 2.68 (d, J = 7.1 Hz, 1H, OH), 3.06 (d, J = 6.1 Hz, 1H, OH), 
3.81 (s, 3H, OCH3), 4.36 (dd, J = 2.7, 6.1 Hz, 1H, 2-H), 4.73 (s, 2H, CH2O), 5.00 (dd, J = 2.7, 6.4 
Hz, 1H, 3-H), 7.32 (d, J = 8.4 Hz, 2H, Ar), 7.36 (d, J = 8.4 Hz, 2H, Ar); HMRS (ESI): m/z: calcd 
for C17H28O5Si: 363.15982 [M+Na]
+
; found: 363.15993. 
 
 
CO2Me
OH
OH
17h
CO2Me
9h
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2
8–9 h (77%)OTBS OTBS  
 
(2S,3R)-Methyl 3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2,3-dihydroxypropanoate 
(17g). A mixture of K3Fe(CN)6 (6.17 g, 18.8 mmol, 3.16 equiv), K2CO3 (2.60 g, 18.8 mmol, 3.16 
equiv), MeSO2NH2 (0.596 g, 6.3 mmol, 1.1 equiv), K2OsO2(OH)4 (9 mg, 0.024 mmol, 0.004 
equiv), and the ligand (DHQD)2PHAL (49 mg, 0.063 mmol, 0.01 equiv) was stirred in a mixture of 
water (30 mL) and tBuOH (30 mL) until dissolved and then the solution was cooled to 0 °C in an 
ice bath. At this point cinnamate 9h (1.90 g, 5.94 mmol) was added and the reaction mixture was 
allowed to reach room temperature slowly while being stirred overnight, at which time a yellow 
suspension was formed and complete or almost complete conversion was observed according to 
TLC (petroleum ether/EtOAc, 1:1). Then solid Na2SO3 (9.4 g, 74.6 mmol, 12.5 equiv) was added 
and the mixture was stirred for several minutes. The suspension was filtered, and the filter cake was 
washed with EtOAc. The filtrate was transferred to a separatory funnel, the organic phase was 
separated, and the water phase was extracted twice with EtOAc. The combined organic extracts 
were washed with saturated NaCl solution, dried with Na2SO4, filtered, and evaporated. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, gradient 2:1 → 1:1) to afford pure 
diol 17h (1.62 g, 77%) as a colorless oil. Rf (petroleum ether/EtOAc, 1:1) 0.53; [α]
20
D = –7.1 (c 
1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = –0.02 (s, 6H, SiCH3), 0.86 (s, 9H, C(CH3)3), 2.81 
(t, J = 7.1 Hz, 2H, ArCH2), 3.10 (brs, 1H, OH), 3.78 (t, J = 7.1 Hz, 2H, CH2OTBS), 3.80 (s, 3H, 
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OCH3), 4.34 (d, J = 2.8 Hz, 1H, 2-H), 4.99 (d, J = 2.8 Hz, 1H, 3-H), 7.20 (d, J = 8.4 Hz, 2H, Ar), 
7.28 (d, J = 8.4 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.4 (SiCH3), 18.3 (C(CH3)3), 25.9 
(C(CH3)3), 39.2 (ArCH2), 52.8 (OCH3), 64.4 (CH2O), 74.2, 74.7, 126.1 (2C, Ar), 129.3 (2C, Ar), 
137.7 (Cquat), 139.1 (Cquat), 173.2 (CO2CH3); HMRS (ESI): m/z: calcd for C18H30O5Si: 377.17547 
[M+Na]
+
; found: 377.17549. 
 
 
NC
CO2Me
OH
OH
17i
NC
CO2Me
9i
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2
8–9 h (42%)  
 
(2S,3R)-Methyl 3-(4-cyanophenyl)-2,3-dihydroxypropanoate (17i). A mixture of K3Fe(CN)6 
(9.84 g, 30 mmol, 3 equiv), K2CO3 (4.14 g, 30 mmol, 3 equiv), MeSO2NH2 (0.95 g, 10 mmol, 1 
equiv), K2OsO2(OH)4 (15 mg, 0.04 mmol, 0.004 equiv), and the ligand (DHQD)2PHAL (78 mg, 0.1 
mmol, 0.01 equiv) was stirred in a mixture of water (50 mL) and tBuOH (50 mL) until dissolved 
and then the solution was cooled to 0 °C in an ice bath. At this point cinnamate 9i (1.87 g, 10.0 
mmol) was added and the reaction mixture was allowed to reach room temperature slowly while 
being stirred overnight, at which time a yellow suspension was formed and complete or almost 
complete conversion was observed according to TLC (petroleum ether/EtOAc, 1:1). Then solid 
Na2SO3 (15 g, 119 mmol, 12 equiv) was added and the mixture was stirred for several min. The 
suspension was filtered, and the filter cake was washed with EtOAc. The filtrate was transferred to 
a separatory funnel, the organic phase was separated, and the water phase was extracted twice with 
EtOAc. The combined organic extracts were washed with saturated NaCl solution, dried with 
Na2SO4, filtered, and evaporated. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, gradient 1:1 → 0:1) to afford pure diol 17i (0.93 g, 42%) as a white solid. Analytical 
data are in agreement with previously reported.
8
 With this diol it turned out to be more difficult to 
separate it from CH3SO3NH2. The diol has limited solubility in EtOAc and CH2Cl2, but good 
solubility in acetone and methanol. 
 
 
Ph
CO2Me
OH
OH
17k
Ph
CO2Me
9k
tBuOH/H2O, 0 
οC to rt
K3Fe(CN)6, K2CO3
K2OsO2(OH)4
(DHQD)2PHAL
MeSO2NH2
8–9 h (47%)  
 
(2S,3R)-Methyl 3-(4-cyanophenyl)-2,3-dihydroxypropanoate (17k). A mixture of K3Fe(CN)6 
(5.78 g, 17.6 mmol, 3.7 equiv), K2CO3 (2.03 g, 14.7 mmol, 3.1 equiv), KHCO3 (1.18 g, 11.8 mmol, 
2.5 equiv), MeSO2NH2 (0.167 g, 1.76 mmol, 0.37 equiv), K2OsO2(OH)4 (6.5 mg, 0.0177 mmol, 
0.0038 equiv), and the ligand (DHQD)2PHAL (22.9 mg, 0.0294 mmol, 0.0063 equiv) was stirred in 
a mixture of water (28 mL) and tBuOH (28 mL) until dissolved and then the solution was cooled to 
0 °C in an ice bath. At this point cinnamate 9k (1.12 g, 4.7 mmol) was added and the reaction 
mixture was allowed to reach room temperature slowly while being stirred overnight, but complete 
conversion was not reached. After work up as previously, a crude mixture (0.937 g), containing 
49% w/w of unreacted cinnamate, 11% w/w MeSO2NH2 and 17k was obtained, that was subjected 
to a second round of oxidation with K3Fe(CN)6 (1.90 g, 5.79 mmol, 3 equiv), K2CO3 (0.67 g, 4.9 
mmol, 2.5 equiv), KHCO3 (0.39 g, 3.9 mmol, 2 equiv), K2OsO2(OH)4 (5.1 mg, 0.0139 mmol, 
0.0072 equiv), and the ligand (DHQD)2PHAL (19 mg, 0.0244 mmol, 0.013 equiv) in water (10 
                                                 
8
 E. J. Corey, M. C. Noe, J. Am. Chem. Soc. 1996, 118, 319-329. 
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mL), tBuOH (10 mL) and CH2Cl2 (4 mL). This time, NMR of crude mixture indicated presence of 
8% of starting cinnamate unreacted and at this point the reaction was stopped. After work up as 
previously, the residue was purified by flash chromatography (petroleum ether/EtOAc, gradient 2:1 
→ 1:1 → 0:1) to afford pure diol 17k (0.267 g) and a solid mixture of 17k with MeSO2NH2 (0.514 
g, containing 90% w/w of 17k). This mixed fraction was washed with diluted aqueous KOH and, 
subsequently, with water on a glas frit to afford pure 17k (0.336 g) as a colorless solid, indicating 
also a mass loss due to concurrent ester saponification. Total yield was 0.603 g (47%). Diol 17k has 
good solubility in CH2Cl2, but limited in EtOAc. Rf (EtOAc) 0.6; [α]
20
D = –8.8 (c 1.00, CH2Cl2); 
1
H 
NMR (400 MHz, CDCl3): δ = 2.73 (d, J = 7.1 Hz, 1H, OH), 3.13 (d, J = 5.6 Hz, 1H, OH), 3.84 (s, 
3H, OCH3), 4.42 (dd, J = 2.5, 5.6 Hz, 1H, 2-H), 5.08 (app d, 1H, 3-H), 7.34 (t, J = 7.4 Hz, 1H, Ar), 
7.42–7.49 (m, 5H, Ar), 7.57–7.61 (d+d, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 53.0 (OCH3), 
74.1, 74.6, 126.6 (2Car), 127.1 (2Car), 127.2 (2Car), 127.4 (Car), 128.8 (2Car), 138.9 (Car), 140.7 
(Car), 141.0 (Car), 173.1 (CO2CH3); HMRS (ESI): m/z: calcd for C16H16O4: 295.09408 [M+Na]
+
; 
found: 295.09407. 
 
ee-Determination for some of the diols 17 
Column Chiralcel OJ-H 
 
diol 17e:  
NO2 rac, hexane/iPrOH 70:30, flow 1 mL min
–1
, injection 5 µL  
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NO2 enantiomer, hexane/iPrOH 70:30, flow 1 mL min
–1
, injection 5 µL 
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diol 17g:  
CH2OTBS acetonide rac, hexane/iPrOH 95:5, flow 1 mL min
–1
, injection 5 µL 
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CH2OTBS acetonide enantiomer, hexane/iPrOH 95:5, flow 1 mL min
–1
, injection 5 µL 
 
m in0 1 2 3 4 5 6 7 8 9
m in0 1 2 3 4 5 6 7 8 9
mAU
0
50
100
150
200
250
300
 DAD1 C, S ig=210,8 Ref= 360,100 (ALZH\EN4AC3.D)
  
A
re
a
: 
5
4
2
0
.8
2
 5
.2
9
1
  
A
re
a
: 
6
7
.2
8
5
9
 6
.3
6
2
 DAD1 E , S ig=280,16 Ref= 360,100 (ALZH\EN4AC3.D)  
 
diol 17i:  
CN rac, hexane/iPrOH 70:30, flow 1 mL min
–1
, injection 5 µL 
 
m in0 2 4 6 8 10 12 14
mAU
0
10
20
30
40
50
 DAD1 B , S ig=254,16 Ref= 360,100 (ALZH\TEST12.D)
  
A
re
a
: 
1
0
7
3
.4
3
 9
.4
2
6
  
A
re
a
: 
1
1
8
9
.4
4
 1
0
.1
0
4
 DAD1 C, S ig=210,8 Ref= 360,100 (ALZH\TEST12.D)  
 
CN enantiomer, hexane/iPrOH 70:30, flow 1 mL min
–1
, injection 5 µL 
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Ph diol 17k did not provide good separation neither as a diol nor as acetonide. 
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Preparation of hydrazoic acid solution: Caution: Hydrazoic acid is a highly volatile, toxic and 
explosive liquid in individual state. However, in solution it is stable and safe. In this study solutions 
up to 5M were used. Sodium azide (3.0 g, 46 mmol) was mixed with water (1.5 mL) and toluene (10 
mL). The suspension was cooled to near 0 °C and concentrated H2SO4 (~2 g, ~1.09 mL, 20 mmol) 
was carefully added while cooling and shaking the round bottom flask (stirring with magnetic 
stirring bar is not sufficient). Crystals were kneaded with a spatula shortly after the addition of the 
acid. Then the mixture was filtered under positive pressure and dried with Na2SO4 (there was no 
water phase remained, and no need to separate it from toluene solution). To rapidly estimate the 
resulting concentration of hydrazoic acid, a known amount of NaOH was dissolved in a small 
amount of water, phenolphthalein was added and the pink solution was titrated with the hydrazoic 
acid solution from an analytical pipette (the concentration was found to be 3.3M against theoretical 
4.0M). 
Note. In the following Mitsunobu reactions, the products 18e and 18i were slightly contaminated 
with diethyl hydrazodicarboxylate (~3 – 5 mol %), having signals δ = 1.28±0.01 (t, 6H), 4.22±0.01 
(q, 4H). This impurity does not cause problems in the subsequent steps. 
 
 
Me
CO2Me
OH
OH
Me
CO2Me
OH
N3
17b
PPh3, HN3
DEAD
THF/toluene
0 οC to rt
18b
(38%)  
 
(2S,3S)-Methyl 3-azido-2-hydroxy-3-p-tolylpropanoate (18b). To a stirred solution of diol 17b 
(0.500 g, 2.38 mmol), triphenylphosphine (0.749 g, 2.85 mmol, 1.2 equiv), hydrazoic acid (1.44 
mL, 3.3M in toluene, 2.0 equiv) in THF (7.0 mL) at 0 °C was added DEAD (1.42 mL, 3.09 mmol, 
40% wt. solution in toluene, 1.3 equiv) via syringe pump within 5 h. Then the cooling bath was 
removed and the resulting mixture was stirred for 18 h at ambient temperature. The mixture was 
treated with saturated NaHCO3 solution (6 mL). After separation of the layers, the aqueous layer 
was extracted with EtOAc (2 × 15 mL). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 4:1) to provide 3-azido propanoate 18b (0.212 g, 38%) as a colorless oil. Rf 
(petroleum ether/EtOAc, 4:1) 0.25; [α]
20
D = +80.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 2.34 (s, 3H, CH3), 2.88 (d, J = 6.6 Hz, 1H, OH), 3.72 (s, 3H, OCH3), 4.50 (dd, J = 6.7, 4.2 Hz, 
1H, 2-H), 4.83 (d, J = 4.1 Hz, 1H, 3-H), 7.12–7.24 (m, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 
21.2 (CH3), 52.7 (OCH3), 67.0 (C-3), 73.7 (C-2), 127.7 (Car), 129.4 (Car), 131.2 (Car), 138.8 (Car), 
171.8 (CO); HRMS (ESI): m/z: calcd for C11H13N3O3 [M+Na]
+
: 258.08491; found: 258.084882. 
 
 
MeO
CO2Me
OH
OH
MeO
CO2Me
OH
N3
17c
PPh3, HN3
DEAD
THF/toluene
0 οC to rt
18c
(48%)  
 
(2S,3S)-Methyl 3-azido-2-hydroxy-3-(4-methoxyphenyl)propanoate (18c). To a stirred solution 
of diol 17c (0.40 g, 1.77 mmol), triphenylphosphine (0.557 g, 2.12 mmol, 1.2 equiv), hydrazoic acid 
(2.2 mL, 1.6M in toluene, 2.0 equiv) in THF (5.0 mL) at 0 °C was added DEAD (1.05 mL, 2.30 
mmol, 40% wt. solution in toluene, 1.3 equiv) via syringe pump within 5 h. Then the cooling bath 
was removed and the resulting mixture was stirred for 18 h at ambient temperature. The mixture 
was treated with saturated NaHCO3 solution (4 mL). After separation of the layers, the aqueous 
layer was extracted with EtOAc (2 × 15 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
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(petroleum ether/EtOAc, 3:1) to provide 3-azido propanoate 18c (0.211 g, 48%) as a colorless oil. A 
small amount of the syn-diastereomer (41 mg, 9%, Rf 0.25) was also isolated as an oil. Rf 
(petroleum ether/EtOAc, 3:1) 0.22; [α]
20
D = +92.6 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 2.89 (d, J = 6.6 Hz, 1H, OH), 3.72 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 4.50 (dd, J = 6.4, 4.1 Hz, 
1H, 2-H), 4.81 (d, J = 4.1 Hz, 1H, 3-H), 6.89 (d, J = 8.7 Hz, 2H, Ar), 7.20–7.29 (m, 2H, Ar); 
13
C 
NMR (100 MHz, CDCl3): δ = 52.8 (OCH3), 55.2 (OCH3), 66.7 (C-3), 73.7 (C-2), 114.1 (Car),126.1 
(Car), 129.1 (Car), 160.0 (Car), 171.8 (CO); HRMS (ESI): m/z: calcd for C11H13N3O4 [M+Na]
+
: 
274.07983; found: 274.079893. 
 
 
F
CO2Me
OH
OH
F
CO2Me
OH
N3
17d
PPh3, HN3
DEAD
THF/toluene
0 οC to rt
18d
(36%)  
 
(2S,3S)-Methyl 3-azido-3-(4-fluorophenyl)-2-hydroxypropanoate (18d). To a stirred solution of 
diol 17d (0.300 g, 1.40 mmol), triphenylphosphine (0.441 g, 1.68 mmol, 1.2 equiv), hydrazoic acid 
(0.85 mL, 3.3M in toluene, 2.0 equiv) in THF (4.0 mL) at 0 °C was added DEAD (0.835 mL, 1.82 
mmol, 40% wt. solution in toluene, 1.3 equiv) via syringe pump within 5 h. Then the cooling bath 
was removed and the resulting mixture was stirred for 18 h at ambient temperature. The mixture 
was treated with saturated NaHCO3 solution (4 mL). After separation of the layers, the aqueous 
layer was extracted with EtOAc (2 × 15 mL). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 4:1) to provide 3-azido propanoate 18d (0.119 g, 36%) as a colorless oil. 
Rf (petroleum ether/EtOAc, 4:1) 0.20; [α]
20
D = +41.7 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3): δ = 2.97 (bs, 1H, OH), 3.72 (s, 3H, OCH3), 4.52 (d, J = 4.1 Hz, 1H, 2-H), 4.86 (d, J = 4.1 
Hz, 1H, 3-H), 6.99–7.10 (m, 2H, Ar), 7.28–7.39 (m, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 
52.8 (OCH3), 66.4 (C-3), 73.6 (C-2), 115.7 (d, J = 21.2 Hz, Car), 129.6 (d, J = 8.1 Hz, Car), 130.2 (d, 
J = 2.9 Hz, Car), 162.6 (d, J = 148.1 Hz, Car), 171.7 (CO); HRMS (ESI): m/z: calcd for 
C11H10FN3O3 [M+Na]
+
: 262.05984; found: 262.05972. 
 
 
O2N
CO2Me
OH
OH
O2N
CO2Me
OH
N3
17e
PPh3, HN3
DEAD
THF/toluene
−25 οC to rt
18e
(58%)  
 
(2S,3S)-Methyl 3-azido-2-hydroxy-3-(4-nitrophenyl)propanoate (18e). To a stirred solution of 
diol 17e (0.228 g, 0.946 mmol), triphenylphosphine (0.297 g, 1.14 mmol, 1.2 equiv), hydrazoic acid 
(0.86 mL, 3.3M in toluene, 3 equiv) in THF (2.0 mL) at –25 °C was added DEAD (0.56 mL, 0.535 
g, 1.23 mmol, 40% wt. solution in toluene, 1.3 equiv), then the cooling bath was removed (slight 
evolution of N2 was observed) and the resulting mixture was stirred overnight at ambient 
temperature (TLC control: petroleum ether/EtOAc, 1:1; NMR control: a sample portion was taken 
from the reaction mixture, evaporated and directly analyzed by NMR). Then the reaction mixture 
was concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 4:1 to 2:1) to yield 3-azido propanoate 18e (0.145 g, 58%) as a slightly orange oil 
which solidified into a waxy solid upon standing. Rf (petroleum ether/EtOAc, 1:1) 0.55; [α]
20
D = 
+101.1 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 3.11 (bs, 1H, OH), 3.73 (s, 3H, OCH3), 
4.58 (d, 1H, 2-H), 5.08 (d, J = 3.8 Hz, 1H, 3-H), 7.53 (d, J = 8.7 Hz, 2H, Ar), 8.23 (d, J = 8.7 Hz, 
2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 53.1 (OCH3), 66.4 (C-3), 73.7 (C-2), 123.7 (Car), 128.7 
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(Car), 141.8 (Car), 148.1 (Car), 171.3 (CO2CH3); HMRS (ESI): m/z: calcd for C10H10N4O5 [M+Na]
+
: 
289.05434; found: 289.05431. 
 
 
CO2Me
OH
OH
CO2Me
OH
N3
17g
PPh3, HN3
DEAD
THF/toluene
−25 οC to rt
18g
(63%)OTBS OTBS  
 
(2S,3S)-Methyl 3-azido-3-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-2-hydroxypropano-
ate (18g). To a stirred solution of diol 17g (1.06 g, 3.1 mmol), triphenylphosphine (0.98 g, 3.72 
mmol, 1.2 equiv), hydrazoic acid (4.7 mL, 2.0M in toluene, 3 equiv) in THF (7.0 mL) at –25 °C was 
added DEAD (1.7 mL, 4.03 mmol, 40% wt. solution in toluene, 1.3 equiv), then the cooling bath 
was removed (slight evolution of N2 was observed) and the resulting mixture was stirred overnight 
at ambient temperature. Then the reaction mixture was concentrated in vacuo. The residue was 
purified by flash chromatography (petroleum ether/EtOAc, 8:1 to 2:1) to yield 3-azido propanoate 
18g (0.719 g, 63%) as colorless oil. Rf (petroleum ether/EtOAc, 2:1) 0.6; [α]
20
D = +75.5 (c 1.00, 
CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.09 (s, 6H, SiCH3), 0.93 (s, 9H, C(CH3)3), 2.88 (d, J = 
6.6 Hz, 1H, OH), 3.71 (s, 3H, OCH3), 4.51 (dd, J = 4.1, 6.6 Hz, 1H, 2-H), 4.73 (s, 2H, CH2O), 4.86 
(d, J = 4.1 Hz, 1H, 3-H), 7.29 (d, J = 8.4 Hz, 2H, Ar), 7.33 (d, J = 8.4 Hz, 2H, Ar); 
13
C NMR (100 
MHz, CDCl3): δ = –5.3 (SiCH3), 18.4 (C(CH3)3), 25.9 (C(CH3)3), 52.7 (OCH3), 64.5 (CH2Ar), 67.0 
(C-3), 73.7 (C-2), 126.2 (Car), 126.7 (Car), 132.7 (Car), 142.3 (Car), 171.8 (CO2CH3); HMRS (ESI): 
m/z: calcd for C17H27N3O4Si [M+Na]
+
: 388.16630; found: 388.16639. 
 
 
CO2Me
OH
OH
CO2Me
OH
N3
17h
PPh3, HN3
DEAD
THF/toluene
−25 οC to rt
18h
(80%)
OTBS OTBS  
 
(2S,3S)-Methyl 3-azido-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-hydroxy-
propanoate (18h). To a stirred solution of diol 17h (1.18 g, 3.33 mmol), triphenylphosphine (1.05 
g, 4.00 mmol, 1.2 equiv), hydrazoic acid (4.2 mL, 2.4M in toluene, 3 equiv) in THF (7.0 mL) at –25 
°C was added DEAD (1.83 mL, 4.33 mmol, 40% wt. solution in toluene, 1.3 equiv), then the 
cooling bath was removed (slight evolution of N2 was observed) and the resulting mixture was 
stirred overnight at ambient temperature. Then the reaction mixture was concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 8:1 to 2:1) to yield 3-azido 
propanoate 18h (0.997 g, 80%) as a colorless oil. Rf (petroleum ether/EtOAc, 2:1) 0.6; [α]
20
D = 
+70.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.06 (s, 6H, SiCH3), 0.84 (s, 9H, 
C(CH3)3), 2.80 (t, J = 6.9 Hz, 2H, ArCH2), 2.86 (brs, 1H, OH), 3.72 (s, 3H, OCH3), 3.79 (t, J = 6.9 
Hz, 2H, CH2OTBS), 4.5 (d, J = 3.8 Hz, 1H, 2-H), 4.84 (d, J = 3.8 Hz, 1H, 3-H), 7.21 (d, J = 8.4 Hz, 
2H, Ar), 7.24 (d, J = 8.4 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.5 (SiCH3), 18.3 
(C(CH3)3), 25.9 (C(CH3)3), 39.2 (ArCH2), 52.7 (OCH3), 64.2 (CH2O), 67.0 (C-3), 73.7 (C-2), 127.7 
(Car), 129.6 (Car), 131.9 (Car), 140.3 (Car), 171.8 (CO2CH3); HMRS (ESI): m/z: calcd for 
C18H29N3O4Si [M+Na]
+
: 402.18195; found: 402.18203. 
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NC
CO2Me
OH
OH
NC
CO2Me
OH
N3
17i
PPh3, HN3
DEAD
THF/toluene
−25 οC to rt
18i
(55%)  
 
(2S,3S)-Methyl 3-azido-3-(4-cyanophenyl)-2-hydroxypropanoate (18i). To a stirred solution of 
diol 17i (0.989 g of crude product containing 0.801 g of diol, 3.5 mmol), triphenylphosphine (1.10 
g, 4.2 mmol, 1.2 equiv), hydrazoic acid (3.2 mL, 3.3M in toluene, 3 equiv) in THF (7.4 mL) at –25 
°C was added DEAD (2.1 mL, 4.55 mmol, 40% wt. solution in toluene, 1.3 equiv), then the cooling 
bath was removed (slight evolution of N2 was observed) and the resulting mixture was stirred 
overnight at ambient temperature. Then the reaction mixture was concentrated in vacuo. The 
residue was purified by flash chromatography (petroleum ether/EtOAc, 2:1) to yield 3-azido 
propanoate 18i (0.472 g, 55%) as a colorless oil. Rf (petroleum ether/EtOAc, 2:1) 0.24; Rf 
(petroleum ether/EtOAc, 1:1) 0.68; [α]
20
D = +107.6 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): 
δ = 3.14 (bs, 1H, OH), 3.71 (s, 3H, OCH3), 4.55 (bs, 1H, 2-H), 4.94 (d, J = 3.8 Hz, 1H, 3-H), 7.46 
(d, J = 8.3 Hz, 2H, Ar), 7.66 (d, J = 8.3 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 53.0 
(OCH3), 66.6 (C-3), 73.7 (C-2), 112.7, 118.2, 128.4 (Car), 132.3 (Car), 139.9 (Car), 171.3 (CO2CH3); 
HMRS (ESI): m/z: calcd for C11H10N4O3 [M+Na]
+
: 269.06451; found: 269.06462. 
 
 
Ph
CO2Me
OH
OH
Ph
CO2Me
OH
N3
17k
PPh3, HN3
DEAD
THF/toluene
−25 οC to rt
18k
(77%)  
 
(2S,3S)-Methyl 3-azido-3-(biphenyl-4-yl)-2-hydroxypropanoate (18k). To a stirred solution of 
diol 17k (0.514 g, 1.89 mmol), triphenylphosphine (0.594 g, 2.27 mmol, 1.2 equiv), hydrazoic acid 
(1.7 mL, 3.3M in toluene, 3 equiv) in THF (4.0 mL) at –25 °C was added DEAD (1.09 mL, 2.38 
mmol, 40% wt. solution in toluene, 1.26 equiv), then the cooling bath was removed (slight 
evolution of N2 was observed) and the resulting mixture was stirred overnight at ambient 
temperature. Then the reaction mixture was concentrated in vacuo. The residue was purified by 
flash chromatography (petroleum ether/EtOAc, petroleum ether/EtOAc 5:1 to 2.5:1) to yield 3-
azido propanoate 18k (0.433 g, 77%) as a colorless solid. Rf (petroleum ether/EtOAc, 2:1) 0.3–0.4; 
[α]
20
D = +121.2 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 2.97 (bs, 1H, OH), 3.75 (s, 3H, 
OCH3), 4.56 (d, J = 4.1 Hz, 1H, 2-H), 4.92 (d, J = 4.1 Hz, 1H, 3-H), 7.34–7.46 (m, 5H, Ar), 7.57–
7.61 (m, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.8 (OCH3), 67.0 (C-3), 73.8 (C-2), 127.1 
(Car), 127.3 (Car), 127.6 (Car), 128.2 (Car), 128.8 (Car), 133.3 (Car), 140.3 (Car), 141.7 (Car), 171.8 
(CO2CH3); HMRS (ESI): m/z: calcd for C16H15N3O3 [M+Na]
+
: 320.10056; found: 320.10058. 
 
Note. In the following methylation reactions, if the substrate was contaminated with diethyl 
hydrazodicarboxylate, a product of methylation was formed, presumably a product of N-
monomethylation, according to NMR. In the corresponding cases, this had the following signals δ = 
1.31 (t, 6H), 3.20 (s, 3H), 4.25 (q, 4H). It causes no problems with the further steps. 
 
 
Me
CO2Me
OH
N3
18b
Me3OBF4
proton sponge
Me
CO2Me
OMe
N3
19b
(78%)
CH2Cl2, rt
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(2S,3S)-Methyl 3-azido-2-methoxy-3-p-tolylpropanoate (19b). To a solution of α-hydroxy ester 
18b (0.260 g, 1.11 mmol) in dry CH2Cl2 (14 mL) was added trimethyloxonium tetrafluoroborate 
(0.572 g, 3.87 mmol, 3.5 equiv) and proton sponge (1.18 g, 5.53 mmol, 5 equiv). The flask was 
covered with aluminum foil. After stirring the suspension at ambient temperature for 20 h, the 
reaction mixture was treated with H2O (10 mL), followed by separation of the layers. The aqueous 
layer was extracted with CH2Cl2 (2 × 20 mL). The combined organic extracts were washed with 1N 
HCl (10 mL), saturated NaHCO3 solution (10 mL), saturated NaCl solution (10 mL), dried with 
Na2SO4, filtered, and concentrated in vacuo. The residue was chromatographed (petroleum 
ether/EtOAc, 7:1) to yield methyl ether 19b (0.215 g, 78%) as a colorless oil. Rf (petroleum 
ether/EtOAc, 7:1) 0.30; [α]
20
D = +47.2 (c 1.0, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 2.34 (s, 
3H, CH3), 3.75 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 3.98 (d, J = 6.6 Hz, 1H, 2-H), 4.72 (d, J = 6.9 
Hz, 1H, 3-H), 7.18 (d, J = 7.9 Hz, 2H, Ar), 7.21–7.27 (m, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ 
= 21.2 (CH3), 52.2 (OCH3), 59.1 (OCH3), 65.8 (C-3), 83.4 (C-2), 127.9 (Car), 129.4 (Car), 132.1 
(Car), 138.7 (Car), 170.3 (CO); HRMS (ESI): m/z: calcd for C12H15N3O3 [M+Na]
+
: 272.10056; 
found: 272.10062. 
 
 
MeO
CO2Me
OH
N3
18c
Me3OBF4
proton sponge
MeO
CO2Me
OMe
N3
19c
(73%)
CH2Cl2, rt
 
 
(2S,3S)-Methyl 3-azido-2-methoxy-3-(4-methoxyphenyl)propanoate (19c). To a solution of α-
hydroxy ester 18c (0.130 g, 0.517 mmol) in dry CH2Cl2 (4 mL) was added trimethyloxonium 
tetrafluoroborate (0.171 g, 1.16 mmol, 2.2 equiv) and proton sponge (0.354 g, 1.65 mmol, 3.2 
equiv). The flask was covered with aluminum foil. After stirring the suspension at ambient 
temperature for 20 h, the reaction mixture was treated with H2O (4 mL), followed by separation of 
the layers. The aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic 
extracts were washed with 1N HCl (5 mL), saturated NaHCO3 solution (5 mL), and saturated NaCl 
solution (5 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The residue was 
chromatographed (petroleum ether/EtOAc, 5:1) to yield methyl ether 19c (0.100 g, 73%) as a 
colorless oil. Rf (petroleum ether/EtOAc, 5:1) 0.23; [α]
20
D = +56.2 (c 0.5, CH2Cl2); 
1
H NMR (400 
MHz, CDCl3): δ = 3.35 (s, 3H, OCH3), 3.72 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.97 (d, J = 6.4 Hz, 
1H, 2-H), 4.70 (d, J = 6.6 Hz, 1H, 3-H), 6.89 (d, J = 8.9 Hz, 2H, Ar), 7.29 (d, J = 8.7 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.2 (OCH3), 55.2 (OCH3), 59.1 (OCH3), 65.4 (C-3), 83.4 (C-2), 
114.0 (Car), 127.1 (Car), 129.3 (Car), 159.9 (Car), 170.2 (CO); HRMS (ESI): m/z: calcd for 
C12H15N3O4 [M+Na]
+
: 288.09548; found: 288.09558. 
 
 
F
CO2Me
OH
N3
18d
Me3OBF4
proton sponge
F
CO2Me
OMe
N3
19d
(75%)
CH2Cl2, rt
 
 
(2S,3S)-Methyl 3-azido-3-(4-fluorophenyl)-2-methoxypropanoate (19d). To a solution of α-
hydroxy ester 18d (0.084 g, 0.351 mmol) in dry CH2Cl2 (5 mL) was added trimethyloxonium 
tetrafluoroborate (0.182 g, 1.23 mmol, 3.5 equiv) and proton sponge (0.376 g, 1.76 mmol, 5 equiv). 
The flask was covered with aluminum foil. After stirring the suspension at ambient temperature for 
20 h, the reaction mixture was treated with H2O (4 mL), followed by separation of the layers. The 
aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The combined organic extracts were washed 
with 1N HCl (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried with 
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Na2SO4, filtered, and concentrated in vacuo. The residue was chromatographed (petroleum 
ether/EtOAc, 6:1) to yield methyl ether 19d (0.067 g, 75%) as a colorless oil. Rf (petroleum 
ether/EtOAc, 7:1) 0.22; [α]
20
D = +19.1 (c 1.0, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 3.37 (s, 
3H, OCH3), 3.73 (s, 3H, OCH3), 3.96 (d, J = 6.6 Hz, 1H, 2-H), 4.75 (d, J = 6.4 Hz, 1H, 3-H), 6.99–
7.11 (m, 2H, Ar), 7.30–7.40 (m, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.3 (OCH3), 59.2 
(OCH3), 65.2 (C-3), 83.3 (C-2), 115.7 (d, J = 22.0 Hz, Car), 129.9 (d, J = 8.8 Hz, Car), 131.0 (d, J = 
2.8, Car), 162.9 (d, J = 248.1 Hz, Car), 170.0 (CO); HRMS (ESI): m/z: calcd for C11H12FN3O3 
[M+Na]+:  276.07549; found: 276.07523. 
 
 
O2N
CO2Me
OH
N3
18e
Me3OBF4
proton sponge
O2N
CO2Me
OMe
N3
19e
(92%)
(CH2Cl)2, 40 °C
 
 
(2S,3S)-Methyl 3-azido-2-methoxy-3-(4-nitrophenyl)propanoate (19e). To a solution of α-
hydroxy ester 18e (0.495 g, 1.86 mmol) in dry 1,2-dichloroethane (1.9 mL) was added 
trimethyloxonium tetrafluoroborate (0.495 g, 3.35 mmol, 1.8 equiv) and proton sponge (0.876 g, 
4.09 mmol, 2.2 equiv). The flask was covered with aluminum foil. After stirring the suspension at 
40 °C overnight, a small probe was taken from the reaction mixture and quenched with 
EtOAc/HClaq for TLC (petroleum ether/EtOAc, 1:1), that indicated full conversion. The reaction 
mixture was cooled, treated with EtOAc/H2O, and acidified with 1N HCl to pH 2–3. The precipitate 
was filtered off and the filtrate was separated. The aqueous phase was extracted once with EtOAc 
and the combined organic extracts were washed with water, and saturated NaCl solution, dried with 
Na2SO4, filtered, and concentrated in vacuo. The residue was chromatographed (petroleum 
ether/EtOAc, 3:1 to 2:1) to yield methyl ether 19e (0.48 g, 92%) as a slightly orange oil. Rf 
(petroleum ether/EtOAc, 2:1) 0.54; [α]
20
D = +49.5 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 3.38 (s, 3H, OCH3), 3.75 (s, 3H, CO2CH3), 3.99 (d, J = 6.1 Hz, 1H, 2-H), 4.89 (d, J = 6.1 Hz, 1H, 
3-H), 7.55 (d, J = 8.7 Hz, 2H, Ar), 8.22 (d, J = 8.7 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 
52.5 (OCH3), 59.3 (OCH3), 65.0 (C-3), 83.0 (C-2), 123.8 (Car), 129.0 (Car), 142.4 (Car), 148.1 (Car), 
169.6 (CO2CH3); HMRS (ESI): m/z: calcd for C11H12N4O5 [M+Na]
+
: 303.06999; found: 303.07002. 
 
 
CO2Me
OH
N3
18g
Me3OBF4
proton sponge CO2Me
OMe
N3
19g
(68%)
(CH2Cl)2, 40 °C
OTBS OTBS  
 
(2S,3S)-Methyl 3-azido-3-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-2-methoxypropano-
ate (19g). To a solution of α-hydroxy ester 18g (0.674 g, 1.84 mmol) in dry 1,2-dichloroethane (3 
mL) was added trimethyloxonium tetrafluoroborate (0.463 g, 3.13 mmol, 1.7 equiv) and proton 
sponge (0.803 g, 3.75 mmol, 2.04 equiv). The flask was covered with aluminum foil. After stirring 
the suspension at 40 °C overnight, the reaction mixture was cooled, treated with EtOAc/H2O, and 
acidified with 1N HCl to pH 2–3. The precipitate was filtered off and the filtrate was separated. The 
aqueous phase was extracted once with EtOAc and the combined organic extracts were washed with 
water, and saturated NaCl solution, dried with Na2SO4, filtered, and concentrated in vacuo. The 
residue was chromatographed (petroleum ether/EtOAc, 10:1) to yield methyl ether 19g (0.475 g, 
68%) as a colorless oil. Rf (petroleum ether/EtOAc, 4:1) 0.49; [α]
20
D = +53.7 (c 1.00, CH2Cl2); 
1
H 
NMR (400 MHz, CDCl3): δ = 0.09 (s, 6H, SiCH3), 0.93 (s, 9H, C(CH3)3), 3.34 (s, 3H, OCH3), 3.74 
(s, 3H, CO2CH3), 3.97 (d, J = 6.6, 1H, 2-H), 4.74 (s, 2H, CH2O), 4.74 (d, J = 6.6 Hz, 1H, 3-H), 7.33 
(s, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.3 (SiCH3), 18.4 (C(CH3)3), 25.9 (C(CH3)3), 52.2 
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(OCH3), 59.1 (OCH3), 64.5 (CH2Ar), 65.8 (C-3), 83.9 (C-2), 126.2 (Car), 127.9 (Car), 133.7 (Car), 
142.2 (Car), 170.2 (CO2CH3); HMRS (ESI): m/z: calcd for C18H29N3O4Si [M+Na]
+
: 402.18195; 
found: 402.18197. 
 
 
CO2Me
OH
N3
18h
Me3OBF4
proton sponge CO2Me
OMe
N3
19h
(77%)
(CH2Cl)2, 40 °C
OTBS OTBS  
 
(2S,3S)-Methyl 3-azido-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-methoxypropano-
ate (19h). To a solution of α-hydroxy ester 18h (0.897 g, 2.3 mmol) in dry 1,2-dichloroethane (3 
mL) was added trimethyloxonium tetrafluoroborate (0.578 g, 3.91 mmol, 1.7 equiv) and proton 
sponge (0.886 g, 4.14 mmol, 1.8 equiv). The flask was covered with aluminum foil. After stirring 
the suspension at 40 °C overnight, the reaction mixture was cooled, treated with EtOAc/H2O, and 
acidified with 1N HCl to pH 2–3. The precipitate was filtered off and the filtrate was separated. The 
aqueous phase was extracted once with EtOAc and the combined organic extracts were washed with 
water, and saturated NaCl solution, dried with Na2SO4, filtered, and concentrated in vacuo. The 
residue was chromatographed (petroleum ether/EtOAc, 10:1) to yield methyl ether 19h (0.584 g, 
77%, based on consumed material) as a colorless oil. The amount of recovered starting material was 
0.167 g. Rf (petroleum ether/EtOAc, 4:1) 0.49; [α]
20
D = +56.9 (c 1.00, CH2Cl2); 
1
H NMR (400 
MHz, CDCl3): δ = –0.06 (s, 6H, SiCH3), 0.84 (s, 9H, C(CH3)3), 2.81 (t, J = 6.9 Hz, 2H, ArCH2), 
3.34 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 3.79 (t, J = 6.9 Hz, 2H, CH2OTBS), 3.96 (d, J = 6.7 Hz, 
1H, 2-H), 4.71 (d, J = 6.7 Hz, 1H, 3-H), 7.21 (d, J = 8.1 Hz, 2H, Ar), 7.27 (d, J = 8.1 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.5 (SiCH3), 18.3 (C(CH3)3), 25.9 (C(CH3)3), 39.2 (ArCH2), 
52.2 (OCH3), 59.1 (OCH3), 64.2 (CH2O), 65.7 (C-3), 83.4 (C-2), 127.9 (Car), 129.5 (Car), 132.9 
(Car), 140.1 (Car), 170.3 (CO2CH3); HMRS (ESI): m/z: calcd for C19H31N3O4Si [M+Na]
+
: 
416.19760; found: 416.19771. 
 
NC
CO2Me
OH
N3
18i
Me3OBF4
proton sponge
NC
CO2Me
OMe
N3
19i
(81%)
(CH2Cl)2, 40 °C
 
 
(2S,3S)-Methyl 3-azido-3-(biphenyl-4-yl)-2-methoxypropanoate (19i). To a solution of α-
hydroxy ester 18i (0.574 g, 2.3 mmol) in dry 1,2-dichloroethane (2.3 mL) was added 
trimethyloxonium tetrafluoroborate (0.621 g, 4.14 mmol, 1.8 equiv) and proton sponge (1.08 g, 5.06 
mmol, 2.2 equiv). The flask was covered with aluminum foil. After stirring the suspension at 40 °C 
overnight, a small probe was taken from the reaction mixture and quenched with EtOAc/HClaq for 
TLC (petroleum ether/EtOAc, 1:1), that indicated full conversion. The reaction mixture was cooled, 
treated with EtOAc/H2O, and acidified with 1N HCl to pH 2–3. The precipitate was filtered off and 
the filtrate was separated. The aqueous phase was extracted once with EtOAc and the combined 
organic extracts were washed with water, and saturated NaCl solution, dried with Na2SO4, filtered, 
and concentrated in vacuo. The residue was chromatographed (petroleum ether/EtOAc, 3:1 to 2:1) 
to yield methyl ether 19i (0.489 g, 81%) as a colorless oil. Rf (petroleum ether/EtOAc, 2:1) 0.41; 
[α]
20
D = +59.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 3.37 (s, 3H, OCH3), 3.74 (s, 3H, 
CO2CH3), 3.97 (d, J = 6.3 Hz, 1H, 2-H), 4.82 (d, J = 6.3 Hz, 1H, 3-H), 7.48 (d, J = 8.3 Hz, 2H, Ar), 
7.66 (d, J = 8.3 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.4 (OCH3), 59.2 (OCH3), 65.3 (C-
3), 82.9 (C-2), 112.7, 118.3, 128.8 (Car), 132.3 (Car), 140.5 (Car), 169.6 (CO2CH3); HMRS (ESI): 
m/z: calcd for C12H12N4O3 [M+Na]
+
: 283.08016; found: 283.08007. 
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Ph
CO2Me
OH
N3
18k
Me3OBF4
proton sponge
Ph
CO2Me
OMe
N3
19k
(81%)
(CH2Cl)2, 40 °C
 
 
(2S,3S)-Methyl 3-azido-3-(biphenyl-4-yl)-2-methoxypropanoate (19k). To a solution of α-
hydroxy ester 18k (0.39 g, 1.31 mmol) in dry 1,2-dichloroethane (1.4 mL) was added 
trimethyloxonium tetrafluoroborate (0.349 g, 2.36 mmol, 1.8 equiv) and proton sponge (0.616 g, 2.2 
equiv). The flask was covered with aluminum foil. After stirring the suspension at 40 °C overnight, 
a small probe was taken from the reaction mixture and quenched with EtOAc/HClaq for TLC 
(petroleum ether/EtOAc, 1:1), that indicated full conversion. The reaction mixture was cooled, 
treated with EtOAc/H2O, and acidified with 1N HCl to pH 2–3. The precipitate was filtered off and 
the filtrate was separated. The aqueous phase was extracted once with EtOAc and the combined 
organic extracts were washed with water, and saturated NaCl solution, dried with Na2SO4, filtered, 
and concentrated in vacuo. The residue was chromatographed (petroleum ether/EtOAc, 5:1 to 2:1) 
to yield methyl ether 19k (0.329 g, 81%) as a colorless oil. Rf (petroleum ether/EtOAc, 2:1) 0.58; 
[α]
20
D = +86.7 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 3.39 (s, 3H, OCH3), 3.77 (s, 3H, 
CO2CH3), 4.04 (d, J = 6.6 Hz, 1H, 2-H), 4.82 (d, J = 6.6 Hz, 1H, 3-H), 7.33–7.37 (m, 1H, Ar), 
7.42–7.46 (m, 4H, Ar), 7.58–7.62 (m, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 52.3 (OCH3), 
59.2 (OCH3), 65.7 (C-3), 83.4 (C-2), 127.1 (Car), 127.4 (Car), 127.5 (Car), 128.4 (Car), 128.8 (Car), 
134.1 (Car), 140.4 (Car), 141.7 (Car), 170.2 (CO2CH3). 
 
 
NC
CO2Me
N3
OMe
CO2Me
N3
OMe
H2O2, K2CO3
MeOH, rt, 2 h
(56%)
19j19i
O
NH2  
 
(2S,3S)-Methyl 3-azido-3-(4-carbamoylphenyl)-2-methoxypropanoate (19j). To a suspension of 
nitrile 19i (65 mg, 0.25 mmol) and K2CO3 (30 mg) in methanol (0.53 mL) was added hydrogen 
peroxide (0.11 mL of 30% solution in water). The reaction mixture was stirred for 2 h at room 
temperature (TLC control: EtOAc). Then it was diluted with water and extracted twice with EtOAc. 
The combined organic extracts was washed with water, dried with Na2SO4, filtered, and evaporated. 
The residue was subjected to flash chromatography (EtOAc/petroleum ether, 1:1 to 1:0) to afford 
the amide 19j (36 mg, 56%) as a colorless oil. A similar yield was obtained in DMF overnight. In 
contrast, in DMSO the reaction proceeded in several minutes and possibly could deliver higher 
yield, but in this case the product was not separable from the dimethyl sulfone by-product. Rf 
(EtOAc) 0.4; [α]
20
D = +60.9 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 3.35 (s, 3H, 
OCH3), 3.72 (s, 3H, CO2CH3), 3.99 (d, J = 6.4 Hz, 1H, 2-H), 4.81 (d, J = 6.4 Hz, 1H, 3-H), 6.29 
(bs, 2H, NH2), 7.43 (d, J = 8.3 Hz, 2H, Ar), 7.81 (d, J = 8.3 Hz, 2H, Ar); 
13
C NMR (100 MHz, 
CDCl3): δ = 52.3 (OCH3), 59.1 (OCH3), 65.4 (C-3), 83.1 (C-2), 127.7 (Car), 128.3 (Car), 133.8 (Car), 
139.1 (Car), 169.0, 169.9. 
 
 
R
CO2Me
OMe
N3
19
H2, Pd/C
MeOH, rt
R
CO2Me
OMe
NH2
8  
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Catalytic hydrogenation of the azides 19 to the amino esters 8. Solutions of azides 19b (Me), 
19c (OMe), 19d (F), 19h ((CH2)2OTBS), 19j (CONH2), and 19k (Ph) (0.1–0.2M) in methanol were 
hydrogenated overnight in a round bottom flask connected to a hydrogen filled balloon, using 10% 
Pd on carbon (catalyst loading: 0.5–1 mol% Pd). Azides 19i (CN) and 19g (CH2OTBS) were 
hydrogenated in shorter times, 4 and 2 h, respectively, to avoid reduction of the CN or benzylic C–
O bond. In each case full conversion of the azides was observed. The solutions were filtered 
through celite and the filtrate evaporated to afford pure amino esters 8 in essentially quantitative 
yields. The amines 8 were used for the subsequent peptide coupling without further purification. 
When the hydrogenation of azide 19g (CH2OTBS) was performed overnight, formation of 20% of 
the corresponding methyl substituted derivative was observed. 
 
 
Me
CO2Me
OMe
NH2
8b  
 
(2S,3S)-Methyl 3-amino-2-methoxy-3-p-tolylpropanoate (8b). A solution of azide 19b (0.197 g, 
0.790 mmol) in MeOH (7 mL) was hydrogenated at room temperature for 5 h to provide 0.175 g 
(99%) of amine 8b as a colorless oil. Rf (petroleum ether/EtOAc, 3:7) 0.23; [α]
20
D = –4.7 (c 1.00, 
CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 1.78 (bs, 2H, NH2), 2.31 (CH3), 3.37 (s, 3H, OCH3), 
3.65 (s, 3H, OCH3), 3.97 (d, J = 5.6 Hz, 1H, 2-H), 4.23 (d, J = 5.6 Hz, 1H, 3-H), 7.11 (d, J = 8.9 
Hz, 2H, Ar), 7.18 (d, J = 8.4 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 21.1 (CH3), 51.7 
(OCH3), 57.4 (C-3), 59.0 (OCH3), 85.4 (C-2), 126.8 (Car), 129.0 (Car), 133.2 (Car), 138.5 (Car), 
171.3 (CO); HRMS (ESI): m/z: calcd for C12H17NO3 [M+Na]
+
: 224.12812; found: 224.12803. 
 
 
MeO
CO2Me
OMe
NH2
8c  
 
(2S,3S)-Methyl 3-amino-2-methoxy-3-(4-methoxyphenyl)propanoate (8c). A solution of azide 
19c (0.100 g, 0.377 mmol) in MeOH (3 mL) was hydrogenated at room temperature for 5 h to 
provide 0.089 g (98%) of amine 8c as a slightly yellow oil. Rf (petroleum ether/EtOAc, 3:7) 0.15; 
[α]
20
D = –8.8 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 1.70 (s, 2H, NH2), 3.36 (s, 3H, 
OCH3), 3.64 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.93 (d, J = 5.3 Hz, 1H, 2-H), 4.21 (d, J = 5.6 Hz, 
1H, 3-H), 6.83 (d, J = 8.7 Hz, 2H, Ar), 7.21 (d, J = 8.4 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ 
= 51.7 (OCH3), 55.2 (OCH3), 57.1 (C-3), 59.0 (OCH3), 85.5 (C-2), 113.7 (Car), 128.0 (Car), 133.7 
(Car), 158.9 (Car), 171.3 (CO); HRMS (ESI): m/z: calcd for C12H17NO4 [M+Na]
+
: 262.10498; found: 
262.10496. 
 
 
F
CO2Me
OMe
NH2
8d  
 
(2S,3S)-Methyl 3-amino-3-(4-fluorophenyl)-2-methoxypropanoate (8d). A solution of azide 19d 
(0.239 g, 0.944 mmol) in MeOH (10 mL) was hydrogenated at room temperature for 5 h to provide 
0.212 g (99%) of amine 8d as a colorless oil. Rf (petroleum ether/EtOAc, 3:7) 0.24; [α]
20
D = –5.8 (c 
1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 1.81 (bs, 2H, NH2), 3.37 (s, 3H, OCH3), 3.64 (s, 
 22
3H, OCH3), 3.94 (d, J = 5.3 Hz, 1H, 2-H), 4.26 (d, J = 5.6 Hz, 1H, 3-H), 6.85–7.04 (m, 2H, Ar), 
7.24–7.31 (m, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 51.7 (OCH3), 57.0 (C-3), 59.0 (OCH3), 
85.2 (C-2), 115.2 (d, J = 21.2 Hz, Car), 128.6 (d, J = 8.1 Hz, Car), 137.14 (d, J = 3.7 Hz, Car), 162.2 
(d, J = 245.9 Hz, Car), 171.1 (CO); HRMS (ESI): m/z: calcd for C11H14FNO3 [M+Na]
+
: 228.10305; 
found: 228.10286. 
 
 
CO2Me
OMe
NH2
8g
OTBS  
 
(2S,3S)-Methyl 3-amino-3-(4-((tert-butyldimethylsilyloxy)methyl)phenyl)-2-methoxypropano-
ate (8g). A solution of azide 19g (74.0 mg, 0.195 mmol) in MeOH (2 mL) was hydrogenated at 
room temperature for 2 h to provide 68 mg (99%) of amine 8g as a colorless oil. Longer reaction 
times might cause reductive cleavage of the benzylic C–O bond. [α]
20
D = –6.0 (c 1.00, CH2Cl2); 
1
H 
NMR (400 MHz, CDCl3): δ = 0.07 (s, 6H, SiCH3), 0.92 (s, 9H, C(CH3)3), 1.70 (bs, 2H, NH2), 3.37 
(s, 3H, OCH3), 3.64 (s, 3H, CO2CH3), 3.96 (d, J = 5.6, 1H, 2-H), 4.25 (d, J = 5.6 Hz, 1H, 3-H), 4.70 
(s, 2H, CH2O), 7.26 (s, 4H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.3 (SiCH3), 18.4 (C(CH3)3), 
25.9 (C(CH3)3), 51.7 (OCH3), 57.5 (C-3), 59.0 (OCH3), 64.7 (CH2Ar), 85.4 (C-2), 126.0 (Car), 126.8 
(Car), 131.2 (Car), 140.7 (Car), 171.3 (CO2CH3); HMRS (ESI): m/z: calcd for C18H31NO4Si [M+H]
+
: 
354.20951; found: 354.20953. 
 
 
CO2Me
OMe
NH2
8h
OTBS  
 
(2S,3S)-Methyl 3-amino-3-(4-(2-(tert-butyldimethylsilyloxy)ethyl)phenyl)-2-methoxypropano-
ate (8h). A solution of azide 19h (0.566 g, 1.44 mmol) in MeOH (7 mL) was hydrogenated at room 
temperature overnight to provide 0.527 g (99%) of amine 8h as a colorless oil. [α]
20
D = –6.4 (c 
1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = –0.03 (s, 6H, SiCH3), 0.86 (s, 9H, C(CH3)3), 1.73 
(bs, 2H, NH2), 2.78 (t, J = 7.1 Hz, 2H, ArCH2), 3.36 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.77 (t, J = 
7.1 Hz, 2H, CH2O), 3.95 (d, J = 5.7 Hz, 1H, 2-H), 4.23 (d, J = 5.7 Hz, 1H, 3-H), 7.14 (d, J = 8.1 Hz, 
2H, Ar), 7.21 (d, J = 8.1 Hz, 2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = –5.4 (SiCH3), 18.3 
(C(CH3)3), 25.9 (C(CH3)3), 39.2 (ArCH2), 51.7 (OCH3), 57.4 (C-3), 59.0 (OCH3), 64.4 (CH2O), 
85.4 (C-2), 126.8 (Car), 129.1 (Car), 138.5 (Car), 139.4 (Car), 171.3 (CO2CH3); HMRS (ESI): m/z: 
calcd for C19H33NO4Si [M+H]
+
: 368.22516; found: 368.22538. 
 
 
NC
CO2Me
OMe
NH2
8i  
 
(2S,3S)-Methyl 3-amino-3-(4-cyanophenyl)-2-methoxypropanoate (8i). A solution of azide 19i 
(43.7 mg, 0.168 mmol) in MeOH (0.9 mL) was hydrogenated at room temperature for 4 h to 
provide 33.6 mg (85%) of amine 8i as a colorless oil. [α]
20
D = –13.7 (c 1.00, CH2Cl2); 
1
H NMR 
(400 MHz, CDCl3): δ = 1.85 (bs, 2H, NH2), 3.37 (s, 3H, OCH3), 3.63 (s, 3H, CO2CH3), 3.94 (d, J = 
 23
5.4 Hz, 1H, 2-H), 4.31 (d, J = 5.4 Hz, 1H, 3-H), 7.41 (d, J = 8.3 Hz, 2H, Ar), 7.58 (d, J = 8.3 Hz, 
2H, Ar); 
13
C NMR (100 MHz, CDCl3): δ = 51.8 (OCH3), 57.4 (C-3), 59.0 (OCH3), 84.7 (C-2), 
111.4, 118.7, 127.9 (Car), 132.0 (Car), 146.8 (Car), 170.6 (CO2CH3); HMRS (ESI): m/z: calcd for 
C12H14N2O3 [M+H]
+
: 235.10772; found: 235.10763. 
 
 
Ph
CO2Me
OMe
NH2
8k  
 
(2S,3S)-Methyl 3-amino-3-(4-cyanophenyl)-2-methoxypropanoate (8k). A solution of azide 19k 
(0.330 g, 1.06 mmol) in MeOH (5 mL) was hydrogenated at room temperature overnight to provide 
0.292 g (97%) of amine 8k as a colorless oil which solidified on standing. Rf (EtOAc) 0.3, 
(CH2Cl2/MeOH 10:1) 0.53; [α]
20
D = –7.7 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 2.26 
(bs, 2H, NH2), 3.42 (s, 3H, OCH3), 3.67 (s, 3H, CO2CH3), 4.05 (d, J = 5.3 Hz, 1H, 2-H), 4.34 (d, J 
= 5.3 Hz, 1H, 3-H), 7.30–7.34 (m, 1H, Ar), 7.37–7.44 (m, 4H, Ar), 7.53–7.58 (m, 4H, Ar); 
13
C 
NMR (100 MHz, CDCl3): δ = 51.8 (OCH3), 57.3 (C-3), 59.2 (OCH3), 85.1 (C-2), 127.0 (Car), 127.1 
(Car), 127.2 (Car), 127.5 (Car), 128.7 (Car), 140.1 (Car), 140.5 (Car), 140.7 (Car), 171.1 (CO2CH3); 
HMRS (ESI): m/z: calcd for C17H19NO3 [M+H]
+
: 308.12571; found: 308.125706. 
 
 
N O
Me
N
NHBoc
H
O
HN
Me
CO2Me
OMe
20b  
 
Tripeptide 20b (Me). To a solution of amine 8b (40 mg, 0.179 mmol, 1 equiv) in DMF (4 mL) 
were added acid 6 (70 mg, 0.179 mmol), HOBt (36 mg, 0.269 mmol, 1.5 equiv), iPr2NEt (0.091 
mL, 0.537 mmol, 3 equiv). At 0 °C TBTU (84 mg, 0.269 mmol, 1.5 equiv) was added and the 
reaction was stirred for 2–3 h at room temperature. The mixture was diluted with water (4 mL) and 
extracted with ethyl acetate (3 × 8 mL). The combined organic layers were washed with 1N HCl 
solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried with 
Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash chromatography 
(petroleum ether/EtOAc, 1:1) gave tripeptide 20b (80 mg, 75%) as a white foam. Rf (petroleum 
ether/EtOAc, 1:1) 0.20; [α]
20
D = +12.6 (c 0.5, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.90 (d, J 
= 6.9 Hz, 3H, Ala CH3), 1.41 (s, 9H, C(CH3)3), 2.28 (s, 3H, ArCH3), 2.94 (s, 3H, NCH3), 3.19–3.29 
(m, 1H, CH2), 3.31–3.36 (m, 1H, CH2), 3.36 (s, 3H, OCH3), 3.59 (s, 3H, OCH3), 4.07 (d, J = 4.8 
Hz, 1H, CHOCH3), 4.46–4.55 (m, 1H, Ala CH), 5.38 (dd, J = 8.7, 4.8 Hz, 1H, β-Tyr CH), 5.43 (d, J 
= 7.6 Hz, 1H, Ala NH), 5.54 (dd, J = 9.9, 6.4 Hz, 1H, Trp CH), 6.90 (s, 1H, Trp HAr), 6.98–7.18 (m, 
7H, β-Tyr HAr, Trp Har, β-Tyr NH), 7.29 (d, J = 8.1 Hz, 1H Trp HAr), 7.57 (d, J = 7.9 Hz, 1H, Trp 
HAr), 8.33 (bs, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 18.0 (Ala CH3), 21.1 (ArCH3), 23.3 
(CH2), 28.3 (C(CH)3), 30.7 (NCH3), 46.7 (Ala CH), 51.8 (OCH3), 53.9 (β-Tyr CH), 56.7 (Trp CH), 
59.1 (OCH3), 79.5 (C(CH)3), 82.4 (CHOCH3), 110.6 (Trp Car), 111.1 (Trp Car), 118.4 (Trp Car), 
119.4 (Trp Car), 122.0 (Trp Car), 122.2 (Trp Car), 127.2 (Trp Car), 127.3 (β-Tyr Car), 129.1 (β-Tyr 
Car), 133.6 (β-Tyr Car), 136.1 (Trp Car), 137.6 (Trp Car), 155.1 (CO), 169.3 (CO), 170.1 (CO), 174.3 
(CO); HRMS (ESI): m/z: calcd for C32H42N4O7 [M+Na]
+
: 617.29457; found: 617.29448. 
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Tripeptide 20c (OMe). To a solution of amine 8c (89 mg, 0.372 mmol, 1 equiv) in DMF (7 mL) 
were added acid 6 (145 mg, 0.372 mmol), HOBt (75 mg, 0.558 mmol, 1.5 equiv), iPr2NEt (0.091 
mL, 0.537 mmol, 3 equiv). At 0 °C TBTU (174 mg, 0.558 mmol, 1.5 equiv) was added and the 
reaction was stirred for 2–3 h at room temperature. The mixture was diluted with water (5 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 1N HCl 
solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried with 
Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash chromatography 
(petroleum ether/EtOAc, 1:1) gave tripeptide 20c (175 mg, 77%) as a white foam. Rf (petroleum 
ether/EtOAc, 1:1) 0.32; [α]
20
D = +17.6 (c 1.0, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.91 (d, J 
= 6.9 Hz, 3H, Ala CH3), 1.40 (s, 9H, C(CH3)3), 2.95 (s, 3H, NCH3), 3.23 (dd, J = 15.5, 9.9 Hz, 1H, 
CH2), 3.27–3.34 (m, 1H, CH2), 3.37 (s, 3H, OCH3), 3.59 (s, 3H, OCH3), 3.74 (OCH3), 4.06 (d, J = 
5.1 Hz, 1H, CHOCH3), 4.45–4.56 (m, 1H, Ala CH), 5.35 (dd, J = 8.5, 5.0 Hz, 1H, β-Tyr CH), 5.41 
(d, J = 7.6 Hz, 1H, Ala NH), 5.53 (dd, J = 9.8, 6.5 Hz, 1H, Trp CH), 6.77 (d, J = 8.9 Hz, 2H, β-Tyr 
Har), 6.89 (s, 1H, Trp Har), 7.04–7.12 (m, 2H, β-Tyr NH, Trp Har), 7.14 (d, J = 7.1 Hz, 2H, β-Tyr 
Har), 7.12–7.18 (m, 1H, Trp Har), 7.29 (d, J = 8.1 Hz, 1H Trp Har), 7.57 (d, J = 7.9 Hz, 1H, Trp Har), 
8.26 (bs, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl): δ = 18.0 (Ala CH3), 23.3 (CH2), 28.3 
(C(CH)3), 30.8 (NCH3), 46.7 (Ala CH), 51.8 (OCH3), 53.7 (β-Tyr CH), 55.1 (OCH3), 56.7 (Trp 
CH), 59.2 (OCH3), 79.6 (C(CH)3), 82.4 (CHOCH3), 110.7 (Trp Car), 111.1 (Trp Car), 113.8 (β-Tyr 
Car), 118.5 (Trp Car), 119.4 (Trp Car), 122.0 (Trp Car), 122.2 (Trp Car), 127.2 (Trp Car), 128.7 (β-Tyr 
Car), 128.8 (β-Tyr Car), 136.1 (Trp Car), 155.1 (CO), 159.2 (β-Tyr Car), 169.3 (CO), 170.1 (CO), 
174.3 (CO); HRMS (ESI): m/z: calcd for C32H42N4O8 [M+Na]
+
: 633.28949; found: 633.28983. 
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Tripeptide 20d (F). To a solution of amine 8d (100 mg, 0.440 mmol, 1 equiv) in DMF (8 mL) 
were added acid 6 (171 mg, 0.440 mmol), HOBt (89 mg, 0.660 mmol, 1.5 equiv), iPr2NEt (0.225 
mL, 1.32 mmol, 3 equiv). At 0 °C TBTU (206 mg, 0.660 mmol, 1.5 equiv) was added and the 
reaction was stirred for 2–3 h at room temperature. The mixture was diluted with water (5 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 1N HCl 
solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried with 
Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash chromatography 
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(petroleum ether/EtOAc, 1:1) gave tripeptide 20d (180 mg, 68%) as a white foam. Rf (petroleum 
ether/EtOAc, 1:1) 0.26; [α]
20
D = +15.3 (c 1.0, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.93 (d, J 
= 6.6 Hz, 3H, Ala CH3), 1.40 (s, 9H, C(CH3)3), 2.96 (s, 3H, NCH3), 3.21 (dd, J=15.6, 9.8 Hz, 1H, 
CH2), 3.32–3.40 (m, 1H, CH2), 3.37 (s, 3H, OCH3), 3.59 (s, 3H, OCH3), 4.06 (d, J = 4.8 Hz, 1H, 
CHOCH3), 4.45–4.55 (m, 1H, Ala CH), 5.33–5.41 (m, 2H, β-Tyr CH, Ala NH), 5.52 (dd, J = 9.7, 
6.6 Hz, 1H, Trp CH), 6.90 (s, 1H, Trp Har), 6.90–6.97 (m, 2H, β-Tyr Har), 7.07–7.22 (m, β-Tyr Har, 
Trp Har, β-Tyr NH), 7.31 (d, J = 7.9 Hz, 1H Trp Har), 7.58 (d, J = 7.9 Hz, 1H, Trp Har), 8.11 (bs, 
1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 18.0 (Ala CH3), 23.4 (CH2), 28.3 (C(CH)3), 30.8 
(NCH3), 46.7 (Ala CH), 51.9 (OCH3), 53.6 (β-Tyr CH), 56.7 (Trp CH), 59.2 (OCH3), 79.6 
(C(CH)3), 82.2 (CHOCH3), 110.7 (Trp Car), 111.1 (Trp Car), 115.3 (d, J = 21.2 Hz), 118.5 (Trp Car), 
119.5 (Trp Car), 122.1 (Trp Car), 127.2 (Trp Car), 129.4 (d, J = 8.8 Hz, β-Tyr Car), 132.7 (d, J = 3.7 
Hz, β-Tyr Car), 136.1 (Trp Car), 155.2 (CO), 163.4 (d, J = 264.3 Hz, β-Tyr Car), 169.4 (CO), 169.9 
(CO), 174.4 (CO); HRMS (ESI): m/z: calcd for C31H39FN4O7 [M+Na]
+
: 621.26950; found: 
621.26986. 
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Reduction of azide 19e and coupling of amine 8e with acid 6 to tripeptide 20e (NO2). A 
solution of azide 19e (89.6 mg, 0.32 mmol) and PPh3 (92.2 mg, 0.352 mmol, 1.1 equiv) in of THF 
(1 mL) was stirred at 40–50 °C for 1 h for clean and complete conversion to the corresponding 
iminophosphorane (TLC control: CH2Cl2/MeOH/NH3, 10:1:0.1, Rf 0.5 for the iminophosphorane). 
Selected 
1
H NMR (400 MHz, CDCl3) data for the iminophosphorane: δ = 7.91 (d, 2H), 3.67 (s, 3H), 
3.13 (s, 3H). Then water (0.1 mL) was added and the mixture was further stirred at 40–50 °C for ~8 
h. Because the Rf values of the iminophosphorane, Ph3P=O and the resulting amine were all the 
same, the reaction progress was conveniently monitored by analyzing small evaporated probes 
taken from the reaction mixture by NMR. Selected 
1
H NMR (400 MHz, CDCl3) data for the amine: 
δ = 8.15 (d, 2H), 3.65 (s, 3H), 3.39 (s, 3H). When appropriately clean and high (~86%) conversion 
was achieved, the mixture was evaporated to yield 0.166 g of a sticky oil, containing ~36% w/w 
amine 8e (assuming the conversion was 80% as the lowest). Then, to a solution of this crude 
mixture (0.108 mg), containing amine 8e (approx. 38.9 mg, 0.153 mmol, 1.24 equiv of the amine) 
in DMF (2.3 mL) were added acid 6 (47.7 mg, 0.123 mmol), HOBt (24.9 mg, 0.184 mmol, 1.5 
equiv), iPr2NEt (0.064 mL, 0.369 mmol, 3 equiv). At –10 °C TBTU (59 mg, 0.184 mmol, 1.5 
equiv) was added and the reaction was stirred for 5–6 h at room temperature. The mixture was 
diluted with water (5 mL) and extracted with ethyl acetate (3 × 8 mL). The combined organic layers 
were washed with 1N NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl 
solution (5 mL), dried with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue 
by flash chromatography (petroleum ether/EtOAc, 2:1) gave tripeptide 20e (58.7 mg, 76%) as a 
white foam. Rf (petroleum ether/EtOAc, 2:1) 0.48. [α]
20
D = +4.0 (c 1.00, CH2Cl2); 
1
H NMR (400 
MHz, CDCl3): δ = 0.97 (d, J = 6.9 Hz, 3H, Ala CH3), 1.40 (s, 9H, tBu), 2.98 (s, 3H, NCH3), 3.17 
(dd, J = 15.5, 9.4 Hz, 1H, CH2), 3.38 (s, 3H, OCH3), 3.38 (m, 1H, CH2), 3.61 (s, 3H, CO2CH3), 4.07 
(d, J = 5.1 Hz, 1H, CHOCH3), 4.48–4.54 (m, 1H, Ala CH), 5.33 (d, J = 7.4 Hz, 1H, Ala NH), 5.44 
(dd, J = 8.1, 5.1 Hz, 1H, β-Tyr CH), 5.53 (dd, J = 8.9, 7.4 Hz, 1H, Trp CH), 6.89 (s, 1H, Trp HAr), 
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7.08 (ddd, J = 7.9, 7.1, 0.8 Hz, 1H, Trp HAr), 7.16 (ddd, J = 7.9, 7.1, 0.8 Hz, 1H, Trp HAr), 7.21 (d, J 
= 8.1 Hz, 1H, β-Tyr NH), 7.31 (d, J = 7.9 Hz, 1H, Trp HAr), 7.34 (d, J = 8.3 Hz, 2H, Ar), 7.57 (d, J 
= 7.9 Hz, 1H, Trp HAr), 8.06 (d, J = 8.3 Hz, 2H, Ar), 8.21 (s, 1H, Trp NH); 
13
C NMR (100 MHz, 
CDCl3): δ = 17.8 (Ala CH3), 23.5 (CH2), 28.3 (C(CH3)3), 30.9 (NCH3), 46.7 (Ala CH), 52.1 
(OCH3), 53.8 (β-Tyr CH), 56.8 (Trp CH), 59.3 (OCH3), 79.7 (C(CH3)3), 81.8 (CHOCH3), 110.5 
(quat. Trp), 111.2, 118.5, 119.5, 122.2 (2C, Trp), 123.4 (2C, Ar), 127.1 (quat. Trp), 128.7 (2C, Ar), 
136.1 (quat. Trp), 144.3 (quat. Ar), 147.5 (quat. Ar), 155.2 (Boc), 169.5, 169.6, 174.5; HMRS 
(ESI): m/z: calcd for C31H39N5O9 [M+Na]
+
: 648.26400; found: 648.26502. 
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Tripeptide 20g (CH2OTBS). To a solution of amine 8g (52.1 mg, 0.147 mmol, 1.2 equiv) in DMF 
(2.3 mL) were added acid 6 (47.7 mg, 0.123 mmol), HOBt (24.9 mg, 0.184 mmol, 1.5 equiv), 
iPr2NEt (0.064 mL, 3 equiv). At –10 °C TBTU (59 mg, 0.184 mmol, 1.5 equiv) was added and the 
reaction was stirred for 5–6 h at room temperature. The mixture was diluted with water (5 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 1N 
NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried 
with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash 
chromatography (petroleum ether/EtOAc, 1:1 to 1:2) gave tripeptide 20g (78.8 mg, 88%) as a white 
foam. Rf (petroleum ether/EtOAc, 1:2) 0.5; [α]
20
D = +11.1 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3): δ = 0.09 (s, 6H, SiCH3), 0.93 (s, 12H, tBu, Ala CH3), 1.41 (s, 9H, tBu), 2.97 (s, 3H, 
NCH3), 3.19 (dd, J = 15.4, 9.7 Hz, 1H, CH2), 3.34 (dd, J = 15.4, 6.8 Hz, 1H, CH2), 3.37 (s, 3H, 
OCH3), 3.58 (s, 3H, CO2CH3), 4.06 (d, J = 5.1 Hz, 1H, CHOCH3), 4.49–4.56 (m, 1H, Ala CH), 4.68 
(s, 2H, OCH2), 5.39 (dd, J = 8.8, 5.1 Hz, 1H, β-Tyr CH), 5.43 (d, J = 7.8 Hz, 1H, Ala NH), 5.50 
(dd, J = 9.7, 6.8 Hz, 1H, Trp CH), 6.82 (d, 1H, Trp HAr), 7.04 (d, J = 8.8 Hz, 1H, β-Tyr NH), 7.07–
7.22 (m, 6H, Ar, Trp HAr), 7.29 (d, J = 7.8 Hz, 1H, Trp HAr), 7.57 (d, J = 7.8 Hz, 1H, Trp HAr), 8.21 
(s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = –5.3 (SiCH3), 18.1 (C(CH3)3), 18.4 (Ala CH3), 
23.4 (CH2), 25.9 (C(CH3)3), 28.3 (C(CH3)3), 30.8 (NCH3), 46.7 (Ala CH), 51.8 (OCH3), 54.0 (β-Tyr 
CH), 56.7 (Trp CH), 59.1 (OCH3), 64.7 (CH2O), 79.5 (C(CH3)3), 82.3 (CHOCH3), 110.5 (quat. 
Trp), 111.1, 118.4, 119.4, 122.0, 122.3, 126.2 (2C, Ar), 127.1 (quat. Trp), 127.5 (2C, Ar), 135.5, 
136.1 (quat. Trp), 140.9, 155.1 (Boc), 169.3, 170.0, 174.2; HMRS (ESI): m/z: calcd for 
C38H56N4O8Si [M+Na]
+
: 747.37596; found: 747.37575. 
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Tripeptide 20h (CH2CH2OTBS). To a solution of amine 8h (68 mg, 0.185 mmol, 1.2 equiv) in 
DMF (2.9 mL) were added acid 6 (60 mg, 0.154 mmol), HOBt (31 mg, 0.231 mmol, 1.5 equiv), 
iPr2NEt (0.081 mL, 0.462 mmol, 3 equiv). At –10 °C TBTU (74 mg, 0.231 mmol, 1.5 equiv) was 
added and the reaction was stirred for 5–6 h at room temperature. The mixture was diluted with 
water (5 mL) and extracted with ethyl acetate (3 × 8 mL). The combined organic layers were 
washed with 1N NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl 
solution (5 mL), dried with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue 
by flash chromatography (petroleum ether/EtOAc, 1:1 to 1:2) gave tripeptide 20h (97.7 mg, 86%) 
as a white foam. Rf (petroleum ether/EtOAc, 1:2) 0.55; (petroleum ether/EtOAc, 1:1) 0.34; [α]
20
D = 
+10.1 (c 1.00, CH2Cl2);
 1
H NMR (400 MHz, CDCl3): δ = –0.01 (s, 6H, SiCH3), 0.86 (s, 9H, tBu), 
0.94 (s, J = 6.8 Hz, 3H, Ala CH3), 1.41 (s, 9H, tBu), 2.76 (t, J = 6.8 Hz, 2H, CH2Ar), 2.97 (s, 3H, 
NCH3), 3.20 (dd, J = 15.4, 9.6 Hz, 1H, CH2), 3.34 (dd, J = 15.4, 6.8 Hz, 1H, CH2), 3.36 (s, 3H, 
OCH3), 3.58 (s, 3H, CO2CH3), 3.79 (t, J = 6.8 Hz, 2H, OCH2), 4.05 (d, J = 5.1 Hz, 1H, CHOCH3), 
4.49–4.56 (m, 1H, Ala CH), 5.37 (dd, J = 8.7, 5.8 Hz, 1H, β-Tyr CH), 5.44 (d, J = 7.6 Hz, 1H, Ala 
NH), 5.49 (dd, J = 9.6, 6.8 Hz, 1H, Trp CH), 6.82 (s, 1H, Trp HAr), 7.00 (d, J = 8.7 Hz, 1H, β-Tyr 
NH), 7.05–7.16 (m, 6H, Ar, Trp HAr), 7.28 (d, J = 7.8 Hz, 1H, Trp HAr), 7.57 (d, J = 7.6 Hz, 1H, 
Trp HAr), 8.31 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = –5.4 (SiCH3), 18.1 (C(CH3)3), 
18.3 (Ala CH3), 23.5 (CH2), 25.9 (C(CH3)3), 28.3 (C(CH3)3), 30.8 (NCH3), 39.2 (CH2Ar), 46.7 (Ala 
CH), 51.8 (OCH3), 53.9 (β-Tyr CH), 56.6 (Trp CH), 59.1 (OCH3), 64.3 (CH2O), 79.5 (C(CH3)3), 
82.3 (CHOCH3), 110.4 (quat. Trp), 111.1, 118.4, 119.3, 121.9, 122.3, 127.1 (quat. Trp), 127.4 (2C, 
Ar), 129.2 (2C, Ar), 134.7, 136.1 (quat. Trp), 138.8, 155.1 (Boc), 169.3, 170.0, 174.2; HMRS 
(ESI): m/z: calcd for C39H58N4O8Si [M+Na]
+
: 761.39161; found: 761.39196. 
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Tripeptide 20i (CN). To a solution of amine 8i (68 mg, 0.154 mmol, 1.2 equiv) in DMF (2.4 mL) 
were added acid 6 (50.2 mg, 0.129 mmol), HOBt (26.1 mg, 0.193 mmol, 1.5 equiv), iPr2NEt (0.068 
mL, 0.387 mmol, 3 equiv). At –10 °C TBTU (62.1 mg, 0.193 mmol, 1.5 equiv) was added and the 
reaction was stirred for 5–6 h at room temperature. The mixture was diluted with water (5 mL) and 
extracted with ethyl acetate (3 × 8 mL). The combined organic layers were washed with 1N 
NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried 
with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash 
chromatography (petroleum ether/EtOAc, 1:1 to 1:2) gave tripeptide 8i (67.1 mg, 86%) as a white 
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foam. [α]
20
D = +4.6 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.95 (d, J = 6.8 Hz, 3H, Ala 
CH3), 1.40 (s, 9H, tBu), 2.96 (s, 3H, NCH3), 3.24 (dd, J = 15.4, 9.6 Hz, 1H, CH2), 3.37 (s, 3H, 
OCH3), 3.38 (dd, J = 15.4, 6.8 Hz, 1H, CH2), 3.60 (s, 3H, CO2CH3), 4.05 (d, J = 5.1 Hz, 1H, 
CHOCH3), 4.47–4.53 (m, 1H, Ala CH), 5.33 (d, J = 7.6 Hz, 1H, Ala NH), 5.39 (dd, J = 8.3, 5.1 Hz, 
1H, β-Tyr CH), 5.52 (dd, J = 9.6, 6.8 Hz, 1H, Trp CH), 6.89 (s, 1H, Trp HAr), 7.09 (ddd, J = 7.1, 
7.1, 0.8 Hz, 1H, Trp HAr), 7.16 (ddd, J = 7.8, 7.1, 0.8 Hz, 1H, Trp HAr), 7.20 (d, J = 8.3 Hz, 1H, β-
Tyr NH), 7.29 (d, J = 8.3 Hz, 2H, Ar), 7.31 (d, J = 7.1 Hz, 1H, Trp HAr), 7.51 (d, J = 8.3 Hz, 2H, 
Ar), 7.56 (d, J = 7.8 Hz, 1H, Trp HAr), 8.22 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 17.8 
(Ala CH3), 23.4 (CH2), 28.3 (C(CH3)3), 30.8 (NCH3), 46.7 (Ala CH), 52.1 (OCH3), 54.0 (β-Tyr 
CH), 56.8 (Trp CH), 59.3 (OCH3), 79.7 (C(CH3)3), 81.8 (CHOCH3), 110.5 (quat. Trp), 111.1, 111.7 
(quat.), 118.4, 118.6 (quat.), 119.5, 122.2 (2C), 127.1 (quat. Trp), 128.5 (2C, Ar), 132.1 (2C, Ar), 
136.1 (quat. Trp), 142.3, 155.2 (Boc), 169.6 (2C), 174.5. 
 
 
N O
Me
N
NHBoc
H
O
HN
CO2Me
OMe
20j
O NH2
 
 
Tripeptide 20j (CONH2). To a solution of amine 8j (40.4 mg, 0.160 mmol, 1.6 equiv) in DMF (2 
mL) were added acid 6 (38.9 mg, 0.100 mmol, 1 equiv), HOBt (20.3 mg, 0.150 mmol, 1.5 equiv), 
iPr2NEt (0.052 mL, 0.3 mmol, 3 equiv). At –10 °C TBTU (48.2 mg, 0.150 mmol, 1.5 equiv) was 
added and the reaction was stirred for 5–6 h at room temperature. The mixture was diluted with 
water (5 mL) and extracted with ethyl acetate (3 × 8 mL). The combined organic layers were 
washed with 1N NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl 
solution (5 mL), dried with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue 
by flash chromatography (CH2Cl2/MeOH, 10:1) gave tripeptide 20j contaminated with DMF and 
TMU, repeated chromatography using EtOAc afforded clean product (46.1 mg, 74%) as a white 
foam. Rf (EtOAc) 0.25; [α]
20
D = +5.9 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 1.01 (d, J 
= 6.9 Hz, 3H, Ala CH3), 1.40 (s, 9H, tBu), 3.01 (s, 3H, NCH3), 3.12 (dd, J = 15.3, 8.7 Hz, 1H, 
CH2), 3.35 (s, 3H, OCH3), 3.37 (dd, J = 15.4, 7.4 Hz, 1H, CH2), 3.58 (s, 3H, CO2CH3), 4.05 (d, J = 
4.8 Hz, 1H, CHOCH3), 4.51–4.57 (m, 1H, Ala CH), 5.37 (dd, J = 8.1, 5.1 Hz, 1H, β-Tyr CH), 5.47 
(d, J = 7.4 Hz, 1H, Ala NH), 5.52 (dd, J = 8.1, 7.9 Hz, 1H, Trp CH), 6.02 (s, 1H, CONH2), 6.36 (s, 
1H, CONH2), 6.78 (s, 1H, Trp HAr), 7.07 (ddd, J = 7.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.12–7.16 (m, 2H, 
Ar, Trp HAr), 7.25 (d, J = 8.1 Hz, 1H, β-Tyr NH), 7.28 (d, J = 7.9 Hz, 1H, Trp HAr), 7.58 (app d, J = 
7.3 Hz, 3H, Ar, Trp HAr), 8.49 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 18.07 (Ala CH3), 
23.8 (CH2), 28.3 (C(CH3)3), 30.9 (NCH3), 46.7 (Ala CH), 52.0 (OCH3), 54.1 (β-Tyr CH), 56.8 (Trp 
CH), 59.2 (OCH3), 79.7 (C(CH3)3), 82.0 (CHOCH3), 110.2 (quat. Trp), 111.3, 118.4, 119.4 (quat.), 
122.0, 122.5, 127.1 (quat. Trp), 127.4 (2C, Ar), 127.7 (2C, Ar), 132.9, 136.2 (quat. Trp), 140.9, 
155.2 (Boc), 169.3, 169.6, 169.9, 174.4; HMRS (ESI): m/z: calcd for C32H41N5O8 [M+Na]
+
: 
646.28473; found: 646.28443. 
 
 
 29
N O
Me
N
NHBoc
H
O
HN
Ph
CO2Me
OMe
20k  
 
Tripeptide 20k (Ph). To a solution of amine 8k (52.0 mg, 0.182 mmol, 1.2 equiv) in DMF (2.9 
mL) were added acid 6 (59.1 mg, 0.152 mmol), HOBt (31 mg, 0.228 mmol, 1.5 equiv), iPr2NEt 
(0.08 mL, 0.456 mmol, 3 equiv). At –10 °C TBTU (73 mg, 0.228 mmol, 1.5 equiv) was added and 
the reaction was stirred for 5–6 h at room temperature. The mixture was diluted with water (5 mL) 
and extracted with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 1N 
NaHSO4 solution (5 mL), saturated NaHCO3 solution (5 mL), saturated NaCl solution (5 mL), dried 
with Na2SO4, filtered, and concentrated in vacuo. Purification of the residue by flash 
chromatography (petroleum ether/EtOAc, 1:1 to 1:2) gave tripeptide 20k (83.3 mg, 83%) as a white 
foam. 
1
H NMR (400 MHz, CDCl3): δ = 0.94 (d, J = 6.6 Hz, 3H, Ala CH3), 1.42 (s, 9H, tBu), 2.97 
(s, 3H, NCH3), 3.24 (dd, J = 15.8, 9.8 Hz, 1H, CH2), 3.35–3.40 (m, 1H, CH2), 3.35 (s, 3H, OCH3), 
3.62 (s, 3H, CO2CH3), 4.11 (d, J = 4.8 Hz, 1H, CHOCH3), 4.50–4.57 (m, 1H, Ala CH), 5.44 (d, J = 
7.6 Hz, 1H, Ala NH), 5.47 (dd, J = 8.4, 4.8 Hz, 1H, β-Tyr CH), 5.56 (dd, J = 9.8, 6.4 Hz, 1H, Trp 
CH), 6.91 (d, J = 1.5 Hz, 1H, Trp Har), 7.08–7.19 (m, 3H, Trp HAr, β-Tyr NH), 7.28–7.34 (m, 4H), 
7.42 (t, 2H), 7.48 (d, J = 8.3 Hz, 2H, Ar), 7.54 (d, J = 7.1 Hz, 2H, Ar), 7.59 (d, J = 7.8 Hz, 1H, Trp 
Har), 8.25 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 18.0 (Ala CH3), 23.3 (CH2), 28.3 
(C(CH3)3), 30.8 (NCH3), 46.7 (Ala CH), 51.9 (OCH3), 53.9 (β-Tyr CH), 56.7 (Trp CH), 59.1 
(OCH3), 79.6 (C(CH3)3), 83.1 (CHOCH3), 110.6 (quat. Trp), 111.1, 118.5, 119.4, 122.0, 122.2, 
127.0 (2C, Ar), 127.11 (2C, Ar), 127.16 (quat. Trp), 127.3 (2C, Ar), 127.9 (Ar), 128.7 (2C, Ar), 
135.7, 136.1 (quat. Trp), 140.6, 140.7, 155.1 (Boc), 169.4, 170.0, 174.4. 
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Tripeptide acid 21b (Me). To a stirred solution of tripeptide ester 20b (57.0 mg, 0.096 mmol) in 
1,2-dichloroethane (1.5 mL) was added Me3SnOH (87 mg, 0.480 mmol). After stirring for 5 h at 80 
°C, TLC showed complete conversion and the reaction mixture was diluted with KHSO4 (5% in 
water, 4 mL). The aqueous layer was extracted with EtOAc (2 × 5 mL) and the combined organic 
layers were dried over Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21b as a 
colorless foam.  
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Tripeptide acid 21c (OMe). To a stirred solution of tripeptide ester 20c (0.135 g, 0.221 mmol) in 
1,2-dichloroethane (3.5 mL) was added Me3SnOH (160 mg, 0.884 mmol). After stirring for 5 h at 
80 °C, TLC showed complete conversion and the reaction mixture was diluted with KHSO4 (5% in 
water, 6 mL). The aqueous layer was extracted with EtOAc (2 × 10 mL) and the combined organic 
layers were dried over Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21c as a 
colorless foam.  
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Tripeptide acid 21d (F). To a stirred solution of tripeptide ester 20d (0.057 g, 0.095 mmol) in 1,2-
dichloroethane (1.5 mL) was added Me3SnOH (86 mg, 0.475 mmol). After stirring for 5 h at 80 °C, 
TLC showed complete conversion and the reaction mixture was diluted with KHSO4 (5% in water, 
4 mL). The aqueous layer was extracted with EtOAc (2 × 5 mL) and the combined organic layers 
were dried over Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21d as a 
colorless foam. 
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Tripeptide acid 21e (NO2). To a solution of methyl ester 20e (55.3 mg, 0.0884 mmol) in THF (0.4 
mL) were added water (0.6 mL), methanol (0.3 mL) and NaOH (7.5 mg, 0.188 mmol, 2.1 equiv). 
The initial biphasic mixture became homogeneous with progressing saponification. After being 
stirred for 1 h at room temperature until complete conversion (controlled by TLC), the mixture was 
diluted with water (5 mL) and ethyl acetate (8 mL). It was carefully acidified with 1M NaHSO4 to 
pH ~ 2 before the layers were separated and the aqueous phase extracted once with ethyl acetate (8 
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mL). The combined organic layers were washed with water, saturated NaCl solution, dried with 
Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21e as a colorless foam. Rf 
(EtOAc/AcOH, 100:1) 0.4; 
1
H NMR (400 MHz, CDCl3): δ = 0.83 (d, J = 6.9 Hz, 3H, Ala CH3), 
1.39 (s, 9H, t-Bu), 2.93 (s, 3H, NCH3), 3.18 (dd, J = 15.3, 9.9 Hz, 1H, CH2), 3.28–3.34 (m, 1H, 
CH2), 3.34 (s, 3H, OCH3), 3.98 (d, J = 6.3 Hz, 1H, CHOCH3), 4.42–4.49 (m, 1H, Ala CH), 5.40 
(dd, J = 7.6, 7.1 Hz, 1H, β-Tyr CH), 5.46 (d, J = 7.4 Hz, 1H, Ala NH), 5.59 (dd, J = 9.9, 7.4 Hz, 
1H, Trp CH), 6.88 (s, 1H, Trp HAr), 7.05 (app t, J = 7.0 Hz, 1H, Trp HAr), 7.13 (app t, J = 7.0 Hz, 
1H, Trp HAr), 7.21 (d, J = 8.6 Hz, 1H, β-Tyr NH), 7.28 (d, J = 7.9 Hz, 1H, Trp HAr), 7.41 (d, J = 8.4 
Hz, 2H, Ar), 7.53 (d, J = 7.9 Hz, 1H, Trp HAr), 8.04 (d, J = 8.4 Hz, 2H, Ar), 8.36 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 17.0 (Ala CH3), 23.2 (CH2), 28.3 (C(CH3)3), 30.6 (NCH3), 46.6 
(Ala CH), 54.0 (β-Tyr CH), 56.7 (Trp CH), 58.8 (OCH3), 80.8 (C(CH3)3), 82.5 (CHOCH3), 110.2 
(quat. Trp), 111.2, 118.4, 119.5, 122.1, 122.3, 123.5 (2C, Ar), 127.1 (quat. Trp), 128.4 (2C, Ar), 
136.1 (quat. Trp), 145.2 (quat. Ar), 147.4 (quat. Ar), 156.3 (Boc), 169.5, 170.7, 174.8; HMRS 
(ESI): m/z: calcd for C30H37N5O9 [M+Na]
+
: 634.24835; found: 634.24819. 
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Tripeptide acid 21g (CH2OTBS). To a solution of methyl ester 20g (75.5 mg, 0.104 mmol) in 
THF (0.4 mL) were added water (0.6 mL), methanol (0.3 mL) and NaOH (8.0 mg, 0.2 mmol, 1.9 
equiv). The initial biphasic mixture became homogeneous with progressing saponification. After 
being stirred for 2 h at room temperature until complete conversion (controlled by TLC), the 
mixture was diluted with water (5 mL) and ethyl acetate (8 mL). It was carefully acidified with 1M 
NaHSO4 to pH ~ 2 before the layers were separated and the aqueous phase extracted once with 
ethyl acetate (8 mL). The combined organic layers were washed with water, saturated NaCl 
solution, dried with Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21g as a 
colorless foam. Since the saponification was accompanied by partial cleavage of the silyl ether [Rf 
(EtOAc/AcOH, 100:1) 0.23 for deprotected acid] the crude material was purified by flash 
chromatography (EtOAc/petroleum ether/AcOH, 100:50:0.6) to provide the acid 21g (61.3 mg, 
82%) as a white foam. Rf (EtOAc/AcOH, 100:1) 0.57; 
1
H NMR (400 MHz, CDCl3): δ = 0.09 (s, 
6H, SiCH3), 0.77 (d, J = 6.9 Hz, 1H, Ala CH3), 0.93 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 2.92 (s, 3H, 
NCH3), 3.20–3.32 (m, 2H, CH2), 3.36 (s, 3H, OCH3), 4.03 (d, J = 5.9 Hz, 1H, CHOCH3), 4.41–4.49 
(m, 1H, Ala CH), 4.69 (s, 2H, OCH2), 5.36–5.40 (m, 2H, β-Tyr CH, Ala NH), 5.60 (dd, J = 9.7, 6.6 
Hz, 1H, Trp CH), 6.88 (s, 1H, Trp HAr), 6.97 (d, J = 9.2 Hz, 1H, β-Tyr NH), 7.07 (t, 1H, Trp HAr), 
7.14 (t, J = 7.4 Hz, 1H, Trp HAr), 7.22–7.30 (d, 3H, Ar, Trp HAr), 7.56 (d, J = 7.9 Hz, 1H, Trp HAr), 
8.24 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = –5.3 (SiCH3), 16.9 (C(CH3)3), 18.4 (Ala 
CH3), 22.9 (CH2), 25.9 (C(CH3)3), 28.3 (C(CH3)3), 30.5 (NCH3), 46.9 (Ala CH), 54.0 (β-Tyr CH), 
56.6 (Trp CH), 58.8 (OMe), 64.6 (CH2O), 80.6 (C(CH3)3), 83.3 (CHOCH3), 110.2, 111.1, 118.4, 
119.3, 121.9, 122.4, 126.2, 127.3 (3C), 136.0, 136.4, 140.9, 156.2 (Boc), 169.2, 171.0, 174.7. 
HMRS (ESI): m/z: calcd for C37H54N4O8Si [M+Na]
+
: 733.36031; found: 733.36067. 
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Tripeptide acid 21h (CH2CH2OTBS). To a solution of methyl ester 20h (94.7 mg, 0.128 mmol) in 
THF (0.3 mL) were added water (0.7 mL), methanol (0.5 mL) and NaOH (10 mg, 0.25 mmol, 2 
equiv). The initial biphasic mixture became homogeneous with progressing saponification. After 
being stirred for overnight at room temperature until complete conversion (controlled by TLC), the 
mixture was diluted with water (5 mL) and ethyl acetate (8 mL). It was carefully acidified with 1M 
NaHSO4 to pH ~ 2 before the layers were separated and the aqueous phase extracted once with 
ethyl acetate (8 mL). The combined organic layers were washed with water, saturated NaCl 
solution, dried with Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21h as a 
colorless foam. Since the saponification was accompanied by partial cleavage of the silyl ether [Rf 
(EtOAc/AcOH, 100:1) 0.31 for deprotected acid] the crude material was purified by flash 
chromatography (EtOAc/petroleum ether/AcOH, 100:50:0.6) to provide the acid 21h (74.2 mg, 
80%) as a white foam; Rf (EtOAc/AcOH, 100:1) 0.62. In addition, 13.7 mg of the byproduct were 
isolated. 
1
H NMR (400 MHz, CDCl3): δ = –0.02 (s, 6H, SiCH3), 0.79 (s, J = 7.1 Hz, 3H, Ala CH3), 
0.86 (s, 9H, t-Bu), 1.42 (s, 9H, t-Bu), 2.78 (t, J = 7.1 Hz, 2H, CH2Ar), 2.93 (s, 3H, NCH3), 3.20–
3.32 (m, 2H, CH2), 3.36 (s, 3H, OCH3), 3.78 (t, J = 7.1 Hz, 2H, OCH2), 4.01 (d, J = 5.9 Hz, 1H, 
CHOCH3), 4.42–4.49 (m, 1H, Ala CH), 5.30 (d, J = 8.1 Hz, 1H, Ala NH), 5.34 (dd, J = 8.9, 5.9 Hz, 
1H, β-Tyr CH), 5.60 (dd, J = 9.7, 6.6 Hz, 1H, Trp CH), 6.88 (d, J = 8 Hz, 1H, β-Tyr NH), 6.80 (s, 
1H, Trp HAr), 7.07–7.11 (m, 4H, Ar, Trp HAr), 7.20 (d, J = 7.9 Hz, 2H, Ar), 7.29 (d, J = 8.1 Hz, 1H, 
Trp HAr), 7.56 (d, J = 7.9 Hz, 1H, Trp HAr), 8.10 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ 
= –5.4 (SiCH3), 17.0 (Ala CH3), 18.3 (C(CH3)3), 23.0 (CH2), 25.9 (C(CH3)3), 28.3 (C(CH3)3), 30.4 
(NCH3), 39.2 (CH2Ar), 46.9 (Ala CH), 54.0 (β-Tyr CH), 56.5 (Trp CH), 58.7 (OMe), 64.4 (CH2O), 
80.7 (C(CH3)3), 83.4 (CHOCH3), 110.4 (quat. Trp), 111.1, 118.5, 119.4, 122.0, 122.3, 127.20 (2C, 
Ar), 127.25 (quat. Trp), 129.3 (2C, Ar), 135.7, 136.1 (quat. Trp), 138.7, 156.4 (Boc), 169.2, 171.0, 
174.6; HMRS (ESI): m/z: calcd for C38H56N4O8Si [M+Na]
+
: 747.37596; found: 747.37579. 
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Tripeptide acid 21i (CN). To a solution of methyl ester 20i (63.8 mg, 0.105 mmol) in THF (0.3 
mL) were added water (0.4 mL), methanol (0.3 mL) and K2CO3 (29 mg, 0.21 mmol, 2 equiv). The 
initial biphasic mixture became homogeneous with progressing saponification. After being stirred 
overnight at room temperature until complete conversion (controlled by TLC), the mixture was 
diluted with water (5 mL) and ethyl acetate (8 mL). It was carefully acidified with 1M NaHSO4 to 
pH ~ 2 before the layers were separated and the aqueous phase extracted once with ethyl acetate (8 
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mL). The combined organic layers were washed with water, saturated NaCl solution, dried with 
Na2SO4, filtered, and concentrated in vacuo to afford the crude acid 21i as a colorless foam. Rf 
(CH2Cl2/MeOH/AcOH, 10:1:0.1) 0.4; 
1
H NMR (400 MHz, CDCl3): δ = 0.81 (d, J = 6.8 Hz, 3H, 
Ala CH3), 1.39 (s, 9H, t-Bu), 2.92 (s, 3H, NCH3), 3.17 (dd, J = 15.4, 10.1 Hz, 1H, CH2), 3.28–3.33 
(m, 1H, CH2), 3.33 (s, 3H, OCH3), 3.96 (d, J = 6.1 Hz, 1H, CHOCH3), 4.42–4.49 (m, 1H, Ala CH), 
5.36 (app t, 1H, β-Tyr CH), 5.43 (d, J = 7.6 Hz, 1H, Ala NH), 5.58 (app t, 1H, Trp CH), 6.89 (s, 
1H, Trp HAr), 7.06 (app t, 1H, Trp HAr), 7.12–7.17 (m, 2H, β-Tyr NH, Trp HAr), 7.291 (d, J = 8.1 
Hz, 1H, Trp HAr), 7.37 (d, J = 8.1 Hz, 2H, Ar), 7.50 (d, J = 8.1 Hz, 2H, Ar), 7.53 (d, J = 7.8 Hz, 1H, 
Trp HAr), 8.34 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 17.0 (Ala CH3), 23.1 (CH2), 28.3 
(C(CH3)3), 30.6 (NCH3), 46.9 (Ala CH), 54.1 (OMe), 56.7 (β-Tyr CH), 58.8 (Trp CH), 80.8 
(C(CH3)3), 82.6 (CHOCH3), 110.3 (quat. Trp), 111.2, 111.6 (quat.), 118.4, 118.6 (quat.), 119.5, 
122.1, 122.3, 127.1 (quat. Trp), 128.2 (2C, Ar), 132.2 (2C, Ar), 136.1 (quat. Trp), 143.3, 156.3 
(Boc), 169.5, 170.8, 174.7; HMRS (ESI): m/z: calcd for C31H37N5O7 [M+Na]
+
: 614.25852; found: 
614.25821. 
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Tripeptide acid 21k (Ph). To a solution of methyl ester 20k (83.3 mg, 0.127 mmol) in THF (0.4 
mL) were added water (0.6 mL), methanol (0.3 mL) and NaOH (10 mg, 0.25 mmol, 2 equiv). The 
initial biphasic mixture became homogeneous with progressing saponification. After being stirred 
for 2 h at room temperature until complete conversion (controlled by TLC), the mixture was diluted 
with water (5 mL) and ethyl acetate (8 mL). It was carefully acidified with 1M NaHSO4 to pH ~ 2 
before the layers were separated and the aqueous phase extracted once with ethyl acetate (8 mL). 
The combined organic layers were washed with water, saturated NaCl solution, dried with Na2SO4, 
filtered, and concentrated in vacuo to afford the crude acid 21k as a colorless foam. Rf 
(EtOAc/AcOH, 100:1) 0.5; 
1
H NMR (400 MHz, CDCl3): δ = 0.76 (d, J = 7.1 Hz, 3H, Ala CH3), 
1.41 (s, 9H, t-Bu), 2.92 (s, 3H, NCH3), 3.21–3.35 (m, 2H, CH2), 3.39 (s, 3H, OCH3), 4.09 (d, J = 
5.8 Hz, 1H, CHOCH3), 4.42–4.49 (m, 1H, Ala CH), 5.42–5.47 (m, 2H, β-Tyr CH, Ala NH), 5.63 
(dd, J = 9.4, 6.8 Hz, 1H, Trp CH), 6.90 (s, 1H, Trp HAr), 7.06–7.15 (m, 3H, Trp HAr, β-Tyr NH), 
7.26–7.42 (m, 6H), 7.48–7.57 (m, 5H), 8.25 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 
17.0 (Ala CH3), 23.0 (CH2), 28.3 (C(CH3)3), 30.5 (NCH3), 46.9 (Ala CH), 54.0 (β-Tyr CH), 56.6 
(Trp CH), 58.8 (OCH3), 80.8 (C(CH3)3), 83.3 (CHOCH3), 110.4 (quat. Trp), 111.1, 118.4, 119.4, 
122.0, 122.3, 127.0 (2C, Ar), 127.22 (2C, Ar), 127.26 (quat. Trp), 127.31 (Ar), 127.8 (2C, Ar), 
128.7 (2C, Ar), 136.1 (quat. Trp), 136.9, 140.6, 140.7, 156.4 (Boc), 169.34, 171.0, 174.7; 
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Depsipeptide 22b (Me). The crude acid 21b, resulting from the hydrolysis of ester 20b (57 mg, 
0.096 mmol), and alcohol 7 (23 mg, 0.146 mmol) were dissolved in THF (6 mL) and Ph3P (75 mg, 
0.288 mmol) was added at 0 °C. This was followed by the dropwise addition of DEAD (0.131 mL, 
0.288 mmol, 40% in toluene). The cooling bath was removed and the mixture stirred overnight at 
room temperature. The reaction mixture was concentrated in vacuo and the residue purified by flash 
chromatography (petroleum ether/EtOAc, 2:1) to give ester 22b (46 mg, 67% over two steps) as a 
colorless foam. Rf (petroleum ether/EtOAc, 2:1) 0.23; [α]
20
D = +3.3 (c 1.00, CH2Cl2); 
1
H NMR (400 
MHz, CDCl3): δ = 0.78 (d, J = 6.6 Hz, 3H, CH3), 0.88 (d, J = 6.3 Hz, 3H, CH3), 0.92 (d, J = 6.8 Hz, 
3H, Ala CH3), 1.02 (d, J = 6.8 Hz, 3H, 2-CH3), 1.40 (s, 9H, C(CH3)3), 1.41 (s, 9H, C(CH3)3), 1.57 
(s, 3H, 4-CH3), 1.93 (dd, J = 13.9, 7.8 Hz, 1H, CH2), 2.27 (s, 3H, ArCH3), 2.34 (dd, J = 13.6, 6.8 
Hz, 1H, CH2), 2.40–2.50 (m, 2H, 2-H, 6-H), 2.95 (s, 3H, NCH3), 3.20–3.28 (m, 1H, Trp CH2), 3.34 
(dd, J = 15.9, 6.3 Hz, 1H, Trp CH2), 3.37 (s, 3H, OCH3), 4.06 (d, J = 4.3 Hz, 1H, CHOCH3), 4.48–
4.60 (m, 2H, Ala CH, 7-H), 4.86 (d, J = 9.4 Hz, 1H, 5-H), 5.37 (dd, J = 8.6, 4.6 Hz, 1H, β-Tyr CH), 
5.44 (d, J = 7.3 Hz, 1H, Ala NH), 5.52 (dd, J = 10.1, 6.3 Hz, 1H, Trp CH), 6.91 (s, 1H, Trp HAr), 
7.04 (d, J = 8.1 Hz, 2H, β-Tyr HAr), 7.06–7.12 (m, 2H, Trp HAr, β-Tyr NH), 7.12–7.19 (m, 3H, Trp 
HAr, β-Tyr HAr), 7.29 (d, J = 8.1 Hz, 1H, Trp HAr), 7.58 (d, J = 7.8 Hz, 1H, Trp HAr), 8.03 (s, 1H, 
Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 16.4 (4-CH3), 16.6 (2-CH3), 17.1 (6-CH3), 17.6 (7-
CH3), 18.1 (Ala CH3), 21.1 (ArCH3), 23.4 (Trp CH2), 28.1 (C(CH)3), 28.3 (C(CH)3), 30.8 (NCH3), 
37.6 (C-6), 38.6 (C-2), 43.4 (CH2), 46.7 (Ala CH), 54.0 (β-Tyr CH), 56.7 (Trp CH), 59.1 (OCH3), 
75.9 (C-7), 79.5 (C(CH)3), 79.9 (C(CH)3), 82.1 (CHOCH3), 110.9 (Trp Car), 111.1 (Trp Car), 118.5 
(Trp Car), 119.5 (Trp Car), 122.1 (Trp Car), 127.3 (Trp Car), 127.9 (β-Tyr Car), 127.9 (C-5), 129.0 (β-
Tyr Car), 133.7 (C-4, β-Tyr Car), 136.1 (Trp Car), 137.6 (β-Tyr Car), 155.1 (CO), 169.3 (CO), 174.3 
(CO), 175.8 (CO); HRMS (ESI): m/z: calcd for C46H66N4O9 [M+Na]
+
: 841.47220; found: 
841.47301. 
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Depsipeptide 22c (OMe). The crude acid 21c, resulting from the hydrolysis of ester 20c (135 mg, 
0.221 mmol) and alcohol 7 (52 mg, 0.336 mmol) were dissolved in THF (12 mL) and Ph3P (174 
mg, 0.663 mmol) was added at 0 °C. This was followed by the dropwise addition of DEAD (0.302 
mL, 0.663 mmol, 40% in toluene). The cooling bath was removed and the mixture stirred overnight 
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at room temperature. The reaction mixture was concentrated in vacuo and the residue purified by 
flash chromatography (petroleum ether/EtOAc, 2:1) to give ester 22c (99 mg, 61% over two steps) 
as a colorless foam. Rf (petroleum ether/EtOAc, 3:2) 0.19; [α]
20
D = +14.8 (c 1.00, CH2Cl2); 
1
H MR 
(400 MHz, CDCl3): δ = 0.79 (d, J = 6.6 Hz, 3H, 6-CH3), 0.88 (d, J = 6.1 Hz, 3H, 7-CH3), 0.91 (d, J 
= 6.9 Hz, 3H, Ala CH3), 1.01 (d, J = 6.9 Hz, 3H, 2-CH3), 1.40 (s, 9H, C(CH3)3), 1.41 (s, 9H, 
C(CH3)3), 1.57 (s, 3H, 4-CH3), 1.93 (dd, J = 13.7, 7.6 Hz, 1H, CH2), 2.34 (dd, J = 13.7, 6.9 Hz, 1H, 
CH2), 2.40–2.51 (m, 2H, 2-H, 6-H), 2.95 (s, 3H, NCH3), 3.23 (dd, J = 15.6, 10.1 Hz, 1H, Trp CH2), 
3.34 (dd, J = 16.0, 6.1 Hz, 1H, Trp CH2), 3.39 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 4.05 (d, J = 4.3 
Hz, 1H, CHOCH3), 4.47–4.54 (m, 1H, Ala CH), 4.53–4.61 (m, 1H, 7-H), 4.86 (d, J = 9.7 Hz, 1H, 5-
H), 5.35 (dd, J = 8.4, 4.6 Hz, 1H, β-Tyr CH), 5.42 (d, J = 7.6 Hz, 1H, Ala NH), 5.52 (dd, J = 9.7, 
6.6 Hz, 1H, Trp CH), 6.75 (d, J = 8.7 Hz, 2H, β-Tyr Har), 6.89 (s, 1H, Trp Har), 7.03–7.08 (m, 1H, 
β-Tyr NH), 7.07–7.11 (m, 1H, Trp Har), 7.15 (t, J = 7.4 Hz, 1H, Trp Har), 7.20 (d, J = 8.4 Hz, 2H, β-
Tyr Har), 7.29 (d, J = 7.9 Hz, 1H, Trp Har), 7.57 (d, J = 7.6 Hz, 1H, Trp Har), 8.19 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 16.4 (4-CH3), 16.6 (2-CH3), 17.1 (6-CH3), 17.6 (7-CH3), 18.1 
(Ala CH3), 23.4 (Trp CH2), 28.0 (C(CH)3), 28.3 (C(CH)3), 30.8 (NCH3), 37.6 (C-6), 38.6 (C-2), 
43.4 (CH2), 46.7 (Ala CH), 53.7 (β-Tyr CH), 55.2 (OCH3), 56.7 (Trp CH), 59.2 (OCH3), 75.8 (C-7), 
79.5 (C(CH)3), 79.8 (C(CH)3), 82.0 (CHOCH3), 110.7 (Trp Car), 111.1 (Trp Car), 113.7 (β-Tyr Car), 
118.5 (Trp Car), 119.4 (Trp Car), 122.0 (Trp Car), 122.1 (Trp Car), 127.2 (Trp Car), 127.9 (C-5), 128.9 
(β-Tyr Car), 129.2 (β-Tyr Car), 133.7 (C-4), 136.1 (Trp Car), 155.1 (CO), 159.2 (β-Tyr Car), 169.2 
(CO), 169.2 (CO), 174.3 (CO), 175.8 (CO); HRMS (ESI): m/z: calcd for C46H66N4O10 [M+Na]
+
: 
857.46712; found: 857.46651. 
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Depsipeptide 22d (F). The crude acid 21d, resulting from the hydrolysis of ester 20d (57 mg, 0.095 
mmol) and alcohol 7 (22 mg, 0.144 mmol) were dissolved in THF (6 mL) and Ph3P (75 mg, 0.285 
mmol) was added at 0 °C. This was followed by the dropwise addition of DEAD (0.130 mL, 0.285 
mmol, 40% in toluene). The cooling bath was removed and the mixture stirred overnight at room 
temperature. The reaction mixture was concentrated in vacuo and the residue purified by flash 
chromatography (petroleum ether/EtOAc, 2:1) to give ester 22d (44 mg, 64% over two steps) as a 
colorless foam. Rf (petroleum ether/EtOAc, 2:1) 0.29; [α]
20
D = +10.5 (c 1.00, CH2Cl2); 
1
H NMR 
(400 MHz, CDCl3): δ = 0.78 (d, J = 6.6 Hz, 3H, 6-CH3), 0.88 (d, J = 6.4 Hz, 3H, 7-CH3), 0.93 (d, J 
= 6.6 Hz, 3H, Ala CH3), 1.02 (d, J = 6.8 Hz, 3H, 2-CH3), 1.40 (s, 9H, C(CH3)3), 1.41 (s, 9H, 
C(CH3)3), 1.57 (s, 3H, 4-CH3), 1.93 (dd, J = 14.0, 7.6 Hz, 1H, CH2), 2.34 (dd, J = 13.7, 6.9 Hz, 1H, 
CH2), 2.39–2.50 (m, 2H, 2-H, 6-H), 2.96 (s, 3H, NCH3), 3.22 (dd, J = 15.5, 9.7 Hz, 1H, Trp CH2), 
3.30–3.39 (m, 1H, Trp CH2), 3.40 (s, 3H, OCH3), 4.05 (d, J = 4.3 Hz, 1H, CHOCH3), 4.45–4.60 (m, 
2H, Ala CH, 7-H), 4.85 (d, J = 9.4 Hz, 1H, 5-H), 5.34–5.41 (m, 2H, β-Tyr CH, Ala NH), 5.52 (dd, J 
= 9.5, 6.5 Hz, 1H, Trp CH), 6.87–6.94 (s, 3H, Trp Har, β-Tyr Har), 7.05–7.13 (m, 2H, Trp Har, β-Tyr 
NH), 7.16 (t, J = 7.6 Hz, 1H, Trp Har), 7.21–7.29 (m, 2H, β-Tyr Har), 7.31 (d, J = 8.1 Hz, 1H, Trp 
Har), 7.58 (d, J = 7.9 Hz, 1H, Trp Har), 8.07 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 16.4 
(4-CH3), 16.6 (2-CH3), 17.1 (6-CH3), 17.6 (7-CH3), 18.0 (Ala CH3), 23.4 (Trp CH2), 28.0 
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(C(CH3)3), 28.3 (C(CH3)3), 30.8 (NCH3), 37.6 (C-6), 38.6 (C-2), 43.4 (CH2), 46.7 (Ala CH), 53.6 
(β-Tyr CH), 56.7 (Trp CH), 59.2 (OCH3), 76.0 (C-7), 79.6 (C(CH3)3), 79.9 (C(CH3)3), 81.8 
(CHOCH3), 110.8 (Trp Car), 111.1 (Trp Car), 115.1 (d, J = 22.0 Hz, β-Tyr Car), 118.5 (Trp Car), 
119.5 (Trp Car), 122.1 (Trp Car), 122.1 (Trp Car), 127.2 (Trp Car), 127.8 (C-5), 129.9 (d, J = 8.1 Hz, 
β-Tyr Car), 132.7 (d, J = 3.7 Hz, β-Tyr Car), 133.8 (C-4), 136.1 (Trp Car), 155.2 (CO), 162.4 (d, J = 
146.6 Hz, β-Tyr Car), 169.1 (CO), 169.3 (CO), 174.4 (CO), 175.8 (CO); HRMS (ESI): m/z: calcd 
for C45H63FN4O9 [M+Na]
+
: 845.44713; found: 845.44760. 
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Depsipeptide 22e (NO2). The crude acid 21e (52 mg, 0.0851 mmol) and alcohol 7 (32.8 mg, 0.128 
mmol, 1.5 equiv) were dissolved in THF (1 mL) and Ph3P (40 mg, 0.152 mmol, 1.8 equiv) was 
added at 0 °C. This was followed by the dropwise addition of DIAD (0.030 mL, 0.152 mmol, 1.8 
equiv). The cooling bath was removed and the mixture stirred overnight at room temperature. The 
reaction mixture was concentrated in vacuo and the residue purified by flash chromatography 
(petroleum ether/EtOAc, 2:1 to 1:1) to give ester 22e (62 mg, 86%) as a colorless foam. Rf 
(petroleum ether/EtOAc, 1:1) 0.30; [α]
20
D = –4.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 0.77 (d, J = 6.6 Hz, 3H, CH3), 0.91 (d, J = 6.1 Hz, 3H, CH3), 0.96 (d, J = 6.8 Hz, 3H, Ala CH3), 
1.01 (d, J = 6.8 Hz, 3H, CH3), 1.40 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 1.56 (s, 3H, CH3), 1.92 (dd, J = 
13.9, 7.6 Hz, 1H, CH2), 2.33 (dd, J = 13.9, 6.8 Hz, 1H, CH2), 2.40–2.51 (m, 2H, 2 CH), 2.97 (s, 3H, 
NCH3), 3.17 (dd, J = 15.4, 9.6 Hz, 1H, CH2), 3.37 (dd, J = 15.4, 7.1 Hz, 1H, CH2), 3.40 (s, 3H, 
OCH3), 4.06 (d, J = 4.5 Hz, 1H, CHOCH3), 4.46–4.61 (m, 2H, Ala CH, CO2CH), 4.84 (d, J = 9.9 
Hz, 1H, =CH), 5.34 (d, J = 7.3 Hz, 1H, Ala NH), 5.43 (dd, J = 8.3, 4.5 Hz, 1H, β-Tyr CH), 5.52 
(dd, J = 9.6, 7.1 Hz, 1H, Trp CH), 6.88 (s, 1H, Trp HAr), 7.07 (ddd, J = 7.8, 7.1, 0.8 Hz, 1H, Trp 
HAr), 7.15 (ddd, J = 8.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.21 (d, J = 8.3 Hz, 1H, β-Tyr NH), 7.30 (d, J = 
8.1 Hz, 1H, Trp HAr), 7.39 (d, J = 8.6 Hz, 2H, Ar), 7.56 (d, J = 7.8 Hz, 1H, Trp HAr), 8.04 (d, J = 
8.6 Hz, 2H, Ar), 8.25 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 16.4, 16.6, 17.1, 17.6, 
17.9, 23.5 (CH2), 28.0 (C(CH3)3), 28.3 (C(CH3)3), 30.9 (NMe), 37.5, 38.6, 43.4 (CH2), 46.7 (Ala 
CH), 53.8 (β-Tyr CH), 56.8 (Trp CH), 59.3 (OCH3), 76.4 (CO2CH), 79.6 (C(CH3)3), 79.9 
(C(CH3)3), 81.4 (CHOCH3), 110.5 (quat. Trp), 111.1, 118.4, 119.5, 122.1, 122.2, 123.3 (2C, Ar), 
127.1 (quat. Trp), 127.5 (=CH), 129.1 (2C, Ar), 134.0 (=C<), 136.1 (quat. Trp), 144.3, 147.4, 155.2 
(Boc), 168.6, 169.5, 174.5, 175.7; HMRS (ESI): m/z: calcd for C45H63N5O11 [M+Na]
+
: 872.44163; 
found: 872.44212. 
 
 
 37
N O
Me
N
NHBoc
H
O
HN
O
OMe
O
tBuO2C
22g
OTBS
 
 
Depsipeptide 22g (CH2OTBS). The crude acid 21g (60.2 mg, 0.0847 mmol) and alcohol 7 (37.7 
mg, 0.147 mmol, 1.7 equiv) were dissolved in THF (1 mL) and Ph3P (40 mg, 0.152 mmol, 1.8 
equiv) was added at 0 °C. This was followed by the dropwise addition of DEAD (0.070 mL of 40% 
in toluene, 1.8 equiv). The cooling bath was removed and the mixture stirred overnight at room 
temperature. The reaction mixture was concentrated in vacuo and the residue purified by flash 
chromatography (petroleum ether/acetone, 3:1 to 2:1) to give ester 22g (64.5 mg, contaminated with 
diethyl hydrazodicarboxylate (9% mass) byproduct = 58.7 mg, 73%) as a white foam. [α]
20
D = +3.4 
(c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.08 (2s, 6H, SiCH3), 0.77 (d, J = 6.8 Hz, 3H, 
CH3), 0.86 (d, J = 6.3 Hz, 3H, CH3), 0.92 (s, 9H, t-BuSi), 0.96 (d, J = 6.6 Hz, 3H, Ala CH3), 1.01 
(d, J = 6.8 Hz, 3H, CH3), 1.40 (s, 18H, t-Bu), 1.56 (s, 3H, CH3), 1.92 (dd, J = 13.9, 7.6 Hz, 1H, 
CH2), 2.33 (dd, J = 13.7, 6.8 Hz, 1H, CH2), 2.40–2.50 (m, 2H, 2 CH), 2.98 (s, 3H, NCH3), 3.17 (dd, 
J = 15.4, 9.3 Hz, 1H, CH2), 3.34 (dd, J = 15.4, 6.6 Hz, 1H, CH2), 3.40 (s, 3H, OCH3), 4.05 (d, J = 
4.6 Hz, 1H, CHOCH3), 4.49–4.58 (m, 2H, Ala CH, CO2CH), 4.66 (s, 2H, ArCH2), 4.85 (d, J = 9.9 
Hz, 1H, =CH), 5.38 (dd, J = 8.7, 4.6 Hz, 1H, β-Tyr CH), 5.44–5.49 (m, 2H, Ala NH, Trp CH), 6.77 
(s, 1H, Trp HAr), 7.02 (d, 1H, J = 8.7 Hz, β-Tyr NH), 7.09 (ddd, J = 7.8, 7.1, 0.8 Hz, 1H, Trp HAr), 
7.13–7.23 (m, 5H, Trp HAr, Ar), 7.28 (d, J = 8.1 Hz, 1H, Trp HAr), 7.57 (d, J = 7.8 Hz, 1H, Trp 
HAr), 8.16 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = –5.30, –5.28, 16.4, 16.6, 17.1, 17.6, 
18.2, 18.4, 23.6 (CH2), 25.9 (SiC(CH3)3), 28.0 (C(CH3)3), 28.3 (C(CH3)3), 30.8 (NCH3), 37.6, 38.6, 
43.4 (CH2), 46.7 (Ala CH), 53.9 (β-Tyr CH), 56.7 (Trp CH), 59.1 (OCH3), 64.8 (CH2O), 75.9 
(CO2CH), 79.5 (C(CH3)3), 79.8 (C(CH3)3), 81.9 (CHOCH3), 110.4 (quat. Trp), 111.1, 118.4, 119.4, 
122.0, 122.3, 126.2, 127.1, 127.91, 127.97, 133.7 (=C<), 135.6, 136.0 (quat. Trp), 140.9, 155.1 
(Boc), 169.1, 169.3, 174.1, 175.8; HMRS (ESI): m/z: calcd for C52H80N4O10Si [M+Na]
+
: 
971.55359; found: 971.55362. 
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Depsipeptide 22h (CH2CH2OTBS). The crude acid 21h (59.0 mg, 0.0814 mmol) and alcohol 7 
(31.4 mg, 0.123 mmol, 1.5 equiv) were dissolved in THF (1 mL) and Ph3P (42.7 mg, 0.163 mmol, 2 
equiv) was added at 0 °C. This was followed by the dropwise addition of DEAD (0.075 mL of 40% 
in toluene, 0.164 mmol, 2 equiv). The cooling bath was removed and the mixture stirred overnight 
at room temperature. The reaction mixture was concentrated in vacuo and the residue purified by 
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flash chromatography (petroleum ether/EtOAc, 1:2) to give ester 22h (51.8 mg, 66%) as a colorless 
foam. In this case separation from the diethyl hydrazodicarboxylate byproduct is difficult and 
requires separation at high Rf’s. [α]
20
D = +1.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 
0.01 (s, 6H, SiCH3), 0.77 (d, J = 6.6 Hz, 3H, CH3), 0.87 (s, 12H, CH3, tBuSi), 0.97 (d, J = 6.9 Hz, 
3H, Ala CH3), 1.01 (d, J = 6.9 Hz, 3H, CH3), 1.41 (s, 18H, tBu), 1.57 (s, 3H, CH3), 1.92 (dd, J = 
13.7, 7.9 Hz, 1H, CH2), 2.33 (dd, J = 13.7, 6.9 Hz, 1H, CH2), 2.40–2.50 (m, 2H, CH+CH), 2.75 (t, J 
= 6.9 Hz, 2H, ArCH2), 2.99 (s, 3H, NCH3), 3.17 (dd, J = 15.3, 9.3 Hz, 1H, CH2), 3.34 (dd, J = 15.3, 
6.6 Hz, 1H, CH2), 3.39 (s, 3H, OCH3), 3.79 (t, J = 6.9 Hz, 2H, CH2O), 4.03 (d, J = 4.6 Hz, 1H, 
CHOCH3), 4.50–4.59 (m, 2H, Ala CH, CO2CH), 4.85 (d, J = 9.7 Hz, 1H, =CH), 5.36 (dd, J = 8.7, 
4.6 Hz, 1H, β-Tyr CH), 5.44–5.48 (m, 2H, Ala NH, Trp CH), 6.79 (s, 1H, Trp HAr), 6.98 (d, 1H, J = 
8.7 Hz, β-Tyr NH), 7.05–7.16 (m, 6H, Ar, Trp HAr), 7.27 (d, J = 8.1 Hz, 1H, Trp HAr), 7.57 (d, J = 
7.9 Hz, 1H, Trp HAr), 8.15 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = –5.36, –5.33, 16.4, 
16.6, 17.1, 17.6, 18.2, 18.3, 23.6 (CH2), 25.9 (SiC(CH3)3), 28.0 (C(CH3)3), 28.3 (C(CH3)3), 30.8 
(NCH3), 37.6, 38.6, 39.2 (ArCH2), 43.4 (CH2), 46.7 (Ala CH), 53.9 (β-Tyr CH), 56.7 (Trp CH), 
59.1 (OCH3), 64.5 (CH2O), 75.8 (CO2CH), 79.5 (C(CH3)3), 79.8 (C(CH3)3), 82.0 (CHOCH3), 110.3 
(quat. Trp), 111.1, 118.4, 119.3, 121.9, 122.3, 127.1 (quat. Trp), 127.9 (3C, Ar, =CH), 129.0 (2C, 
Ar), 133.7 (=C<), 134.7, 136.1 (quat. Trp), 138.6, 155.1 (Boc), 169.1, 169.2, 174.1, 175.8; HMRS 
(ESI): m/z: calcd for C53H82N4O10Si [M+Na]
+
: 985.56924; found: 985.56858. 
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Depsipeptide 22i (CN). The crude acid 21i (54.9 mg, 0.0927 mmol) and alcohol 7 (35.7 mg, 0.139 
mmol, 1.5 equiv) were dissolved in THF (0.93 mL) and Ph3P (41.3 mg, 0.158 mmol, 1.7 equiv) was 
added at 0 °C. This was followed by the dropwise addition of DIAD (0.031 mL, 0.158 mmol, 1.7 
equiv). The cooling bath was removed and the mixture stirred overnight at room temperature. The 
reaction mixture was concentrated in vacuo and the residue purified by flash chromatography 
(petroleum ether/EtOAc, 1:1 to 1:2) to give ester 22i (60.1 mg, 78%) as a colorless foam. Rf 
(petroleum ether/EtOAc, 1:2) 0.58; [α]
20
D = –5.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 0.77 (d, J = 6.6 Hz, 3H, CH3), 0.89 (d, J = 6.3 Hz, 3H, CH3), 0.95 (d, J = 6.8 Hz, 3H, Ala CH3), 
1.02 (d, J = 6.8 Hz, 3H, CH3), 1.40 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 1.57 (s, 3H, CH3), 1.93 (dd, J = 
13.7, 7.7 Hz, 1H, CH2), 2.33 (dd, J = 13.7, 6.8 Hz, 1H, CH2), 2.40–2.50 (m, 2H, 2 CH), 2.97 (s, 3H, 
NCH3), 3.19 (dd, J = 15.7, 9.6 Hz, 1H, CH2), 3.37 (dd, J = 15.7, 6.3 Hz, 1H, CH2), 3.40 (s, 3H, 
OCH3), 4.03 (d, J = 4.8 Hz, 1H, CHOCH3), 4.47–4.60 (m, 2H, Ala CH, CO2CH), 4.85 (d, J = 9.4 
Hz, 1H, =CH), 5.34 (d, J = 7.6 Hz, 1H, Ala NH), 5.39 (dd, J = 8.3, 4.8 Hz, 1H, β-Tyr CH), 5.51 
(dd, J = 8.9, 6.8 Hz, 1H, Trp CH), 6.90 (s, 1H, Trp HAr), 7.09 (ddd, J = 7.8, 7.1, 0.8 Hz, 1H, Trp 
HAr), 7.15–7.20 (m, 2H, Trp HAr, NH), 7.32 (d, J = 8.1 Hz, 1H, Trp HAr), 7.36 (d, J = 8.1 Hz, 2H, 
Ar), 7.51 (d, J = 8.1 Hz, 2H, Ar), 7.57 (d, J = 7.8 Hz, 1H, Trp HAr), 8.05 (s, 1H, Trp NH); 
13
C NMR 
(100 MHz, CDCl3): δ = 16.4, 16.7, 17.1, 17.6, 18.0, 23.5 (CH2), 28.1 (C(CH3)3), 28.3 (C(CH3)3), 
30.9 (NCH3), 37.5, 38.6, 43.4 (CH2), 46.7 (Ala CH), 54.0 (β-Tyr CH), 56.8 (Trp CH), 59.3 (OCH3), 
76.4 (CO2CH), 79.7 (C(CH3)3), 79.9 (C(CH3)3), 81.5 (CHOCH3), 110.7 (quat. Trp), 111.1, 111.8, 
118.5, 118.6, 119.6, 122.1, 122.2, 127.1 (quat. Trp), 127.6 (=CH), 129.0, 132.0, 134.0 (=C<), 136.1 
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(quat. Trp), 142.3, 155.2 (Boc), 168.7, 169.5, 174.5, 175.7; HMRS (ESI): m/z: calcd for 
C46H63N5O9 [M+Na]
+
: 852.45180; found: 852.45123. 
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Depsipeptide 22k (Ph). The crude acid 21k (81.5 mg, 0.127 mmol) and alcohol 7 (39.2 mg, 0.152 
mmol, 1.2 equiv) were dissolved in THF (1.3 mL) and Ph3P (50 mg, 0.190 mmol, 1.5 equiv) was 
added at 0 °C. This was followed by the dropwise addition of DIAD (0.037 mL, 0.190 mmol, 1.5 
equiv). The cooling bath was removed and the mixture stirred overnight at room temperature. The 
reaction mixture was concentrated in vacuo and the residue purified by flash chromatography 
(petroleum ether/EtOAc, 2:1 to 1:1 to 0:1) to give ester 22k (62.6 mg, 56%) as a colorless foam. 
[α]
20
D = –10.0 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.77 (d, J = 6.6 Hz, 3H, CH3), 
0.89 (d, J = 6.1 Hz, 3H, CH3), 0.93 (d, J = 6.8 Hz, 3H, Ala CH3), 1.01 (d, J = 6.8 Hz, 3H, CH3), 
1.41 (s, 18H, t-Bu), 1.56 (s, 3H, CH3), 1.93 (dd, J = 13.9, 7.6 Hz, 1H, CH2), 2.34 (dd, J = 13.9, 6.8 
Hz, 1H, CH2), 2.40–2.51 (m, 2H, 2 CH), 2.97 (s, 3H, NCH3), 3.24 (dd, J = 15.7, 10.1 Hz, 1H, CH2), 
3.37 (dd, J = 15.7, 6.6 Hz, 1H, CH2), 3.43 (s, 3H, OCH3), 4.10 (d, J = 4.3 Hz, 1H, CHOCH3), 4.50–
4.62 (m, 2H, Ala CH, CO2CH), 4.86 (d, J = 9.6 Hz, 1H, =CH), 5.56 (m, 2H, Ala NH, β-Tyr CH), 
5.56 (dd, J = 9.9, 6.6 Hz, 1H, Trp CH), 6.90 (s, 1H, Trp HAr), 7.08–7.20 (m, 3H, Trp HAr, β-Tyr 
NH), 7.29–7.35 (m, 4H), 7.41 (t, 2H), 7.46 (d, 2H, J = 8.1 Hz), 7.52 (d, 2H, J = 7.1 Hz), 7.59 (d, 
1H, J = 7.6 Hz), 8.18 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 16.4, 16.6, 17.1, 17.6, 
18.1, 23.4 (CH2), 28.0 (C(CH3)3), 28.3 (C(CH3)3), 30.8 (NCH3), 37.6, 38.6, 43.4 (CH2), 46.7 (Ala 
CH), 53.9 (β-Tyr CH), 56.8 (Trp CH), 59.2 (OCH3), 76.0 (CO2CH), 79.5 (C(CH3)3), 79.8 
(C(CH3)3), 82.0 (CHOCH3), 110.7 (quat. Trp), 111.1, 118.5, 119.4, 122.05, 122.14, 127.00, 127.03, 
127.19, 127.24, 127.8 (=CH), 128.4, 128.7, 133.7 (=C<), 135.8, 136.1 (quat. Trp), 140.72, 140.76, 
155.1 (Boc), 169.2, 169.3, 174.3, 175.8. HMRS (ESI): m/z: calcd for C51H68N4O9 [M+Na]
+
: 
903.48785; found: 903.48732. 
 
Chondramide A analogues 
Deprotection. Double Boc-deprotection was carried out in 1:10 v/v solution of TFA/CH2Cl2 at 
room temperature overnight at 0.03M concentration of a substrate (the progress of reaction was 
easily monitored by TLC in CH2Cl2/MeOH/NH3 10:1:0.1 and NMR, in each case complete and 
clean conversion was achieved after ~20 h). The solvent was removed in vacuo. For azeotropic 
removal of TFA, the residue was taken up in toluene (3 × 0.5 mL) and concentrated in vacuo each 
time. 
Macrolactam formation. In most cases macrolactamization was carried out at 0.0025M 
concentration instead of 0.001M without loss of efficacy. The crude product from the deprotection 
step was dissolved in DMF and iPr2NEt (5 equiv), HOBt (1.5 equiv), and TBTU (1.5 equiv) were 
added. The solution was stirred at room temperature for 20 h and then diluted with water and 
EtOAc. The aqueous layer was extracted with EtOAc (3 times) and the combined organic layers 
were washed with 5% aqueous KHSO4 solution, water, saturated NaHCO3 solution, water, and 
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saturated NaCl solution. The combined organic extracts were dried over Na2SO4, filtered, and 
concentrated in vacuo. The residue was purified by column chromatography. 
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Chondramide 2b (Me). To a stirred solution of compound 22b (42 mg, 0.051 mmol) in CH2Cl2 (1 
mL) was added TFA (38 µL, 0.51 mmol) at 0 °C. The reaction mixture was allowed to warm to 
room temperature and after stirring for 22 h, the solvent was removed in vacuo. For azeotropic 
removal of TFA the residue was taken up in toluene (3 × 0.5 mL) and concentrated in vacuo each 
time. The crude product was dissolved in DMF (50 mL) and iPr2NEt (34 µL, 0.204 mmol), HOBt 
(24.0 mg, 0.179 mmol) and TBTU (56.0 mg, 0.179 mmol) were added. The solution was stirred at 
room temperature for 20 h and then diluted with water (25 mL) and EtOAc (25 mL). The aqueous 
layer was extracted with EtOAc (3 × 20 mL) and the combined organic layers were washed with 
5% aqueous KHSO4 solution (25 mL), water (25 mL), saturated NaHCO3 solution (25 mL), water 
(2 × 25 mL) and saturated NaCl solution (20 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo. Purification by flash chromatography (petroleum 
ether/acetone, 2:1) of the residue to give depsipeptide 2b (11 mg, 33% over two steps) as a colorless 
foam. Rf (petroleum ether/acetone, 2:1) 0.18; [α]
20
D = +23.9 (c 0.83, CH2Cl2); 
1
H NMR (400 MHz, 
CD3OD): δ = 0.81 (d, J = 7.1 Hz, 3H, Ala CH3), 0.86 (d, J = 6.3 Hz, 3H, 7-CH3), 0.91 (d, J = 6.8 
Hz, 3H, 6-CH3), 1.08 (d, J = 6.8 Hz, 3H, 2-CH3), 1.69 (s, 3H, 4-CH3), 1.98–2.06 (m, 1H, CH2), 
2.15–2.27 (m, 1H, CH2), 2.32 (s, 3H, ArCH3), 2.45–2.55 (m, 1H, 6-H), 2.60–2.71 (m, 1H, 2-H), 
3.01 (d, J = 8.1 Hz, 2H, Trp CH2), 3.08 (s, 3H, NCH3), 3.13 (s, 3H, OCH3), 3.88 (d, J = 9.9 Hz, 1H, 
CHOCH3), 4.48–4.57 (m, 1H, 7-H), 4.74–4.81 (m, 1H, Ala CH), 4.82–4.85 (m, 1H, 5-H), 5.06 (d, J 
= 9.9 Hz, 1H, β-Tyr CH), 5.52 (dd, J = 8.0, 8.0 Hz, 1H, Trp CH), 6.83 (s, 1H, Trp Har), 6.97 (t, J = 
7.1, 1H, Trp Har), 7.00–7.08 (m, 5H, β-Tyr Har, Trp Har), 7.25 (d, J = 8.1 Hz, 1H, Trp Har), 7.55 (d, 
J = 7.8 Hz, 1H, Trp Har); 
13
C NMR (100 MHz, CD3OD): δ = 16.0 (4-CH3), 17.9 (6-CH3), 18.4 (Ala 
CH3), 18.9 (7-CH3), 19.0 (2-CH3), 21.2 (ArCH3), 26.5 (Trp CH2), 30.9 (NCH3), 38.7 (C-6), 40.2 (C-
2), 45.9 (Ala CH), 46.0 (CH2), 55.9 (β-Tyr CH), 56.9 (Trp CH), 58.2 (OCH3), 79.2 (C-7), 83.3 
(CHOCH3), 110.1 (Trp Car), 112.2 (Trp Car), 119.4 (Trp Car), 119.6 (Trp Car), 122.2 (Trp Car), 124.4 
(Trp Car), 128.3 (β-Tyr Car), 128.5 (Trp Car), 129.0 (C-5), 129.9 (β-Tyr Car), 134.7 (C-4), 137.4 (β-
Tyr Car), 137.9 (Trp Car), 138.4 (β-Tyr Car), 171.3 (CO), 173.4 (CO), 174.9 (CO), 176.9 (CO); 
HRMS (ESI): m/z: calcd for C37H48N4O6 [M+Na]
+
: 667.34661; found: 667.34683. 
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Chondramide 2c (OMe). To a stirred solution of compound 22c (87.0 mg, 0.104 mmol) in CH2Cl2 
(1 mL) was added TFA (154 µL, 2.08 mmol) at 0 °C. The reaction mixture was allowed to warm to 
room temperature and after stirring for 22 h, the solvent was removed in vacuo. For azeotropic 
removal of TFA the residue was taken up in toluene (3 × 0.5 mL) and concentrated in vacuo each 
time. The crude product was dissolved in DMF (104 mL) and iPr2NEt (71 µL, 0.416 mmol), HOBt 
(49.0 mg, 0.364 mmol) and TBTU (114 mg, 0.364 mmol) were added. The solution was stirred at 
room temperature for 20 h and then diluted with water (50 mL) and EtOAc (50 mL). The aqueous 
layer was extracted with EtOAc (3 × 50 mL) and the combined organic layers were washed with 
5% aqueous KHSO4 solution (50 mL), water (50 mL), saturated NaHCO3 solution (50 mL), water 
(2 × 40 mL) and saturated NaCl solution (50 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 2:7) to give depsipeptide 2c (21.3 mg, 31% over 
two steps) as a colorless foam. Rf (petroleum ether/EtOAc, 2:7) 0.20; [α]
20
D = +6.0 (c 0.40, MeOH); 
1
H NMR (400 MHz, CD3OD): δ = 0.83 (d, J = 6.9 Hz, 3H, Ala CH3), 0.86 (d, J = 6.1 Hz, 3H, 7-
CH3), 0.92 (d, J = 6.9 Hz, 3H, 6-CH3), 1.08 (d, J = 6.9 Hz, 3H, 2-CH3), 1.69 (s, 3H, 4-CH3), 2.04 
(dd, J = 13.1, 2.9 Hz, 1H, CH2), 2.23 (dd, J = 12.5, 12.5 Hz, 1H, CH2), 2.46–2.58 (m, 1H, 6-H), 
2.61–2.72 (m, 1H, 2-H), 2.97–3.06 (m, 2H, Trp CH2), 3.08 (s, 3H, NCH3), 3.13 (s, 3H, OCH3), 3.78 
(s, 3H, OCH3), 3.85 (d, J = 9.9 Hz, 1H, CHOCH3), 4.48–4.56 (m, 1H, 7-H), 4.75–4.81 (m, 1H, Ala 
CH), 4.81–4.85 (m, 1H, 5-H), 5.05 (d, J = 9.9 Hz, 1H, β-Tyr CH), 5.53 (dd, J = 8.0, 8.0 Hz, 1H, Trp 
CH), 6.77 (d, J = 8.7 Hz, 2H, β-Tyr Har), 6.83 (s, 1H, Trp Har), 6.95–7.01 (m, 1H, Trp Har), 7.04 (d, 
J = 8.7 Hz, 2H, β-Tyr Har), 7.05–7.08 (m, 1H, Trp Har), 7.25 (d, J = 8.1 Hz, 1H, Trp Har), 7.57 (d, J 
= 7.6 Hz, 1H, Trp Har); 
13
C NMR (100 MHz, CD3OD): δ = 16.0 (4-CH3), 17.9 (6-CH3), 18.4 (Ala 
CH3), 18.9 (7-CH3), 19.0 (2-CH3), 26.5 (Trp CH2), 30.9 (NCH3), 38.7 (C-6), 40.2 (C-2), 45.9 (Ala 
CH), 46.1 (CH2), 55.6 (β-Tyr CH), 55.7 (OCH3), 56.9 (Trp CH), 58.2 (OCH3), 79.2 (C-7), 83.4 
(CHOCH3), 110.1 (Trp Car), 112.2 (Trp Car), 114.6 (β-Tyr Car), 119.4 (Trp Car), 119.6 (Trp Car), 
122.3 (Trp Car), 124.5 (Trp Car), 128.5 (Trp Car), 129.0 (C-5), 129.5 (β-Tyr Car), 132.5 (β-Tyr Car), 
134.7 (C-4), 137.9 (Trp Car), 160.5 (β-Tyr Car), 171.2 (CO), 173.4 (CO), 174.9 (CO), 176.9 (CO); 
HRMS (ESI): m/z: calcd for C37H48N4O7 [M+Na]
+
: 683.34152; found: 683.34136. 
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Chondramide 2d (F). To a stirred solution of compound 22d (30 mg, 0.036 mmol) in CH2Cl2 (1 
mL) was added TFA (40 µL, 0.54 mmol) at 0 °C. The reaction mixture was allowed to warm to 
room temperature and after stirring for 22 h, the solvent was removed in vacuo. For azeotropic 
removal of TFA the residue was taken up in toluene (3 × 0.5 mL) and concentrated in vacuo each 
time. The crude product was dissolved in DMF (36 mL) and iPr2NEt (24 µL, 0.144 mmol), HOBt 
(17 mg, 0.126 mmol) and TBTU (29 mg, 0.126 mmol) were added. The solution was stirred at 
room temperature for 20 h and then diluted with water (20 mL) and EtOAc (20 mL). The aqueous 
layer was extracted with EtOAc (3 × 20 mL) and the combined organic layers were washed with 
5% aqueous KHSO4 solution (20 mL), water (20 mL), saturated NaHCO3 solution (20 mL), water 
(2 × 20 mL) and saturated NaCl solution (20 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography (petroleum ether/acetone, 2:1) of the residue to give depsipeptide 2d (9.00 mg, 
31% over three steps) as a colorless foam. Rf (petroleum ether/acetone, 2:1) 0.16; [α]
20
D = +13.3 (c 
0.67, CH2Cl2); 
1
H NMR (400 MHz, CD3OD): δ = 0.87 (d, J = 6.1 Hz, 3H, 7-CH3), 0.91 (d, J = 6.8 
Hz, 3H, Ala CH3), 0.92 (d, J = 6.6 Hz, 3H, 6-CH3), 1.09 (d, J = 6.6 Hz, 3H, 2-CH3), 1.70 (s, 3H, 4-
CH3), 2.05 (dd, J = 13.0, 3.2 Hz, 1H, CH2), 2.16–2.27 (m, 1H, CH2), 2.46–2.58 (m, 1H, 6-H), 2.63–
2.73 (m, 1H, 2-H), 3.07 (d, J = 8.3 Hz, 2H, Trp CH2), 3.10 (s, 3H, NCH3), 3.12 (s, 3H, OCH3), 3.82 
(d, J = 10.1 Hz, 1H, CHOCH3), 4.48–4.55 (m, 1H, 7-H), 4.78–4.84 (m, 2H, Ala CH, 5-H), 5.05 (d, 
J = 10.1 Hz, 1H, β-Tyr CH), 5.52 (dd, J = 8.1, 8.0 Hz, 1H, Trp CH), 6.79 (s, 1H, Trp Har), 6.88–
6.94 (m, 2H, β-Tyr Har), 6.95–7.00 (m, 1H, Trp Har), 7.03–7.09 (m, 3H, β-Tyr Har, Trp Har), 7.25 (d, 
J = 8.1 Hz, 1H, Trp Har), 7.58 (d, J = 7.8 Hz, 1H, Trp Har); 
13
C NMR (100 MHz, CD3OD): δ = 16.0 
(4-CH3), 18.0 (6-CH3), 18.5 (Ala CH3), 19.0 (7-CH3, 2-CH3), 26.7 (Trp CH2), 30.9 (NCH3), 38.7 
(C-6), 40.2 (C-2), 45.9 (Ala CH), 46.2 (CH2), 55.5 (β-Tyr CH), 57.0 (Trp CH), 58.2 (OCH3), 79.4 
(C-7), 83.1 (CHOCH3), 109.9 (Trp Car), 112.2 (Trp Car), 115.4 (d, J = 21.2 Hz, β-Tyr Car), 119.4 
(Trp Car), 119.6 (Trp Car), 122.3 (Trp Car), 124.5 (Trp Car), 128.5 (Trp Car), 129.0 (C-5), 130.2 (d, J 
= 8.1 Hz, β-Tyr Car), 134.7 (C-4), 136.4 (d, J = 2.9 Hz, β-Tyr Car), 137.9 (Trp Car), 171.2 (CO), 
173.3 (CO), 174.8 (CO), 176.9 (CO); HRMS (ESI): m/z: calcd for C36H45FN4O6 [M+Na]
+
: 
671.32153; found: 671.32177. 
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Chondramide 2e (NO2). To a stirred solution of compound 22e (62.7 mg, 0.0738 mmol) in CH2Cl2 
(2.2 mL) was added TFA (0.22 mL, 0.34 g, 2.98 mmol) at 0 °C. The reaction mixture was allowed 
to warm to room temperature and after stirring for 22 h, the solvent was removed in vacuo (TLC 
control: CH2Cl2/MeOH/NH3, 10:1:0.1). For azeotropic removal of TFA the residue was taken up in 
toluene (3 × 0.5 mL) and concentrated in vacuo each time. The crude product was dissolved in 
DMF (30 mL) and iPr2NEt (64 µL, 47.7 mg, 0.369 mmol, 5 equiv), HOBt (19.9 mg, 0.147 mmol, 2 
equiv) and TBTU (47.4 mg, 0.147 mmol, 2 equiv) were added. The solution was stirred at room 
temperature for 20 h and then diluted with water (20 mL) and EtOAc (20 mL). The aqueous layer 
was extracted with EtOAc (3 × 20 mL) and the combined organic layers were washed with 5% 
aqueous KHSO4 solution (20 mL), water (20 mL), saturated NaHCO3 solution (20 mL), water (2 × 
20 mL) and saturated NaCl solution (20 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography (petroleum ether/EtOAc, 1:3 to 0:1) to give depsipeptide 2e (27.3 mg, 48%) as a 
colorless foam. Rf (EtOAc) 0.41; [α]
20
D = +18.5 (c 1.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 
0.84 (d, J = 6.6 Hz, 3H, CH3), 0.85 (d, J = 6.1 Hz, 3H, CH3), 1.07 (d, J = 6.8 Hz, 3H, CH3), 1.17 (d, 
J = 6.8 Hz, 3H, CH3), 1.64 (s, 3H, CH3), 1.88 (d, J = 13.1 Hz, 1H, CH2), 2.36–2.51 (m, 3H, 2 CH, 
CH2), 2.95 (s, 3H, NCH3), 3.17 (dd, J = 15.2, 8.6 Hz, 1H, CH2), 3.22 (s, 3H, OCH3), 3.31 (dd, J = 
15.2, 7.8 Hz, 1H, CH2), 3.75 (d, J = 8.1 Hz, 1H, CHOCH3), 4.77–4.83 (m, 2H, Ala CH, CO2CH), 
4.90 (d, J = 9.1 Hz, 1H, =CH), 5.30 (t, J = 8.3 Hz, 1H, β-Tyr CH), 5.60 (t, J = 8.1 Hz, 1H, Trp CH), 
6.50 (d, J = 7.3 Hz, 1H, Ala NH), 6.82 (s, 1H, Trp HAr), 7.06 (d, J = 8.8 Hz, 1H, β-Tyr NH), 7.10 
(ddd, J = 8.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.17 (ddd, J = 8.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.24 (d, J = 
8.6 Hz, 2H, Ar), 7.32 (d, J = 8.1 Hz, 1H, Trp HAr), 7.59 (d, J = 8.1 Hz, 1H, Trp HAr), 8.06 (d, J = 
8.6 Hz, 2H, Ar), 8.11 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 15.8, 16.6, 17.3, 18.6, 
20.0, 23.6 (CH2), 30.2 (NCH3), 37.0, 40.2, 44.1 (CH2), 45.2 (Ala CH), 54.4 (β-Tyr CH), 56.0 (Trp 
CH), 58.2 (OCH3), 76.8 (CO2CH), 81.9 (CHOCH3), 110.2 (quat. Trp), 111.2, 118.5, 119.6, 122.2, 
122.3, 123.4, 127.1 (quat. Trp), 127.8 (=CH), 127.9, 134.3 (=C<), 136.1 (quat. Trp), 144.5, 147.3, 
169.77, 169.82, 174.1, 174.5; HMRS (ESI): m/z: calcd for C36H45N5O8 [M+Na]
+
: 698.31603; found: 
698.31672. 
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Chondramide 2f (NH2). By catalytic hydrogenation: A solution of chondramide 2e (6.1 mg, 9.03 
µmol) in methanol (0.5 mL) was hydrogenated overnight in a round bottom flask connected to a 
hydrogen filled balloon, using 10% Pd on carbon (TLC control: CH2Cl2/MeOH, 10:1). Upon 
complete conversion, the solvent was evaporated and the residue purified by flash chromatography 
(CH2Cl2/MeOH, 30:1 to 20:1) to afford chondramide 2f (2.7 mg, 47%) as white foam. A mixed 
fraction, containing 2f and another unknown compound as major components was also isolated. 
Complete conversion was observed, but the reaction was not very clean, likely because of formation 
of RNO and/or RNHOH, as suggested by LC/MS examination of the mixed fraction. No evidence 
for competitive hydrogenation of the double bond was found. 
By reduction with sodium dithionite: Alternatively, reduction of chondramide 2e (5.8 mg, 8.58 
µmol) was carried out in solution in THF (0.5 mL), H2O (0.5 mL) in the presence of Na2S2O4 (20 
mg, 0.115 mmol) overnight at room temperature. Conversion was high but not complete. The 
reaction mixture was diluted with saturated NaCl solution and EtOAc with addition of some 
saturated NaHCO3 solution. The water phase was extracted once more with EtOAc. The combined 
organic extracts were dried with Na2SO4, filtered, and evaporated. The desired NH2-chondramide 2f 
(2 mg, 36%) was isolated successfully by flash chromatography (CH2Cl2/MeOH 30:1 to 20:1) as a 
white foam. Rf (CH2Cl2/MeOH 20:1) 0.26. [α]
20
D = +24.9 (c 0.35, CH2Cl2);
 1
H NMR (400 MHz, 
CDCl3): δ = 0.80 (d, J = 6.3 Hz, 3H, CH3), 0.85 (d, J = 6.8 Hz, 3H, CH3), 1.03 (d, J = 6.8 Hz, 3H, 
Ala CH3), 1.15 (d, J = 7.1 Hz, 3H, CH3), 1.63 (s, 3H, CH3), 1.80 (d, J = 13.9 Hz, 1H, CH2), 2.33–
2.40 (m, 2H, 2 CH), 2.53 (d, J = 10.4, 13.6 Hz, 1H, CH2), 2.94 (s, 3H, NCH3), 3.14 (dd, J = 15.5, 
9.2 Hz, 1H, CH2), 3.23 (s, 3H, OCH3), 3.27 (dd, J = 15.5, 6.8 Hz, 1H, CH2), 3.68 (bs, 2H, NH2), 
3.75 (d, J = 7.3 Hz, 1H, CHOCH3), 4.77–4.84 (m, 2H, Ala CH, 7-H), 4.90 (d, J = 8.8 Hz, 1H, 
=CH), 5.25 (dd, J = 7.3, 9.1 Hz, 1H, β-Tyr CH), 5.60 (dd, J = 7.1, 9.1 Hz, 1H, Trp CH), 6.58 (d, J = 
7.3 Hz, 1H, Ala NH), 6.58 (d, J = 8.3 Hz, 2H, Ar), 6.81 (d, J = 2.2 Hz, 1H, Trp HAr), 6.92–6.96 (m, 
3H, β-Tyr NH, Ar), 7.11 (ddd, J = 8.1, 7.8, 1.0 Hz, 1H, Trp HAr), 7.17 (ddd, J = 8.1, 7.8, 1.0 Hz, 
1H, Trp HAr), 7.30 (d, J = 7.8 Hz, 1H, Trp HAr), 7.90 (d, J = 7.8 Hz, 1H, Trp HAr), 7.87 (s, 1H, Trp 
NH); 
13
C NMR (100 MHz, CDCl3): δ = 15.3, 16.6, 17.6, 18.6, 20.5, 23.3 (CH2), 30.1 (NCH3), 37.1, 
40.3, 43.8 (CH2), 45.3 (Ala CH), 53.9 (β-Tyr CH), 55.7 (Trp CH), 58.0 (OCH3), 77.2 (CO2CH), 
82.6 (CHOCH3), 110.7 (quat. Trp), 111.0, 115.0 (2C, Ar), 118.6, 119.4, 122.05, 122.11, 127.2 
(quat. Trp), 127.7 (quat. Ar), 127.9 (2C, Ar), 128.4 (=CH), 134.1 (=C<), 136.1 (quat. Trp), 145.9, 
169.6, 170.6, 174.0, 174.5; HMRS (ESI): m/z: calcd for C36H47N5O6 [M+Na]
+
: 668.34186; found: 
668.34224. 
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Chondramide 2g (CH2OH). To a stirred solution of compound 22g (64.7 mg, which corresponds 
to ~58.9 mg of pure peptide, 0.0621 mmol) in CH2Cl2 (2 mL) was added TFA (0.2 mL, 0.307 g, 
2.69 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature and after 
stirring for 22 h, the solvent was removed in vacuo (TLC control: CH2Cl2/MeOH/NH3, 10:1:0.1). 
For azeotropic removal of TFA the residue was taken up in toluene (3 × 0.5 mL) and concentrated 
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in vacuo each time. NMR examination indicated complete deprotection and installation of 
CH2OC(O)CF3 in place of CH2OTBS (δ = 5.25, s, 2H, ArCH2OC(O)CF3). The crude product was 
dissolved in DMF (25 mL, that corresponds to 0.0025M concentration of the starting amino acid) 
and iPr2NEt (54 µL, 40 mg, 0.310 mmol, 5 equiv), HOBt (16.7 mg, 0.124 mmol, 2 equiv) and 
TBTU (39.9 mg, 0.124 mmol, 2 equiv) were added. The solution was stirred at room temperature 
for 20 h and then diluted with water (20 mL) and EtOAc (20 mL). The aqueous layer was extracted 
with EtOAc (3 × 20 mL) and the combined organic layers were washed with 5% aqueous KHSO4 
solution (20 mL), water (20 mL), diluted K2CO3 solution (20 mL, at this point trifluoroacetic ester 
moiety is hydrolyzed), water (2 × 20 mL) and saturated NaCl solution (20 mL). The combined 
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude product 
was purified by flash chromatography (CH2Cl2/MeOH, 20:1) to give depsipeptide 2g (8.1 mg, 20%) 
as a colorless foam.  
 
Note. ArCH2OTFA is hydrolyzed in a few minutes in weakly alkaline media during washings (as 
was the case in synthesis of 2h). But in this case the less polar product (on TLC), which was 
initially assumed to be ArCH2OTFA ester, in fact was stable to hydrolysis and was eventually 
proved to be the ArCH2OBt ether!). Obviously, the benzylic trifluoroacetate has led to extensive 
formation of the nucleophilic substitution product due to enhanced susceptibility to nucleophilic 
attack.  
 
2g: Rf (CH2Cl2/MeOH 20:1) 0.14; [α]
20
D = +23.4 (c 0.80, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ 
= 0.77 (d, J = 6.3 Hz, 3H, CH3), 0.86 (d, J = 6.8 Hz, 3H, CH3), 1.08 (d, J = 6.8 Hz, 3H, Ala CH3), 
1.16 (d, J = 6.6 Hz, 3H, CH3), 1.65 (s, 3H, CH3), 1.87 (d, J = 13.1 Hz, 1H, CH2), 2.27 (bs, 1H, OH), 
2.35–2.42 (m, 2H, 2 CH), 2.48 (dd, J = 13.1, 11.1 Hz, 1H, CH2), 2.98 (s, 3H, NCH3), 3.00 (dd, J = 
15.2, 7.8 Hz, 1H, CH2), 3.21 (s, 3H, OCH3), 3.27 (dd, J = 15.2, 8.1 Hz, 1H, CH2), 3.78 (d, J = 8.1 
Hz, 1H, CHOCH3), 4.68 (s, 2H, ArCH2), 4.72–4.78 (m, 1H, 7-H), 4.79–4.86 (m, 1H, Ala CH), 4.89 
(d, J = 9.1 Hz, 1H, =CH), 5.26 (dd, J = 8.1, 8.8 Hz, 1H, β-Tyr CH), 5.49 (dd, J = 7.8, 8.1 Hz, 1H, 
Trp CH), 6.54 (d, J = 7.8 Hz, 1H, Ala NH), 6.56 (d, J = 2.3 Hz, 1H, Trp HAr), 6.82 (d, J = 9.4 Hz, 
1H, β-Tyr NH), 7.07–7.11 (m, 3H, Trp HAr, Ar), 7.16 (ddd, J = 8.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.24 
(d, J = 8.1 Hz, 2H, Ar), 7.29 (d, J = 8.1 Hz, 1H, Trp HAr), 7.58 (d, J = 7.8 Hz, 1H, Trp HAr), 8.13 (s, 
1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 15.9, 16.4, 17.7, 18.8, 20.0, 23.9 (CH2), 30.2 
(NCH3), 37.2, 40.2, 44.2 (CH2), 45.2 (Ala CH), 54.5 (β-Tyr CH), 55.9 (Trp CH), 58.1 (OCH3), 65.1 
(CH2O), 76.5 (CO2CH), 82.1 (CHOCH3), 109.8 (quat. Trp), 111.2, 118.4, 119.3, 121.9, 122.5, 
127.0 (quat. Trp), 127.2 (2C, Ar), 127.5 (2C, Ar), 128.2 (=CH), 133.1 (=C<), 136.1, 137.8, 140.0, 
169.4, 170.5, 173.9, 174.4; HMRS (ESI): m/z: calcd for C37H48N4O7 [M+Na]
+
: 683.34152; found: 
683.34136. 
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Chondramide 2h (CH2CH2OH). To a stirred solution of depsipeptide 22h (18.2 mg, 0.0189 
mmol) in CH2Cl2 (0.6 mL) was added TFA (0.06 mL, 0.092 g, 0.808 mmol) at 0 °C. The reaction 
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mixture was allowed to warm to room temperature and after stirring for 22 h, the solvent was 
removed in vacuo (TLC control: CH2Cl2/MeOH/NH3, 10:1:0.1). For azeotropic removal of TFA the 
residue was taken up in toluene (3 × 0.5 mL) and concentrated in vacuo. NMR examination 
indicated complete deprotection and installation of CH2CH2OC(O)CF3 in place of CH2CH2OTBS. 
The crude product was dissolved in DMF (7.50 mL, that corresponds to 0.0025M concentration of 
the starting amino acid) and iPr2NEt (16 µL, 11.8 mg, 0.092 mmol, 5 equiv), HOBt (5.1 mg, 0.038 
mmol, 2 equiv) and TBTU (12.1 mg, 0.038 mmol, 2 equiv) were added. The solution was stirred at 
room temperature for 20 h and then diluted with water (10 mL) and EtOAc (10 mL). The aqueous 
layer was extracted with EtOAc (3 × 10 mL) and the combined organic layers were washed with 
5% aqueous KHSO4 solution (10 mL), water (10 mL), diluted K2CO3 solution (10 mL, at this point 
complete hydrolysis of trifluoroacetic ester moiety should be secured), water (2 × 10 mL) and 
saturated NaCl solution (10 mL). The combined organic extracts were dried over Na2SO4, filtered, 
and concentrated in vacuo. In case of incomplete hydrolysis, the residue was dissolved in MeOH, 
catalytic amount of K2CO3 was added and the silution stirred for 5 minutes until disappearance of 
the trifluoroacetate residue (Rf (EtOAc) 0.4, 
1
H NMR (CDCl3): δ = 4.50 (t, CH2OC(O)CF3)). But 
normally, the trifluoroacetate is hydrolized within a few minutes in weakly alkaline media during 
washings, which was also observed by TLC. The crude product was purified by flash 
chromatography (EtOAc) to give depsipeptide 2h (7.7 mg, 60%) as a colorless foam. Rf 
(CH2Cl2/MeOH 20:1) 0.14; Rf (EtOAc) 0.3; [α]
20
D = +6.3 (c 0.80, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3): δ = 0.77 (d, J = 6.3 Hz, 3H, CH3), 0.86 (d, J = 6.8 Hz, 3H, CH3), 1.14 (d, J = 6.8 Hz, 3H, 
Ala CH3), 1.16 (d, J = 6.6 Hz, 3H, CH3), 1.66 (s, 3H, CH3), 1.81 (bt, J = 4.3 Hz, 1H, OH), 1.91 (d, J 
= 11.4 Hz, 1H, CH2), 2.35–2.47 (m, 3H, 2 CH, CH2), 2.87 (t, J = 6.1 Hz, 2H, ArCH2), 2.92 (dd, J = 
14.5, 6.6 Hz, 1H, CH2), 3.02 (s, 3H, NCH3), 3.18 (s, 3H, OCH3), 3.28 (dd, J = 14.5, 8.9 Hz, 1H, 
CH2), 3.75 (d, J = 8.7 Hz, 1H, CHOCH3), 3.94–4.02 (m, 2H, CH2OH), 4.68–4.74 (m, 1H, 7-H), 
4.80–4.86 (m, 1H, Ala CH), 4.88 (d, J = 9.4 Hz, 1H, =CH), 5.22 (dd, J = 8.9, 8.9 Hz, 1H, β-Tyr 
CH), 5.41 (dd, J = 6.9, 9.2 Hz, 1H, Trp CH), 6.46–6.49 (m, 2H, Ala NH, Trp HAr), 6.52 (d, J = 7.9 
Hz, 1H, β-Tyr NH), 7.02 (d, J = 7.9 Hz, 2H, Ar), 7.08–7.17 (m, 4H, Trp HAr, Ar), 7.27 (d, 1H, Trp 
HAr), 7.59 (d, J = 7.6 Hz, 1H, Trp HAr), 8.43 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 
16.27, 16.30, 17.8, 18.9, 19.7, 24.4 (CH2), 30.3 (NCH3), 37.4, 38.6 (ArCH2), 40.1, 44.4 (CH2), 45.1 
(Ala CH), 54.5 (β-Tyr CH), 56.1 (Trp CH), 58.0 (OCH3), 63.5 (CH2OH), 76.7 (CO2CH), 82.1 
(CHOCH3), 109.3 (quat. Trp), 111.2, 118.3, 119.1, 121.7, 122.8, 126.9 (quat. Trp), 127.2 (2C, Ar), 
128.2 (=CH), 129.1 (2C, Ar), 133.7 (=C<), 136.1 (quat. Trp), 136.6, 138.2, 169.2, 170.6, 173.7, 
174.2; HMRS (ESI): m/z: calcd for C38H50N4O7 [M+Na]
+
: 697.35717; found: 697.35723. 
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Chondramide 2i (CN). To a stirred solution of depsipeptide 22i (24.5 mg, 0.0295 mmol) in CH2Cl2 
(0.9 mL) was added TFA (0.09 mL, 0.138 g, 1.21 mmol) at 0 °C. The reaction mixture was allowed 
to warm to room temperature and after stirring for 22 h, the solvent was removed in vacuo (TLC 
control: CH2Cl2/MeOH/NH3, 10:1:0.1). For azeotropic removal of TFA the residue was taken up in 
toluene (3 × 0.5 mL) and concentrated in vacuo each time. The crude product was dissolved in 
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DMF (11.8 mL, that corresponds to 0.0025M concentration of the starting amino acid) and iPr2NEt 
(26 µL, 19.3 mg, 0.149 mmol, 5 equiv), HOBt (8.0 mg, 0.059 mmol, 2 equiv) and TBTU (18.9 mg, 
0.059 mmol, 2 equiv) were added. The solution was stirred at room temperature for 20 h and then 
diluted with water (20 mL) and EtOAc (20 mL). The aqueous layer was extracted with EtOAc (3 × 
20 mL) and the combined organic layers were washed with 5% aqueous KHSO4 solution (20 mL), 
water (20 mL), saturated NaHCO3 solution (20 mL), water (2 × 20 mL) and saturated NaCl solution 
(20 mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography (petroleum ether/EtOAc, 1:3 to 0:1 
or petroleum ether/acetone, 3:2) to give depsipeptide 2i (8.7 mg, 45%) as a colorless foam. In order 
to obtain pure 2i, the chromatography was done twice. Rf (EtOAc) 0.4; [α]
20
D = +20.1 (c 0.8, 
CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.81 (d, J = 6.4 Hz, 3H, CH3), 0.85 (d, J = 6.9 Hz, 3H, 
CH3), 1.05 (d, J = 6.9 Hz, 3H, CH3), 1.17 (d, J = 6.6 Hz, 3H, CH3), 1.63 (s, 3H, CH3), 1.85 (d, J = 
13.5 Hz, 1H, CH2), 2.35–2.44 (m, 2H, 2 CH), 2.50 (dd, J = 10.5, 13.5 Hz, 1H, CH2), 2.94 (s, 3H, 
NCH3), 3.10 (dd, J = 15.2, 8.6 Hz, 1H, CH2), 3.23 (s, 3H, OCH3), 3.30 (dd, J = 15.2, 7.4 Hz, 1H, 
CH2), 3.75 (d, J = 7.6 Hz, 1H, CHOCH3), 4.76–4.83 (m, 2H, Ala CH, 7-H), 4.89 (d, J = 8.9 Hz, 1H, 
=CH), 5.30 (dd, J = 8.1, 8.3 Hz, 1H, β-Tyr CH), 5.62 (t, J = 7.4, 8.6 Hz, 1H, Trp CH), 6.49 (d, J = 
7.1 Hz, 1H, Ala NH), 6.85 (d, J = 2.3 Hz, 1H, Trp HAr), 7.08–7.13 (m, 2H, β-Tyr NH, Trp HAr), 
7.19 (ddd, J = 8.1, 7.1, 0.8 Hz, 1H, Trp HAr), 7.24 (d, J = 8.6 Hz, 2H, Ar), 7.33 (d, J = 8.1 Hz, 1H, 
Trp HAr), 7.53 (d, J = 8.4 Hz, 2H, Ar), 7.60 (d, J = 7.9 Hz, 1H, Trp HAr), 7.98 (s, 1H, Trp NH); 
13
C 
NMR (100 MHz, CDCl3): δ = 15.5, 16.7, 17.3, 18.6, 20.2, 23.4 (CH2), 30.2 (NCH3), 37.0, 40.2, 
44.0 (CH2), 45.2 (Ala CH), 54.4 (β-Tyr CH), 55.9 (Trp CH), 58.2 (OCH3), 76.5 (CO2CH), 81.9 
(CHOCH3), 110.4 (quat. Trp), 111.2, 111.5, 118.55, 118.60, 119.6, 122.16, 122.20, 127.1 (quat. 
Trp), 127.8 (=CH), 127.8, 132.1, 134.4 (=C<), 136.1 (quat. Trp), 143.4, 169.82, 169.92, 174.2, 
174.5; HMRS (ESI): m/z: calcd for C37H45N5O6 [M+Na]
+
: 678.32621; found: 678.32685. 
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Chondramide 2j (CONH2). To a solution of chondramide 2i (4.5 mg, 6.87 µmol) in DMSO (0.1 
mL) were added at 10 °C K2CO3 (10 mg, 0.072 mmol) and 30% aqueous H2O2 (0.01 mL). The 
reaction mixture was stirred for 5–10 min when TLC (EtOAc) showed complete conversion. The 
reaction mixture was diluted with water (0.5 mL) and extracted twice with EtOAc. The combined 
organic extracts were washed with water, saturated NaCl solution, dried with Na2SO4, filtered, and 
concentrated in vacuo. The residue purified by flash chromatography (CH2Cl2/MeOH, 15:1 to 10:1) 
to afford chondramide 2j (3 mg, 67%) as white foam (contaminated with 1.9 % w/w DMSO). [α]
20
D 
= +26.7 (c 0.30, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.79 (d, J = 6.3 Hz, 3H, CH3), 0.85 (d, J 
= 6.8 Hz, 3H, CH3), 1.09 (d, J = 6.8 Hz, 3H, Ala CH3), 1.17 (d, J = 6.8 Hz, 3H, CH3), 1.64 (s, 3H, 
CH3), 1.87 (d, J = 13.4 Hz, 1H, CH2), 2.35–2.42 (m, 2H, 2 CH), 2.48 (dd, J = 10.9, 13.4 Hz, 1H, 
CH2), 2.98 (s, 3H, NCH3), 3.03 (dd, J = 14.9, 8.1 Hz, 1H, CH2), 3.21 (s, 3H, OCH3), 3.30 (dd, J = 
14.9, 8.1 Hz, 1H, CH2), 3.77 (d, J = 8.1 Hz, 1H, CHOCH3), 4.74–4.86 (m, 2H, Ala CH, 7-H), 4.89 
(d, J = 9.1 Hz, 1H, =CH), 5.26 (dd, J = 8.3, 8.6 Hz, 1H, β-Tyr CH), 5.57 (t, J = 8.1, 8.1 Hz, 1H, Trp 
CH), 5.68 (bs, 1H, CONH2), 6.14 (bs, 1H, CONH2), 6.54 (d, J = 7.6 Hz, 1H, Ala NH), 6.70 (d, J = 
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2.3 Hz, 1H, Trp HAr), 6.98 (d, J = 8.8 Hz, 1H, β-Tyr NH), 7.09–7.19 (m, 4H, Trp HAr, Ar), 7.33 (d, 
J = 7.8 Hz, 1H, Trp HAr), 7.60–7.64 (d+d, 3H, Trp HAr, Ar), 8.14 (s, 1H, Trp NH); 
13
C NMR (100 
MHz, CDCl3): δ = 15.8, 16.6, 17.6, 18.8, 20.1, 23.8 (CH2), 30.2 (NCH3), 37.1, 40.2, 44.1 (CH2), 
45.2 (Ala CH), 54.5 (β-Tyr CH), 56.0 (Trp CH), 58.2 (OCH3), 77.2 (CO2CH), 82.0 (CHOCH3), 
110.2, 111.3, 118.5, 119.4, 122.1, 122.3, 127.1, 127.2, 127.4, 128.1, 132.6, 134.1 (=C<), 136.1, 
142.3, 169.1, 169.6, 170.2, 174.0, 174.4; HMRS (ESI): m/z: calcd for C37H47N5O7 [M+Na]
+
: 
696.33677; found: 696.337415. 
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Chondramide 2k (Ph). To a stirred solution of compound 22k (62.4 mg, 0.0708 mmol) in CH2Cl2 
(2.1 mL) was added TFA (0.21 mL, 0.322 g, 2.82 mmol) at 0 °C. The reaction mixture was allowed 
to warm to room temperature and after stirring for 21 h, the solvent was removed in vacuo [TLC 
control: CH2Cl2/MeOH/NH3, 10:1:0.1, Rf (amino ester intermediate) 0.47, (amino acid) 0.2]. For 
azeotropic removal of TFA the residue was taken up in toluene (3 × 0.5 mL) and concentrated in 
vacuo each time. The crude product was dissolved in DMF (35 mL, that corresponds to 0.002M 
concentration of the starting amino acid) and iPr2NEt (62 µL, 46.0 mg, 0.356 mmol, 5 equiv), HOBt 
(14.3 mg, 0.106 mmol, 2 equiv) and TBTU (34.1 mg, 0.106 mmol, 2 equiv) were added. The 
solution was stirred at room temperature for 20 h and then diluted with water (20 mL) and EtOAc 
(20 mL). The aqueous layer was extracted with EtOAc (3 × 20 mL) and the combined organic 
layers were washed with 5% aqueous KHSO4 solution (20 mL), water (20 mL), saturated NaHCO3 
solution (20 mL), water (2 × 20 mL) and saturated NaCl solution (20 mL). The combined organic 
extracts were dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography (EtOAc) to give depsipeptide 2k (27.3 mg, 54%) as a colorless 
foam. Rf (EtOAc) 0.4; [α]
20
D = +20.3 (c 2.00, CH2Cl2); 
1
H NMR (400 MHz, CDCl3): δ = 0.74 (d, J 
= 6.6 Hz, 3H, CH3), 0.84 (d, J = 6.1 Hz, 3H, CH3), 1.03 (d, J = 6.8 Hz, 3H, CH3), 1.16 (d, J = 6.8 
Hz, 3H, CH3), 1.63 (s, 3H, CH3), 1.81 (d, J = 13.9 Hz, 1H, CH2), 2.33–2.40 (m, 3H, 2 CH), 2.55 
(dd, J = 13.9, 10.1 Hz, 1H, CH2), 2.95 (s, 3H, NCH3), 3.16 (dd, J = 15.7, 9.2 Hz, 1H, CH2), 3.27 (s, 
3H, OCH3), 3.30 (dd, J = 15.2, 7.0 Hz, 1H, CH2), 3.86 (d, J = 7.1 Hz, 1H, CHOMe), 4.78–4.86 (m, 
2H, Ala CH, 7-H), 4.91 (d, J = 8.8 Hz, 1H, =CH), 5.41 (dd, J = 9.1, 7.1, Hz, 1H, β-Tyr CH), 5.68 
(dd, J = 9.2, 7.0 Hz, 1H, Trp CH), 6.60 (d, J = 7.3 Hz, 1H, Ala NH), 6.84 (d, J = 2.0 Hz, 1H, Trp 
HAr), 7.09–7.18 (m, 3H, β-Tyr NH, Trp HAr), 7.23–7.36 (m (d+d+t), 4H, Ar, Trp HAr), 7.43 (dd, J = 
7.1, 7.8 Hz, 2H, Ar), 7.50 (d, J = 8.3 Hz, 2H, Ar), 7.55 (d, J = 7.1 Hz, 2H, Ar), 7.62 (d, 1H, J = 7.6 
Hz, Trp HAr), 8.05 (s, 1H, Trp NH); 
13
C NMR (100 MHz, CDCl3): δ = 15.1, 16.6, 17.5, 18.6, 20.5, 
23.2 (CH2), 30.1 (NCH3), 37.0, 40.3, 43.8 (CH2), 45.3 (Ala CH), 54.2 (β-Tyr CH), 55.7 (Trp CH), 
58.0 (OCH3), 75.9 (CO2CH), 82.4 (CHOCH3), 110.5 (quat. Trp), 111.1, 118.6, 119.4, 122.0, 122.1, 
127.0, 127.1 (quat. Trp), 127.2, 127.3, 127.4 (=CH), 128.4, 128.8, 134.2 (=C<), 136.1 (quat. Trp), 
136.6, 140.55, 140.58, 169.9, 170.3, 174.1, 174.6; HMRS (ESI): m/z: calcd for C42H50N4O6 
[M+Na]
+
: 729.36226; found: 729.36180. 
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LC-MS-traces of some of the chondramide A analogues 
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Chon CH2OH 2g  
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Chon CN 2i  
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Chon CONH2 2j (mixture of the hydrolysis reaction, the Chon CN peak is at ~8.94 min) 
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Proof of structure of benzotriazolyl ether 
N
O
N O
H
H
N
O
Me
O
O
N
H
OMe
N
O
N O
H
t-BuO2C
NHBoc
Me
O
O
N
H
OMe
OTBS
O
N
O
N O
H
HO2C
NH3
Me
O
O
N
H
OMe
O
O
CF3 N
N N
N
O
N O
H
H
N
O
Me
O
O
N
H
OMe
OH
2. HOBt, TBTU,
    DIPEA,
    DMF, r.t.
1. CH2Cl2/TFA 10:1
    r.t.
CF3CO2
−
+
K2CO3,
MeOH, H2O
N
O
N O
H
H
N
O
Me
HO
CO2H
N
H
OMe
O
N
N N
 
Alkaline hydrolysis (K2CO3, MeOH, H2O, rt, overnight) of the less polar product, which was 
initially assumed to be the CH2OTFA ester (because of the high shift benzylic methylene proton, δ 
= 5.49, s, overlapped, 2H, ArCH2OBt), did not lead to the desired chondramide, and the polar 
compound, that obviously must be some open-chained chondramide derivative (acid), was isolated 
by column chromatography (CH2Cl2/MeOH/AcOH 10:1:0.05; Rf in 10:1:0.1 is 0.38). NMR 
examination revealed that the high shift benzylic methylene proton (δ = 5.48, s, 2H, ArCH2OBt) is 
still present. It became clear that during macrolactamization, the trifluororacetate changed to a 
functionality stable to hydrolysis. This could be only benzotriazolyl ether, resulting from 
nucleophilic attack of HOBt present in excess in the reaction mixture. Unambigouosly, this was 
proved by HRMS analysis of the acid. HMRS (ESI): m/z: calcd for C43H53N7O8 [M+Na]
+
: 
818.38479; found: 818.38525. 
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1H and 13C NMR spectra of the products 
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13C NMR (100 MHz) spectrum of enoate 9g in CDCl3
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1H NMR (400 MHz) spectrum of enoate 9h in CDCl3
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13C NMR (100 MHz) spectrum of enoate 9h in CDCl3
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H NMR (400 MHz) spectrum of depsipeptide 22b in CDCl3
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H NMR (400 MHz) spectrum of depsipeptide 22c in CDCl3
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C NMR (100 MHz) spectrum of depsipeptide 22g in CDCl3
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H NMR (400 MHz) spectrum of depsipeptide 22h in CDCl3
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H NMR (400 MHz) spectrum of depsipeptide 22i in CDCl3
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13C NMR (100 MHz) spectrum of depsipeptide 22i in CDCl3
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H NMR (400 MHz) spectrum of depsipeptide 22k in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2b in CDCl3
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C NMR (100 MHz) spectrum of chondramide 2b in CD3OD
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H NMR (400 MHz) spectrum of chondramide 2c in CDCl3
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C NMR (100 MHz) spectrum of chondramide 2c in CD3OD
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H NMR (400 MHz) spectrum of chondramide 2d in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2e in CDCl3
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C NMR (100 MHz) spectrum of chondramide 2e in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2f in CDCl3
 
N
O
N O
NH2
H
H
N
O
Me
O
O
N
H
OMe
2f
 177
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
ppm
1
5
.
3
1
6
.
6
1
7
.
6
1
8
.
6
2
0
.
5
2
3
.
3
3
0
.
1
3
7
.
1
4
0
.
3
4
3
.
8
4
5
.
3
5
3
.
9
5
5
.
7
5
8
.
0
7
5
.
9
7
7
.
0
8
2
.
6
1
1
0
.
7
1
1
1
.
0
1
1
5
.
0
1
1
8
.
6
1
1
9
.
4
1
2
2
.
1
1
2
2
.
1
1
2
7
.
2
1
2
7
.
7
1
2
7
.
9
1
2
8
.
4
1
3
4
.
1
1
3
6
.
1
1
4
5
.
9
1
6
9
.
6
1
7
0
.
6
1
7
4
.
0
1
7
4
.
5
13
C NMR (100 MHz) spectrum of chondramide 2f in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2g in CDCl3
 
N
O
N O
H
H
N
O
Me
O
O
N
H
OMe
2g
OH
 179
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
ppm
1
5
.
9
1
6
.
4
1
7
.
7
1
8
.
8
2
0
.
0
2
3
.
8
3
0
.
2
3
7
.
2
4
0
.
2
4
4
.
2
4
5
.
1
5
4
.
5
5
5
.
9
5
8
.
1
6
5
.
1
7
6
.
5
7
7
.
0
8
2
.
1
1
0
9
.
81
1
1
.
2
1
1
8
.
4
1
1
9
.
3
1
2
1
.
9
1
2
2
.
5
1
2
7
.
0
1
2
7
.
2
1
2
7
.
5
1
2
8
.
2
1
3
3
.
9
1
3
6
.
0
1
3
7
.
8
1
4
0
.
0
1
6
9
.
4
1
7
0
.
5
1
7
3
.
9
1
7
4
.
4
13
C NMR (100 MHz) spectrum of chondramide 2g in CDCl3
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1H NMR (400 MHz) spectrum of chondramide 2h in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2i in CDCl3
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H NMR (400 MHz) spectrum of chondramide 2j in CDCl3 + 14% DMSO-d6
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H NMR (400 MHz) spectrum of chondramide 2k in CDCl3
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